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CHAPTER I 
INTRODUCTION 
Central nervous system (CNS) serotonin (5-hydroxytryptamine; 
5-HT) neurons appear to be involved in a number of important physiolog-
ical and psychological processes, including the regulation of sleep-
wakefulness cycles, emotional states, and sexual and consummatory 
behaviors. Dysfunctions in CNS 5-HT neurotransmission are thought to 
contribute to the development of eating, anxiety and depressive dis-
orders. 
CNS 5-HT perikarya are organized in distinct clusters which are 
found only in the mesial brain stem, in association with the raphe nu-
clei (Taber et al. , 1960). Designated Bl - B9 (Dahlstrom and Fuxe, 
1964), these 5-HT containing cell groups are the source of the in-
doleamine innervation of the entire neuraxis. The Bl - B3 cell groups 
provide the primary 5-HT innervation to the spinal cord, while the B7-
B9 and, to a lesser extent, the B4-B6 cell groups are the principal 
origin of the 5-HT innervation of the di- and telencephalon (fore-
brain). Anatomically, the B7 and· B8 groups are associated with the 
dorsal and median midbrain raphe nuclei (DR and MR, respectively). 
Only about 30% and 70% of the neurons in the MR and DR, respectively, 
contain 5-HT (Crunelli and Segal, 1985). 
It is important to note that the CNS contains low 5-HT concen-
trations (in the ng/g range), and that well over 90% of the 5-HT in the 
1 
2 
body is found peripherally in the enteric nervous system and blood 
platelets. 
Early attempts to elucidate the function of central 5-HT systems 
employed pharmacological and lesion techniques to deplete or reduce CNS 
5-HT content. Unfortunately, these methods produce dissimilar effects 
on central and peripheral 5-HT levels. For instance, parenteral treat-
ment with parachlorophenylalanine (PCPA), a tryptophan hydroxylase in-
hibitor, produces short-term depletion of both peripheral and central 
5-HT stores. Systemic administration of parachloroamphetamine (PCA), 
on the other hand, results in the acute release of 5-HT and norepin-
ephrine (NE) from nerve terminals, and long-term neurotoxic effects on 
5-HT processes in the brain, but not in the spinal cord or periphery. 
The behavioral effects of these drugs also differ. For example, in 
contrast to PCA, PCPA enhances an animal's response to noxious stimuli 
[see Lorens (1978) for a review]. 
Electrolytic destruction of the DR and/or MR has been used to 
study the functional role of the 5-HT projections to the forebrain. 
These lesions produce significant reductions in forebrain 5-HT levels 
and major behavioral changes, including increases in locomotor activity 
(LMA) and abnormalities in conditioned avoidance learning (Jacobs et 
al. , 1974; Srebro and Lorens, 1975; Geyer et al. , 1976). However, 
subsequent lesion studies employing the selective 5-HT neurotoxin, 5,7-
dihydroxytryptamine (5,7-DHT; Baumgarten et al., 1972, 1973), failed to 
reproduce the behavioral effects obtained following electrolytic raphe 
lesions (Geyer et al., 1976; Hole et al., 1976; Lorens et al., 1976; 
3 
Lorens, 1978). Thus, the depletion approach has not been successful in 
ascertaining the role of 5-HT in behavior. 
The discovery of multiple 5-HT recognition sites (5-HT1 2 3 and 
' ' 
subtypes) has led to the development of a number of novel pharmacolog-
ical tools for studying 5-HT function (Peroutka and Snyder, 1979; 
Goodwin and Green, 1985; Tricklebank, 1985; Peroutka, 1988). However, 
parenteral administration of 5-HT agonists and antagonists will affect 
peripheral as well as central 5-HT receptors. Thus, intracerebral drug 
administration appears to provide the best available means to study 
central 5-HT processes. 
Electrophysiologic investigations suggest that raphe 5-HT neurons 
are modulated by local -y-aminobutyric acid (GABA) neurons (Gallagher 
and Aghajanian, 1976; Mugnaini and Oertel, 1984). Przewlocka et al. 
(1979) were the first to report that intra-DR injections of the GABAA 
agonist, muscimol, increase LMA and induce feeding. Subsequently, 
Sainati and Lorens (1982) found that muscimol infusions into the DR and 
MR dose-dependently increase LMA, and that the MR was approximately 
four times more sensitive than the DR to the hyperkinetic effects of 
muscimol. The effects of muscimol also were shown to be potentiated by 
benzodiazepine pretreatment (Sainati and Lorens, 1983). 
Little work has been done to study the regulation of raphe cells 
by extrinsic neurons, such as those which release substance P (SP). 
The midbrain raphe has been shown to contain SP-like immunoreactive 
fibers, but not SP-like perikarya (Ljungdahl et al., 1979; Neckers et 
al., 1979). Paris and Lorens (1987 a,b) demonstrated that infusions 
into the MR of the metabolically stable SP analog, DiMe-C7 (Sandberg et 
4 
al., 1981), produce dose-dependent increases in LMA which can be 
blocked by prior treatment with PCPA and by intra-MR 5, 7-DHT inj ec-
tions. These observations suggest that the LMA effects of intra-raphe 
DiMe-C7 administration depends on the integrity of 5-HT neurons. In 
contrast, the effects of intra-MR muscimol on LMA are not mediated by 
5-HT neurons (Paris and Lorens, 1987 a,b; Wirtshafter et al., 1987). 
Infusions of DiMe-C7 into the ventral tegmental area (VTA), just 
rostral to the MR, have been reported to produce locomotor hyperactiv-
ity (Eison et al., 1982 a,b). These observations suggest that the 
behavioral effects observed following intra-MR infusions of DiMe-C7 
might be due to diffusion of the peptide to the adjacent VTA. However, 
it has been demonstrated that lesions of the MR produced by the excit-
atory amino acid neurotoxin, ibotenic acid, which destroys cell bodies 
but spares fibers of passage (Coyle and Schwarcz, 1983), completely 
prevent the effects of intra-MR DiMe-C7 and muscimol on LMA (Paris and 
Lorens, 1987 a). In addition, pretreatment with the dopamine (DA) 
antagonist, haloperidol (200 µg/ml, i.p.), has been shown to block the 
hyperactivity produced by intra-MR infusions of DiMe-C7. In contrast, 
haloperidol does not affect the LMA effects of intra-raphe muscimol 
(Wirtshafter et al., 1987; our unpublished data). 
These observations suggest that two distinct pathways involving 
the MR modulate behavioral arousal: one is a GABA---non-5-HT---non-DA 
circuit, and the second is a neurokinin---5-HT---DA circuit. This view 
is supported by observations that, in contrast to DiMe-C7, muscimol in-
fusions into the MR produce dose-dependent increases in food intake and 
5 
in plasma adrenocorticotrophic hormone (ACTH) and corticosterone levels 
(Klitenick and Wirtshafter, 1986; Lee, J. et al., 1987). 
SP belongs to a family of bioactive peptides called tachykinins. 
The tachykinins share the common C-terminal amino acid sequence, Phe-X-
Gly-Leu-Ket-NH2 (Erspamer, 1981; Harmar, 1984). Three of these pep-
tides and their messenger RNA (mRNA) precursors have been localized in 
the periphery and CNS of mammals: SP, neurokinin A (NKA), and neuro-
kinin B (NKB). Non-mammalian tachykinins include eledoisin, physal-
aemin, and kassinin. 
The neurokinins possess three distinct binding sites in the CNS 
and periphery (Quirion, 1985). These recognition sites have been 
designated NK-1, NK-2, and NK-3, and correspond to the preferred bind-
ing sites for SP, NKA, and NKB, respectively (Lee, C.M. et al., 1986; 
Henry, 1987). 
Several investigators have studied the distribution of neurokinin 
recognition sites in the CNS. Moderate numbers of NK-1 and NK-3 sites 
(measured as [1251]-Bolton-Hunter SP and eledoisin binding) have been 
observed in the MR and DR (Beauj ouan et al., 1986; Saffroy et al., 
1988). NKA-binding also has been detected in the midbrain raphe, as 
well as in other brain areas (Quirion and Dam, 1985; Buck et al., 
1986). The existence of NK-2 recognition sites in the CNS, however, 
has been debated (Saffroy et al., 1988). Nevertheless, SP-like immuno-
reactive (SPLI) fibers, as well as NKA-immunoreactivity (Cuello and 
Kanaza~a, 1978; Ljungdahl et al., 1978 a; Takano et al., 1987), have 
been discerned in the midbrain raphe. 
6 
Our preliminary studies indicated that much higher doses of SP 
than DiMe-C7 had to be injected into the MR in order to elicit hyperac-
tivity. DiMe-C7, furthermore, has been recently shown to have a·great-
er affinity for the NK-3 than for the NK-1 binding site (Regoli et al., 
1987; Weinrich et al., 1987). Thus, the first major goal of the dis-
sertation project was to determine which neurokinin(s) and receptor(s) 
mediate(s) the I.MA effects observed following intra-MR infusion. To 
achieve this aim, we compared the behavioral effects of the distinct 
tachykinins and their analogues following their injection into the MR. 
Optimally, in order to reach any conclusions concerning receptor 
selectivity, one should use a specific competitive antagonist to block 
the action of a particular group of agonists. For the tachykinins, 
however, this pharmacological approach has several limitations. Al-
though a number of neurokinin antagonists have been developed (Folkers 
et al., 1981; Regoli et al., 1984 b), they have been shown to be neuro-
toxic, to have local anesthetic properties, and to have non-specific 
actions following their central administration in the rat (Hokfelt et 
al., 1981; Freedman et al., 1986; Yusof and Coote, 1987). Tachykinin 
antagonists have been used in behavioral studies (Elliott and Iversen, 
1987). However, these authors found that the neurokinin antagonists 
produced extensive histological damage following their central admin-
istration into the rat (Dr. Peter J. Elliott, personal communication, 
1986). On the basis of these data, neurokinin antagonists were not 
employed. 
Two series of experiments were performed. The first series 
consisted of ten experiments which analyzed the behavioral effects of 
7 
tachykinin administration into the MR. The second series of experi-
ments studied the anatomical origin of the neurokinin innervation of 
the MR. 
The first behavioral experiments examined the dose-dependent 
effects of DiMe-C7 on I.MA. The effects of the non-mammalian and mam-
malian tachykinins, as well as the selective NKB selective agonist, 
senktide (Laufer et al., 1986 b; Wormser et al., 1986), then were com-
pared to the effects of vehicle and DiMe-C7. Subsequently, lower doses 
of NKA, senktide and NKB were studied. 
The objective of the next experiment was to determine whether the 
hyperkinetic effects of the neurokinins are mediated by raphe 5-HT 
neurons and their projections to the forebrain. This was examined by 
producing 5,7-DHT lesions in the MR and in the 5-HT fibers which ascend 
in the medial forebrain bundle. 
To further characterize the behavioral effects of intra-MR neuro-
kinin infusions, rats were observed in an open field arena. In the 
first experiment, we injected the neurokinins into the MR, then placed 
the animals in a novel environment. In the second experiment, we ex-
amined the effects of the neurokinins on the animals' behavior in a 
familiar environment. The purpose of these studies was 1) to analyze 
the types of behaviors elicited by intra-MR neurokinin injections, and 
2) to determine whether the behavioral patterns evoked varied as a 
function of the novelty of the test environment. 
Although SP-like and other neurokinin-like afferents to the MR 
have been postulated to originate in the lateral habenular nucleus 
(Neckers et al., 1979), this region does not contain neurokinin-like 
8 
cell bodies (Ljungdahl et al., 1978 a). Thus, the second major goal of 
the dissertation project was to determine the origin of the neurokinin 
innervation of the MR. This was investigated by injecting the.retro-
gradely transported fluorescent dye, Fluoro-Gold, into the MR and 
mapping the labeled cells. This was necessary because the afferents to 
the MR have not been thoroughly documented. Next, using irnmunocyto-
chemical techniques, SP- and neurokinin-like fibers were localized in 
the raphe. Finally, by combining irnmunocytochemistry and retrograde 
tracing, an attempt was made to localize the neurokinin-containing 
perikarya which send axons to the MR. 
Thus, the overall goals of the dissertation project were to study 
the regulation of median raphe 5-HT neurons by a particular group of 
peptides, the neurokinins, and to determine the origin of the neuro-
kinin projections to the MR. 
CHAPTER II 
REVIEW OF THE RELEVANT LITERATURE 
A. Midbrain Raphe Nuclei 
The groups of neurons which occupy the midsagittal plane of the 
brain stem are referred to as the raphe nuclei. Although recognized 
since the earliest studies of neuroanatomy, the seminal reports con-
cerning the nomenclature, topography, afferent and efferent connections 
were first published in 1960 (Brodal et al. , 1960 a, b; Taber et al. , 
1960). Interest in the raphe nuclei was piqued after Dahlstrom and 
Fuxe (1964), utilizing the Falck-Hillarp formaldehyde-induced fluores-
cence technique, identified nine distinct clusters of 5-HT containing 
neurons in the brain stem raphe nuclei of the rat. These 5-HT cell 
groups were designated Bl - B9, according to their caudorostral posi-
tion (Dahlstrom and Fuxe, 1964). The B7 and BS 5-HT cell groups over-
lap the midbrain dorsal and median raphe nuclei (DR and MR), respec-
tively. These observations subsequently have been substantiated and 
extended using immunocytochemical techniques (see Steinbusch and Nieu-
wenhuys, 1983, for a review). 
Perikarya also have been localized within the midbrain raphe 
which contain dopamine (DA; Ochi and Shimizu, 1978), GABA (Mugnaini and 
Oertel, 1985), cholecystokinin (Vanderhaeghen et al., 1980), met-en-
kephalin (Uhl et al., 1979; Murakami et al., 1987), and corticotropin-
9 
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releasing factor (CRF; Sakanaka et al., 1987). SP-containing cell 
bodies have been observed in the DR, but not in the MR (Ljungdahl et 
al., 1978; Chan-Palay et al., 1978). 
Co-localization of Transmitters within the Midbrain Raphe 
One of the most exciting but least understood aspects of neuro-
transmission is the coexistence of more than one neurotransmitter in 
the same neuron. Several questions have been raised concerning the 
possible co-release, pre- versus post-synaptic effects, and neurohumor-
al roles of the co-localized substances. In most instances, little is 
known beyond the anatomical information. The potential coexistence of 
5-HT with other neurotransmitters has been investigated by several 
laboratories. Cell bodies which contain both 5-HT and GABA have been 
observed in various raphe nuclei, with the greatest number being found 
in the DR (Belin et al., 1983; Magoul et al., 1986; Harandi et al., 
1987; Millhorn et al., 1987). However, these results should be inter-
preted cautiously. Some have relied on the combined use of immunocyto-
chemistry with the uptake of radiolabeled 5-HT and GABA (Magoul et al., 
1986; Harandi et al., 1987). False-positive staining can occur due to 
non-specific cellular accumulation, particularly by glial cells (Kelly 
and Dick, 1976). The fixation procedures used for combined autoradiog-
raphy and immunocytochemistry represent a compromise between the opti-
mal techniques for one of the methods alone, and may actually interfere 
with the visualization of the reaction products (Harandi et al., 1987). 
Similarly, the visualization of one-substance by the peroxidase-anti-
peroxidase (PAP) method can interfere with the fluorescent label used 
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to view the other (Belin et al., 1983). The coexistence of GABA and 5-
HT in the midbrain raphe is an interesting possibility, but requires 
additional confirmatory evidence. 
Serotonin and leu-enkephalin also have been reported to coexist 
in the cat DR and nucleus raphe magnus (Glazier et al., 1981). The co-
localization of serotonin with N-acetyl-aspartyl-glutamate, an acidic 
dipeptide proposed as a neurotransmitter in some putative glutaminergic 
pathways (Koller and Coyle, 1984), has been found in the brain stem 
raphe, including the rat MR and DR (Forloni et al., 1987). 
Co-localization with Substance P 
The coexistence of SP and 5-HT in the caudal brain stem raphe has 
been demonstrated in several species (Chan-Palay et al., 1978; Hokfelt 
et al. , 1978; Pelletier et al. , 1981). In addition, thyrotropin-re-
leasing hormone (TRH) has been found to coexist with both SP and 5-HT 
in the same neuron (Johansson et al., 1981). The 5-HT/SP containing 
neurons send axons exclusively to the spinal cord and a great deal of 
work has focussed on their interactions in this region (see Holstege 
and Kuypers, 1987; Thor and Helke, 1987). Only one report has sug-
gested the possibility of SP/5-HT co-localization within the DR (Magoul 
et al., 1986). This study relied on the use of radiolabeled 5-HT 
uptake, combined with SP immunocytochemistry, and has not been con-
firmed by other investigators. 
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Efferent Projections of the Midbrain Raphe 
The 5-HT and non-5-HT projections of the midbrain raphe have been 
studied extensively. Early reports indicated that the MR and DR are 
the source of the 5-HT fibers which ascend in the medial forebrain 
bundle and innervate the forebrain (Heller and Moore, 1965; Anden et 
al., 1966). It also has been shown that neurons of the midbrain raphe 
project to almost all areas of the brain (Conrad et al., 1974; Bobil-
lier et al., 1975; Parent et al., 1981). Although the axonal projec-
tions of the raphe nuclei overlap and are highly collateralized, they 
are topographically organized. For instance, the hippocampus and 
neostriatum receive 5-HT projections which arise predominantly in the 
MR and DR, respectively (Jacobs et al., 1974; Lorens and Guldberg, 
1974; Geyer et al., 1976 a, b; Azmitia and Segal, 1978; Kohler and 
Steinbusch, 1982). There also is a great deal of evidence concerning 
the divergence and collateralization of raphe projections (de Olmos and 
Heimer, 1980; van der Kooy and Hattori, 1980; Fallon and Loughlin, 
1982). Recently, Imai and colleagues (1986) have suggested that the 
projections of the midbrain raphe are topographically organized. These 
authors reported that cells positioned rostrally in the MR and DR 
project to the basal ganglia, while those situated caudally send axons 
to limbic structures. Projections to the amygdala appear to arise from 
a distinct group of cells in the DR (Imai et al., 1986). Thus, neurons 
within the midbrain raphe are in a position to modulate neuronal sys-
terns throughout the di- and telencephalon. However, the extent to 
which these forebrain systems reciprocally communicate with raphe 
neurons has not been adequately examined. 
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Afferent Connections of the Midbrain Raphe 
A number of transmitter-specific fibers and terminals have been 
localized within the midbrain raphe. These include DA, norepinephrine, 
GABA, cholecystokinin, neurotensin, and enkephalin (see review by 
Steinbusch and Nieuwenhuys, 1983). The origin of the afferent projec-
tions to the raphe in the cat were studied originally using a retro-
grade degeneration technique (Brodal et al., 1960 b). Since then, the 
retrograde transport of horseradish-peroxidase has been employed to 
study MR and DR afferents in the rat and rabbit, but only in comparison 
to those of the pontine reticular formation (Pasquier et al., 1976; 
Aghajanian and Wang, 1977; Hayakawa and Zyo, 1986). The origin of the 
afferents to the rat MR (summarized below) is based on a review of 
studies which focussed primarily on the efferents from various fore-
brain regions. In most of these studies, the efferent projections to 
the MR are diagrammatically plotted, but rarely commented upon. The 
anterograde transport of tritiated amino acids has been the most fre-
quent technique used. Recent studies have employed the kidney bean 
lectin, Phaseolus vulgaris leucoagglutinin (Gerfen and Sawchenko, 
1984). 
Afferents to the MR have been reported to originate in: the 
frontal cortex, septal region and diagonal band of Broca (Aghaj anian 
and Wang, 1977; Swanson and Cowan, 1979; Swanson, 1982; Swanson et al., 
1987; Tomimoto et al. , 1987); the medial and lateral preoptic areas 
(Swanson et al., 1984, 1987); the lateral border of the internal cap-
sule (Haber et al., 1985); the lateral hypothalamus (Saper et al., 
1979; Swanson et al., 1984); the perifornical nucleus (Pasquier et al., 
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1976); the subfornical organ (Lind, 1986); the laterodorsal tegmental 
nucleus (Satoh and Fibiger, 1986); and, the interpeduncular nucleus 
(Hamill and Jacobowitz, 1984; Groenewegen et al., 1986; Shibata et al., 
1986). A major fiber system from the lateral habenular nucleus to the 
MR has been demonstrated as well (Pasquier et al., 1976; Aghajanian and 
Wang, 1977). Projections from the B9 5-HT cell group to the brain stem 
also have been reported (Aghajanian and Wang, 1977). A thorough ex-
amination of the afferents to the MR using a retrograde tracing techni-
que is important in order to substantiate the results reviewed above. 
Behavioral Effects of Midbrain Raphe Lesions 
Some of the earliest experiments investigating the role of fore-
brain 5-HT in behavior focussed on the 5-HT depleting effects of elec-
trolytic destruction of the midbrain raphe nuclei. Electrolytic les-
ions of the MR, which produce a greater than 80% reduction in hippocam-
pal 5-HT levels, also produce significant increases in LMA (Jacobs et 
al., 1974). These authors suggested that the reduction in hippocampal 
5-HT concentrations could account for the increase in activity. These 
effects were subsequently corroborated by others (Srebro and Lorens, 
1975; Geyer et al., 1976). Combined MR and DR lesions also were found 
to facilitate avoidance acquisition in a shuttle box and a Y-maze (Lor-
ens et al., 1971; Steranka and Barrett, 1974). More recently, electro-
lytic raphe lesions have been found to impair the acquisition and 
performance. of an 8-arm radial maze task, and the reversal of a learned 
position habit, but not the acquisition or reversal of a simultaneous 
brightness discrimination task (Wirtshafter and Asin, 1983, 1986). 
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Subsequent lesion studies found that electrolytic destruction of 
the DR and MR enhanced the hyperkinetic effects of d-amphetamine (Lucki 
and Harvey, 1979). Studies by Asin and Fibiger (1983) indicate that 
lesions of the MR with ibotenic acid, a neurotoxic excitatory amino 
acid which destroys cell bodies in a region but spares fibers of pas-
sage (Coyle and Schwarcz, 1983), also produce hyperactivity and poten-
tiate the locomotor stimulant effect of d-amphetamine. 
These studies suggest that the midbrain raphe nuclei play an 
important role in several behavioral processes, but say little about 
the role of 5-HT neurons. Since mechanical and excitotoxic lesions of 
the midbrain raphe simultaneously produce reductions in forebrain 5-HT 
concentrations, there was a consensus that the behavioral effects were 
due to the degeneration of ascending 5-HT fibers. However, these types 
of lesions also destroy non-5-HT elements within the raphe. With the 
discovery and use of the serotonergic neurotoxins, 5,6-dihydroxytrypt-
amine and 5, 7 -DHT (Baumgarten et al. , 1972, 1973), a new method to 
selectively produce deficits in forebrain 5-HT was available. The 
potential of these neurotoxins was great since discrepancies had been 
noted with various other methods of depleting forebrain 5-HT (Lorens, 
1978). It was found that 5,7-DHT lesions of the MR, DR or ascending 5-
HT fibers, which produced significant reductions in forebrain 5-HT 
concentrations, did not affect activity levels or avoidance condition-
ing (Hole et al., 1976; Lorens et al., 1976; Asin and Fibiger, 1983). 
Wirtshafter and colleagues (1986) subsequently demonstrated that the 
LMA effects following raphe damage can be disassociated from forebrain 
5-HT depletion, and suggest that a descending pathway may be involved 
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in the generation of MR mediated changes in LMA. It had become ap-
parent that other techniques besides lesions were necessary to study 
the function of· midbrain raphe 5-HT neurons. 
Pharmacological Manipulations of Midbrain Raphe Neurons 
A method developed to specifically and acutely affect the activ-
ity of raphe neurons was the microinjection of compounds directly into 
brain areas containing 5-HT perikarya. Several investigators have used 
this approach to confirm that GABA serves as an inhibitory transmitter 
within the raphe (Gallager and Aghajanian, 1976; Gallager, 1978; For-
chetti and Meek, 1981), and that benzodiazepine/GABA interactions are 
important to drug induced changes in raphe function (Gallager, 1978). 
Przewlocka and associates (1979) demonstrated that injection of the 
GABAA agonist, muscimol, into the DR, produces increases in LMA and 
food intake. At the same time, Arnt and Scheel-Kruger (1979) demon-
strated a similar effect after muscimol injections into the "caudal-
VTA" (which most likely affected neurons within the rostral portion of 
the MR). Subsequently, Sainati and Lorens (1982) found that muscimol 
produced dose-dependent increases in LMA when injected into the MR and 
DR, and that the MR was approximately four times more sensitive. The 
effect of intra-MR muscimol injections also was shown to be potentiated 
by intra-raphe administration of benzodiazepines (Sainati and Lorens, 
1983). Although originally thought to be mediated by 5-HT neurons 
{Sainati and Lorens, 1982), it has subsequently been demonstrated that 
the hyperkinetic effects of intra-MR muscimol infusions are not media-
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ted by 5-HT neurons (Paris and Lorens, 1987 a,b; Wirtshafter et al., 
1987 a). 
It has been suggested that the projection from the lateral haben-
ular nucleus to the MR utilizes an excitatory amino acid neurotrans-
mitter (Kalen et al., 1985, 1986). Injection of the glutamate ana-
logue, kainic acid, into the MR has been reported to suppress LMA 
(Wirtshafter and McWilliams, 1987). However, these results are some-
what equivocal since injections of N-methyl-D-aspartate (NMDA) into the 
MR produce explosive short bursts of hyperactivity which can be blocked 
by the NMDA antagonist, DL-2-amino-5-phosphonovaleric acid (APV; un-
published observations). Further studies are necessary to clarify this 
phenomenon. More recently, intra-MR injections of the herbicide, 
paraquat [an analogue of the MPTP (N-rnethyl-4-phenyl-1,2,3,6-tetra-
hydropyridine) metabolite, MPP+ (N-methyl-4-phenyl-pyridinium)], have 
been reported to produce increases in LMA, circling, and wet-dog shakes 
(DeGori et al., 1988). The mechanism of these effects is not under-
stood. 
Thus, the local application of substances has demonstrated that 
behavioral effects can be elicited by acutely affecting the activity of 
raphe neurons. 
Raphe 5-HT Neurons and Ingestive Behaviors 
The role of 5-HT in food intake and eating disorders has been 
extensively reviewed (Sugrue, 1987; Morley and Blundell, 1988), and 
stems from early observations of the anorectic effect of the 5-HT 
releasing drug, fenfluramine (as reviewed in Rowland and Carlton, 
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1986). The role of raphe neurons in the regulation of food intake 
initially was investigated pharmacologically by Przewlocka and col-
leagues (1979); who reported that injections of muscimol into the DR 
produced increases in food intake in non-food deprived rats. Arnt and 
Scheel-Kruger (1979) found that muscimol injections into the "caudal 
VTA" (rostral MR) produce similar effects. It was reported subsequent-
ly that the hyperphagia induced by muscimol could be inhibited by (+)-
fenfluramine pretreatment (Borsini et al., 1983). The involvement of 
5-HT in muscimol induced hyperphagia also was suggested by the observa-
tion that 5-HT or norfenfluramine (a bioactive metabolite of fenflur-
amine) infusions into the nucleus. accumbens could inhibit muscimol, but 
not starvation-induced eating in rats (Bendotti et al., 1986 b). These 
authors went on to suggest that muscimol's effects were modulated in 
part by DA neurons since the DA antagonist, fluphenazine, could atten-
uate intra-DR muscimol-induced eating when the antagonist was injected 
into either the caudate-putamen or the nucleus accumbens (Bendotti et 
al., 1986 a). On the other hand, it has been shown that the MR is more 
sensitive than the DR to the hyperphagic effects of muscimol, and that 
5,7-DHT lesions of the MR or DR do not prevent the feeding induced by 
muscimol infusions into the raphe (Borsini et al., 1983; Klitenick and 
Wirtshafter, 1986, 1987). These results suggest that, like the effects 
of muscimol on LMA, muscimol-induced hyperphagia is mediated by non-5-
HT elements within the midbrain raphe. 
The results observed with muscimol are interesting in light of 
the fact that there is a considerable body of evidence that the 5-HT1A 
agonist, 8-hydroxy-2-(di-N-propylamino)-tetralin (8-0HDPAT; Arvridsson 
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et al., 1981; Hj orth et al., 1982) elicits feeding following its ad-
ministration either peripherally or directly into the raphe (Dourish et 
al., 1985 a,b,c, 1986 b; Bendotti and Samanin, 1986; Hutson et al., 
1986). It is postulated that these effects occur through a decrease in 
the firing rate of 5-HT neurons via activation of 5-HT1A somatoden-
dritic autoreceptors (de Montigny et al., 1984; Dourish et al., 1985 a, 
1986 a; Verge et al., 1985; Weissmann-Nanapoulos et al., 1985). How-
ever, controversy exists as to whether the 8-0HDPAT-induced hyperphagia 
is due to non-specific gnawing or to stimulation of appetite which may 
counter a tonic 5-HT inhibitory influence on feeding (Fletcher, 1987; 
Dourish et al., 1988). 
Raphe 5-HT Neurons and Anxiety 
The role of 5-HT in anxiety, and in the anxiolytic effects of the 
benzodiazepines, has been extensively reviewed and contested in recent 
years (Gardner, 1986; Johnston and File, 1986; Soubrie, 1986; Thiebot, 
1986). The midbrain raphe has been analyzed in terms of the effects of 
benzodiazepine/GABA/5-HT interactions (Thiebot et al., 1980, 1982, 
1984; Sainati and Lorens, 1983; Nishikawa and Scatton, 1983; Green and 
Hodges, 1986; Mendelson et al., 1987). Intra-DR injections of the ben-
zodiazepine inverse agonist, methyl-~-carboline-carboxylate (~-CCM), 
reduce social interaction in pairs of rats, suggesting an anxiogenic-
type of effect (File and Hyde, 1978; File et al., 1982; Guy and Gard-
ner, 1985; Jones et al., 1986). 
Clinically, interest in the role of 5-HT neurons in the control 
of anxiety has been heightened by the recent Food and Drug Administra-
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tion approval (1987) of buspirone (BuSparR), a non-benzodiazepine aza-
spirodecanedione, approved for use in the treatment of anxiety (Tayler 
et al., 1985). · Buspirone binds with a high affinity to 5-HT1A ·recep-
tors (Peroutka, 1985), and decreases the activity of DR 5-HT neurons 
(Vander Maelen et al., 1986). Since buspirone also has been reported 
to have DA binding properties (Riblet et al., 1982), an analogue of 
buspirone, gepirone, which is devoid of DA binding properties, but has 
a high affinity for 5-HT1A receptors (Yocca et al., 1986; see Blier and 
de Montigny, 1987), has been studied. Electrophysiologically, gepirone 
also decreases the firing rate of 5-HT neurons (Blier and de Montigny, 
1987), and is efficacious in the treatment of anxiety (Cott et al., 
1986; Csanalosi et al., 1987). Furthermore, 8-0HDPAT has been reported 
to have anxiolytic properties in rats (Carli and Samanin, 1988). Thus, 
the data indicate that 5-HT circuits play a role in anxiety, and in the 
mechanism of action 5-HT1A anxiolytics, as well as the benzodiazepines. 
B. Neurokinins 
Since its discovery by von Euler and Gaddum (1931), the bioactive 
peptide, substance P (SP), has been the subject of a considerable 
amount of research (see reviews by Maggio, 1988; Nicoll et al., 1980; 
Pernow, 1983). Recent work, however, has focused upon the family of 
peptides related to SP, called the "tachykinins." These were so-named 
because they have a characteristic fast onset of action on gut tissue, 
in comparison to the much slower acting bradykinins. 
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Nomenclature 
As shown in Table I, the tachykinins share a common carboxy-
terminal sequence -Phe-X-Gly-Leu-Ket-NH2, where X can be an aromatic 
or branched aliphatic amino acid (Erspamer, 1981, Harmar, 1984). Three 
of the tachykinins listed in Table I exist only in non-mammalian spe-
cies. These are eledoisin (Erspamer and Anastasi, 1962), physalaemin 
(Erspamer et al., 1964), and kassinin (Anastasi et al., 1977). The 
tachykinins found in mammals are referred to as neurokinins, and in-
clude SP, neurokinin A (NKA; formerly known as substance K and neuro-
kinin a; Kimura et al., 1983, 1984), and neurokinin B (NKB; formerly 
referred to as neuromedin K and neurokinin {3; Kangawa et al., 1983). 
Another endogenous neurokinin, neuropeptide K (NPK; Tatemoto et al., 
1985), may or may not be an intermediate in NKA biosynthesis. 
Molecular Biology 
The neurokinins, like other neuropeptides, are derived from 
larger protein precursors which are synthesized in the neuronal cell 
body. Post-translational modification of the precursor molecules 
occurs as they are transported to the nerve terminal. Here, the final 
products are stored until released. Studies have shown that two genes 
contain codons for the three mammalian neurokinins: the preprotachy-
kinin A gene encodes for SP and NKA; and, the preprotachykinin B gene 
encodes for NKB (Kotani et al., 1986, Nawa et al., 1983, 1984). The 
preprotachykinin A gene produces three different preprotachykinin (PPT) 
mRNAs: a, f3 and~· 
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Table I: Tachykinin and Analogue Amino Acid Sequences 
Tachykinin MW Abbreviation 
substance p 1348 SP 
Neurokinin A 1133 NKA 
Neurokinin B 1211 NKB 
Physalaemin 1266 PHY 
Eledoisin 1189 ELE 
Kassinin 1335 KAS 
Dimethyl-C7 880 DiMe-C7 
Senktide 842 
a (common amino acids are underlined) 
b Sar - N-methyl glycine 
Amino acid sequence a 
Arg-Pro-Lys-Pro-Gln-Gln-
-Phe-Phe-Gly-Leu-Met-NH2 
His-Lys-Thr-Asp-Ser-
-Phe-Val-Gly-Leu-Met-NH2 
Asp-Met-His-Asp-Phe-
-Phe-Val-Gly-Leu-Met-NH2 
pGlu-Ala-Asp-Pro-Asn-Lys-
-Phe-Tyr-Gly-Leu-Met-NH2 
pGlu-Pro-Ser-Lys-Asp-Ala-
-Phe-Ile-Gly-Leu-Met-NH2 
Asp-Val-Pro-Lys-Ser-Asp-Gln-
-Phe-Val-Gly-Leu-Met-NH2 
pGlu-Gln-Phe-MePhe-SarQ-Leu-
-Met-NH2 
Succinyl-Asp-Phe-MePhe-Gly-
-Leu-Met-NH2 
The a PPT encodes for SP only, while the ~ and 1 forms encode for both 
SP and NKA (Krause et al., 1987). Furthermore, it is now known that~-
PPT also encodes for neuropeptide K (Tatemoto et al., 1985), which 
probably represents an elongated or pre-form of NKA (Martling et al., 
1987; Deacon and Conlon, 1987). Precursor forms of SP (intermediates 
in proteolytic processing) also have been detected in rat brain (Kream 
et al., 1985). The PPT mRNA and tachykinin precursors have been found 
in human brain as well (Nyberg et al., 1985; Chesselet and Affolter, 
1987). 
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Release 
Neurokinin release from nerve terminals may be mediated by a 
calcium and potassium dependent mechanism (Lindefors et al., 1985 a). 
This has been demonstrated in slice and synaptosomal preparations of 
hypothalamus, ventral mesencephalon, and substantia nigra (Iversen et 
al., 1976; Schenker et al., 1976; Jessel, 1978; Kronheim et al., 1980; 
Torrens et al. , 1981). Electrically-stimulated release also has been 
demonstrated in brain and spinal cord (Otsuka and Konishi, 1976; Miche-
lot et al., 1979; Akagi et al., 1980). 
Degradation 
The degradation and inactivation of tachykinins are important 
considerations in the study of the pharmacology and physiology of these 
peptides. A number of peptidases have been postulated to be involved 
in the enzymatic cleavage and degradation of SP. These include: angio-
tensin-converting enzyme (Thiele et al., 1985), enkephalinase (endopep-
tidase 24.11; Matsas et al., 1984), dipeptidylaminopeptidase IV (Hey-
mann and Mentlein, 1978), the so-called "substance P-degrading enzyme" 
(Lee et al., 1981; Probert and Hanley, 1987), "bacitracin-sensitive 
enzyme" (Horsthemke et al., 1984), and calpain (Hatanaka et al., 1985). 
Since many of these studies employed exogenous peptide, it has been 
suggested they may not accurately represent the activity of the pepti-
dases in vivo (Mauborgne et al., 1987). Using superfused slice prepar-
ations, these authors have suggested that the endogenous SP released 
from the substantia nigra is primarily inactivated by enkephalinase and 
calpain (Mauborgne et al., 1987). Others have suggested the involve-
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ment of enkephalinase in the physiological degradation of SP (Oblin et 
al., 1988). Indeed, recent studies indicate that enkephalinase hydro-
lyses NKA and NKB, as well as SP (Hooper and Turner, 1986; Turner and 
Hooper, 1987). However, the physiological relevance of these findings 
has yet to be determined. 
Neurokinin Antagonists 
There have been a number of SP-related antagonists developed 
(Engberg et al., 1981; Folkers et al., 1981; Rosell and Folkers, 1982; 
Regoli, 1985; Escher et al., 1987; Regoli et al., 1987), and used to 
classify neurokinin binding sites (see below; Regoli et al., 1984; 
Jacoby et al., 1987; Murray et al., 1987; Vaught et al., 1987). How-
ever, several studies indicate that these compounds are neurotoxic, 
have local anesthetic properties, and actions not related to their 
antagonist activities, thus making them unsuitable for use as in-vivo 
competitive blockers (Hokfelt et al., 1981; Salt et al., 1982; Post et 
al., 1985; Freedman et al., 1986; Lembeck et al., 1986; Yusof and 
Coote, 1987; Dr. Peter J. Elliott, personal communication, 1986). 
Interestingly, recent studies have revealed that rats are uniquely 
susceptible to these non-specific neurotoxic actions (Post et al. , 
1987; Vaught and Scott, 1987). It has been suggested that D-trp sub-
stitution may underlie this neurotoxicity (Post and Paulsson, 1985; 
Vaught and Scott, 1987). The development of specific, non-neurotoxic, 
non-anesthetic neurokinin antagonists is necessary. 
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Localization Within the CNS 
Using immunocytochemical procedures and polyclonal antisera 
directed against SP, Ljungdahl et al. (1978 a,b) and Cuello and Kana-
zawa (1978), published the first major studies on the distribution of 
SP-like cell bodies and fibers in the adult rat CNS. These were fol-
lowed by the studies of Inagaki et al. (1982) and Sakanaka et al. 
(1982) on the distribution of SP-like neurons in the pre-and post-natal 
rat brain. Although other reports preceded these (for example, Nilsson 
et al., 1974; Hokfelt et al., 1975), the aforementioned studies repre-
sent the first detailed mapping of SP-containing perikarya and fibers 
in the rat CNS. Accordingly, SP-like immunoreactive (SPLI) cell bodies 
have been localized in many brain regions, including: the nucleus 
accumbens, the septal area, the basal forebrain, caudate-putamen, bed 
nucleus of the stria terminal is, medial habenular nucleus, thalamus, 
zona incerta, amygdala, hippocampus, lateral hypothalamus, central 
gray, interpeduncular nucleus, dorsal raphe nucleus, superior collic-
ulus, medullary raphe nuclei, medullary ventrolateral reticular form-
ation, and, the spinal cord (Ljungdahl et al., 1978 a). SPLI fibers 
and terminals, furthermore, have been observed in most regions of the 
brain (Cuello and Kanazawa, 1978; Ljungdahl et al., 1978 a). Impor-
tantly, SPLI has been discerned in the midbrain raphe nuclei (Cuello 
and Kanazawa, 1978; Ljungdahl et al., 1978 a; Shults et al., 1984). 
Since the discovery of the other mammalian neurokinins, namely, 
NKA and NKB, no one has attempted to thoroughly map the neurokinin-
containing cell bodies within the CNS. Most of the recent work has 
focussed on discrete projection systems and specific areas. Warden and 
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Young (1988), however, recently mapped SP and NKB mRNAs in the rat CNS, 
and found that these mRNAs have distinct patterns of distribution. 
The antibodies originally used to detect SPLI have been found to 
cross-react with the other neurokinins or their precursors (Dr. Tomas 
Hokfelt, personal communication, 1986; Brodin et al., 1986). Thus, 
with the demonstration that other neurokinins and their mRNAs exist in 
the mammalian CNS, the specificity for SP-like immunoreactivity of the 
early mapping studies has been questioned (Dr. Tomas Hokfelt, personal 
communication, 1986). 
Biochemical procedures, such as radioimmunoassay (RIA), and high 
performance liquid chromatography (HPLC), have been used to examine the 
distributions and concentration of the neurokinins in the CNS. Since 
these techniques employ tissue extractions, antisera can be developed 
which recognize portions of the peptide strand inaccessible in vivo. 
Hence, the antibodies are more specific and less cross-reactive. A 
number of investigators have used these methods to determine the con-
centration of the neurokinins in distinct CNS structures (Brownstein et 
al., 1976; Minamino et al., 1984; Theordorsson-Norheim et al., 1984; 
Lindefors et al., 1985, 1986; Shults et al., 1985 b; Arai and Emson, 
1986; Brodin et al., 1986; Nagashima et al., 1987; Diez-Guerra et al., 
1988). 
Binding Sites 
Ligand-binding and in vitro bioassay studies have led to the 
identification of three distinct neurokinin recognition sites: NK-1 
(SP-preferring), NK-2 (NKA-preferring), and NK-3 (NKB-preferring; Lee 
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et al., 1982, 1986; Regoli et al., 1984 a,b; Quirion, 1985; Henry, 
1987). An effort has been made to correlate binding affinity with bio-
logical activity (Dion et al., 1987). In the discussion which follows, 
the characterization of peripheral neurokinin binding sites will be 
considered briefly, followed by a more detailed discussion of their 
properties in the CNS. 
Peripheral Pharmacological Neurokinin Bioassays 
The physiological properties of the neurokinins have been exam-
ined in various smooth muscle preparations, including the guinea pig 
ileum, trachea, and gallbladder; the rat vas deferens, duodenum, and 
portal vein; the rabbit pulmonary artery, heart, and mesenteric vein; 
the pig coronary artery; the dog carotid artery; and, the isolated 
human urinary bladder (Regoli et al., 1984 a,b,c; Mastrangelo et al., 
1986; Osakada et al., 1986; Shook and Burks, 1986; Dion et al., 1987; 
Guard and Watson, 1987; Gulati et al., 1987; Munekata et al., 1987; 
Rovero and Pestellini 1987; Tousignant et al., 1987; Maggi et al., 
1988). Some of the contractile effects of the neurokinins may be 
mediated through the release of other transmitters, such as acetyl-
choline (Holzer and Lembeck, 1980; Guard and Watson, 1987). 
Based upon the relative potency of various agonists to contract 
smooth muscle, and their blockade by competitive antagonists, different 
muscles are thought to possess differing numbers or densities of neuro-
kinin receptors. For example, in the isolated pig coronary artery the 
relative rank order of potency of the tachykinins is: SP - PHY> ELE > 
KAS > NKA > NKB, with SP being 9 and 90 times more potent than NKA and 
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NKB, respectively. This smooth muscle preparation appears to contain a 
high density of NK-1 sites, and can be used as an assay for NK-1 agon-
ists (Gulati et al., 1987). The guinea pig ileum can be used as a 
bioassay for the NK-2 binding site (Shook and Burks, 1986). In this 
smooth muscle preparation, the relative rank order of potency for the 
force of contraction is: NKA > KAS > ELE >> PHY> SP, with NKA approxi-
mately 175 times more potent than SP. The contraction of the detrusor 
muscle of the human isolated urinary bladder also has been shown to be 
mediated predominantly by NK-2 sites (Maggi et al., 1988). The rat 
isolated portal vein bioassay has been demonstrated to be most sensi-
tive to NKB (Mastrangelo et al., 1986; Dion et al., 1987). Recently, 
there has been an effort to correlate the effects of neurokinins in in 
vitro receptor bioassays with in vivo physiology (Kuwahara and Yanai-
hara, 1987; Maggi et al., 1987). 
Characterization of CNS Neurokinin Binding Sites 
The characteristics and localization of neurokinin binding sites 
in the CNS have been reviewed recently (Glowinski et al., 1987; Saffroy 
et al., 1988). The delineation of the neurokinin binding sites has 
relied on the use of 125I-Bolton-Hunter (BH) and 3H-labeled peptides, 
and analogues in membrane and synaptosomal preparations. In rat corti-
cal synaptosomes, binding of 125I-BH-SP to NK-1 sites, and 125I-BH-ELE 
to NK-3 sites (Beaujouan et al., 1986; Bergstrom et al., 1987), is 
specific, temperature-dependent, saturable, and reversible, with Kd's 
in the nanomolar range (Bergstrom et al., 1987; Viger et al., 1985). 
These authors report that Scatchard and Hill plots for each indicate a 
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single class of non-interacting binding sites. Competitive studies 
have revealed that SP and NKB inhibit binding of 1251-BH-SP and 1251-
BH-ELE, respectively, in the nanomolar range (Glowinski et al., 1987). 
It has been shown that the length of the peptide or analogue will 
affect its binding. For instance, longer fragments are more potent at 
NK-1 sites than shorter C-terminal fragments and analogues, such as 
DiMe-C7 and senktide (see Table 1), which are more potent at NK-3 
binding sites (Cascieri and Liang, 1983; Torrens et al., 1984; Viger et 
al., 1985). 3H-NKB and 1251-BH-ELE have been reported to label identi-
cal sites (Bergstrom et al., 1987). 
NK-2 Binding Sites in the CNS 
NK-2 binding sites have been distinguished from NK-1 and NK-3 
sites in peripheral tissues (Buck et al., 1984, 1986; Burcher et al., 
1986). Their presence in the CNS has been suggested, chiefly through 
autoradiographic studies (Mantyh et al., 1984 b; Quirion and Dam, 1985; 
Shults et al., 1985 a; Buck et al., 1986). However, the presence of 
NK-2 recognition sites in the CNS has been questioned. Competition 
studies using rat cortical synaptosomes have shown that 1251-BH-NKA has 
a higher affinity than NKA for sites labeled with 1251-BH-ELE or 3H-
NKB, suggesting that NK-3 sites are being labeled (Bergstrom et al., 
1987; Glowinski et al., 1987; Saffroy et al., 1988). Autoradiographic 
analysis, furthermore, has indicated that the specific binding of 1251-
NKA and 3H-NKA is very low, and that they label sites identical to 
those which bind 3H-SP or 1251-BH-SP. Likewise, 1251-BH-NKA 3H-NKB 
' 
and 1251-BH-ELE appear to label the same recognition sites (Buck et 
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al., 1986; Saffroy et al., 1988). Thus, the presence of NK-2 binding 
sites within the CNS needs to be examined more thoroughly. 
Second-Messenger Coupling 
There is some evidence that the neurokinins can stimulate 
phosphotidylinositol breakdown in the periphery and in the CNS (Watson 
and Downes, 1983; Mantyh et ~l., 1984 c; Watson, 1984; Torrens et al., 
1986). There also is evidence that SP receptors are coupled to guanine 
nucleotide proteins (Sharma and Musacchio, 1987). However, details of 
events at the molecular level following neurokinin binding need to be 
more thoroughly examined. 
Conformational Studies 
Recently, a number of studies have been aimed at determining the 
three-dimensional structure of the neurokinins and related peptides and 
how they interact with their respective binding sites (Chassaing et 
al., 1986, 1987; Drapeau et al., 1987; Hashimoto et al., 1987; Ploux et 
al., 1987; Rovero and Pestellini, 1987; Lavielle et al., 1988). Through 
the construction of conformationally constrained analogues, it is hoped 
that selective and stable analogues and/or antagonists will be found. 
This approach has led to the development of a number of neurokinin 
analogues including: DiMe-C7 [(pGluS, MePhe8, Sar9)SP(S-11)], original-
ly developed as a metabolically stable analogue of SP (Sandberg et al., 
1982); septide [ (pGluS, Pro9)SP(6-ll)], a selective agonist for NK-1 
binding sites (Laufer et al., 1986 a; Wormser et al., 1986), and 
senktide [ (succ-Asp6, MePhe8)SP(6-ll)], a selective agonist for NK-3 
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sites (Laufer et al., 1986 b; Wormser et al., 1986). It has been shown 
that compounds with an N-methyl group at position 8, such as DiMe-C7 
and senktide, are associated with a dramatic loss of potency at NK-1 
sites and an increase in potency at NK-3 sites (Drapeau et al., 1987; 
Lavielle et al., 1986; Plowe et al., 1987). Ploux et al. (1987) and 
Lavielle et al. (1988) have suggested that the a helical core which the 
neurokinins adopt when dissolved in methanol, may be related to their 
bioactive conformation in vivo. After these peptides bind to their 
receptor, they appear to form similar three-dimensional structures. 
However, the non-homologous N-terminal sequences may influence the 
orientation of the C-terminal Gly-Leu-Met-NH2 trimer such that it binds 
to its appropriate neurokinin receptor. 
Distribution of CNS Neurokinin Binding Sites 
The localization and distribution of neurokinin binding sites has 
been extensively studied using autoradiography (Wolf et al. , 1983; 
Mantyh et al., 1984 a,b; Shults et al., 1984, 1985 a,b; Buck et al., 
1986; Danks et al., 1986; Beauj ouan et al., 1986; Saffroy et al., 
1988). These studies have indicated that neurokinin binding sites are 
present, to varying degrees, throughout the CNS. Although neurokinin 
binding sites tend to be rather ubiquitous, certain differences in 
distribution can be found. For instance, high densities of NK-1 sites 
have been found in the olfactory bulb; the prefrontal cortex; the hip-
pocampus; the anterior cortical nucleus of the amygdala; the septal 
area; the medial habenular nucleus; the dorsal raphe; the superior col-
liculus; cerebellar lobules 9 and 10; the dorsal tegmental nucleus of 
~·-
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Gudden; the locus ceruleus; and, the dorsal motor nucleus of the vagus 
(Mantyh et al., 1984 a; Beaujouan et al., 1986; Buck et al., 1986; Saf-
froy et al., 1988). The density of NK-3 binding sites is highest in 
the cerebral cortex; the basolateral amygdaloid nucleus (anterior); the 
zona incerta; magnocellular part of the paraventricular hypothalamic 
nucleus; the perifornical and supraoptic hypothalamic nuclei; the 
interpeduncular nucleus; the ventral tegmental area; and, the nucleus 
of the solitary tract (Beaujouan et al., 1986; Buck et al., 1986; Danks 
et al., 1986; Saffroy et al., 1988). 
With respect to the midbrain raphe, Saffroy et al. (1988) found a 
greater number of NK-1 than NK-3 sites in the DR, but about the same 
number (although less than in the DR) of both in the MR. Others, 
however, have found more 125r-BH-SP binding sites than 125r-BH-ELE 
sites in the MR (Buck et al., 1986). 
Neurokinin Transmitter/Binding Site Mismatches 
In certain brain regions, mismatches occur between the localiza-
tion of a peptide and its receptor or binding site (Kuhar et al., 1985; 
Herkenham, 1987). For the neurokinins, the most illustrative and most 
often cited example of a brain structure which displays this phenomenon 
is the substantia nigra. This area contains the highest concentrations 
of SP and NKA in the brain (Kanazawa et al., 1984; Brodin et al., 1986) 
with negligible amounts of NKB (Kanazawa et al., 1984; Arai and Emson, 
1986). Behavioral, electrophysiological, and biochemical effects have 
been observed following SP and NKA injections into the pars compacta 
and pars reticulata of the substantia nigra (Cheramy et al., 1977; 
!"'· 
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Kelley and Iversen, 1978 a,b, 1979; Pinnock and Dray, 1982; Innis et 
al., 1985). However, NK-1 sites have not been localized in this region 
(Mantyh et al., 1984 a; Shults et al., 1984; Beauj ouan et al.,· 1986; 
Buck et al., 1986; Danks et al., 1986; Saffroy et al., 1988). Only a 
small number of NK-2 and NK-3 sites, furthermore, have been discerned 
in the substantia nigra (Mantyh et al., 1984 b; Quirion and Dam, 1985; 
Shults et al., 1985 a; Beaujouan et al., 1986; Buck et al., 1986; Danks 
et al., 1986; Saffroy et al., 1988). 
Explanations for the peptide concentration/receptor density mis-
matches include: 1) technical problems associated with autoradiographic 
techniques; 2) low affinity but physiologically functional binding 
sites, which are not detectable autoradiographically; 3) internaliza-
tion of receptors; and, 4) endogenous ligands occupying.the receptors 
thus preventing the binding of radiolabeled compounds (Herkenham et 
al., 1987). Anatomical substance/receptor mismatch suggests that the 
substance has no function in that particular brain region, or that it 
has some undetectable neurohumoral or maintenance function. Behavior-
al, electrophysiological, and biochemical studies, nevertheless, may 
indicate a function, but the mechanism is unclear. Neurokinin/binding 
site mismatches in the substantia nigra remain an anomaly which, when 
resolved, will surely add to our knowledge of neurotransmitter/receptor 
interactions. 
Recent Advances in Neurokinin Receptor Analysis 
Some recent biochemical studies have led to the solubilization 
and characterization of a specific SP binding protein (Nakata et al., 
1988). 
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Molecular biologists have been able to successfully isolate 
cDNA clones for bovine NKA and SP receptor mRNAs, and to express func-
tional receptors in a Xenopus oocyte system (Masu et al., 1987; Buck et 
al., 1988). These unique and exciting approaches will allow the char-
acterization of neurokinin receptors, and provide models for examining 
ligand-receptor coupling, second messenger systems, and receptor-mem-
brane interactions. 
Electrophysiology 
The electrophysiology of the neurokinins has not been thoroughly 
explored. Until recently, most reports have dealt primarily with the 
effects of SP. A number of studies have reported that iontophoretic 
application or micropressure injection of SP and other neurokinins 
produce excitatory effects. For example, SP induces a slow depolariza-
tion probably by decreasing potassium conductance (Dun, 1985). SP also 
has an excitatory effect on neurons in the hypothalamic-preoptic area 
(Shibota et al., 1988), locus ceruleus (Olpe et al., 1987 b), caudal 
trigeminal nucleus (Salt and Hill, 1980), chick sympathetic ganglia 
(Ramirez and Chiappinelli, 1987), dorsal root ganglia (Roberts and 
Wright, 1981), and interpeduncular nucleus (Sastry, 1978). Both SP and 
NKA have been shown to excite cells in the substantia nigra (Pinnock 
and Dray, 1982; Innis et al., 1985) and spinal cord (Henry, 1976; Henry 
and Salter, 1987). Excitatory and inhibitory responses to SP have been 
observed in the spinal cord (Belcher and Ryall, 1977) and dorsolateral 
septum (Nayar et al., 1987). SP-induced depression of neuronal activ-
ity in the rat olfactory bulb is thought to be mediated by GABA inter-
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neurons (Olpe et al., 1987 a). Although the tachykinins excite spinal 
cord neurons, physalaemin has been reported to enhance the depressant 
effect of adenosine triphosphate (Salter and Henry, 1987). 
Problems encountered in electrophysiological studies with tachy-
kinins include their degradation within and adherence to the glass 
micropipettes used for iontophoresis (Gozlan et al., 1977; Guyenet et 
al., 1979; Lamour et al., 1983). Micropressure application (Palmer et 
al., 1986) does not require ejection or retaining currents, and may be 
a more suitable method for the delivery of these peptides during elec-
trophysiological experiments (Dray et al., 1983). 
Behavioral Effects of Neurokinins 
The majority of studies concerning the behavioral effects of the 
neurokinins have been focused on the A9 and AlO DA cell groups in the 
ventral mesencephalon. SP has been shown to activate DA systems which 
originate in this region (Davies and Dray, 1976; Cheramy et al., 1977). 
The initial behavioral studies found that bilateral infusions of SP 
into the ventral tegmental area (VTA) increased l.MA and enhanced ex-
ploratory behavior (Stinus et al., 1978). These authors also reported 
that the behavioral arousal induced by the systemic administration of 
d-amphetamine was potentiated by a prior infusion of SP into the VTA. 
Subsequent studies suggested that DA neurons mediate SP-induced behav-
ioral arousal. Infusions of haloperidol into and 6-hydroxydopamine (6-
0HDA) lesions of the nucleus accumbens block the hyperactivity produced 
by intra-VTA SP (Kelley et al., 1979). SP infusions into the substan-
tia nigra (SN) have been observed to stimulate l.MA and to produce 
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grooming, stereotyped rearing, and sniffing (Kelley and Iversen, 1978 
a b 1979), which could be blocked by 6-0HDA lesions in the caudate nu-
' ' 
cleus (Kelley and Iversen, 1979). Thus, SP infusions into the VTA 
markedly increase LMA and exploratory behavior, whereas SP infusions 
into the SN produced stereotypic behaviors (Stinus et al., 1978; Kelley 
and Iversen, 1979). The behavioral effects elicited by repeated injec-
tions of SP into the VTA do not change in either their appearance or 
intensity, whereas those observed following repeated SN infusions 
change from increased rearing to increased sniffing and grooming (Stin-
us et al., 1978; Kelley and Iversen, 1979). 
Unilateral intranigral SP infusions increase the activity of 
nigrostriatal DA neurons (Davies and Dray, 1976), increase DA turnover 
in the ipsilateral stria tum (Cheramy et al., 1977; Baruch et al., 
1987), and produce contralateral turning (James and Starr, 1977; Olpe 
and Koella, 1977). James and Starr (1979) later demonstrated that 
infusions of SP into the pars reticulata of the SN produce contralat-
eral circling and increased DA turnover in the ipsilateral neostriatwn, 
whereas infusions into the pars compacta induce ipsilateral circling, 
decreased DA turnover, and increased 5-HT turnover in the ipsilateral 
neostriatwn. 
The behavioral effects observed after SP administration are short 
lived (5-15 min). DiMe-C7, which was developed as a metabolically 
stable SP analogue (Sandberg et al., 1981), produces behavioral effects 
of a greater duration (30-60 min; Eison et al., 1982 a,b). Subsequent-
ly, NKA-immunoreactive fibers and receptors were demonstrated in the 
VTA, and intra-VTA NKA injections were shown to produce behavioral 
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effects after doses approximately ten times lower than the minimally 
effective SP dose (Kalivas et al., 1985). 
Elliott and Iversen (1986) have characterized the behavioral 
effects of the tachykinins after their bilateral administration into 
the lateral ventricles and the VTA. They reported that ELE and DiMe-C7 
were more potent than SP at increasing LMA. These authors also found 
that the ability of the various peptides to produce wet dog shakes and 
grooming varied as a function of the injection site. DiMe-C7 and ELE 
were more potent in producing wet dog shakes when administered into the 
ventricles, whereas DiMe-C7 and SP were more potent when administered 
into the VTA (Elliott and Iversen, 1986). They found that grooming was 
stimulated more effectively by SP and physalaemin by either route of 
administration. These studies illustrate the importance of employing 
several different tachykinins in order to delineate the function of the 
neurokinin receptors in a given brain region. 
Behavioral Effects of Substance P Fragments 
Stewart and colleagues have suggested that the N-terminal and C-
terminal portions of the SP molecule produce different behavioral ef-
fects (Stewart et al., 1982; Hall and Stewart, 1983). Others have ad-
vanced this notion as well (Pinnock et al., 1983). The N- and C-ter-
minal fragments can produce opposite effects on grooming, hot plate 
latencies, and stress-induced analgesia (Hall et al., 1987). These 
differential effects may be due to the processing of the SP molecule 
allowing the cleavage products to bind, perhaps, to different receptors 
(Hall and Stewart, 1983). These findings provide a means to explain 
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the diversity of effects induced by SP. On the other hand, as previ-
ously discussed, the short C-terminal fragments have a higher affinity 
for the NK-3 binding site (Cascieri and Liang, 1983; Torrens e.t al., 
1984; Viger et al., 1985). Thus, the SP fragments many bind to the 
different receptors and thereby produce different functional changes. 
Conformational studies also suggest that the entire SP molecule is 
necessary for biological activity (Ploux et al., 1987; Lavielle et al., 
1988). More work is needed to elucidate the physiological role of SP 
fragments in vivo. 
Avoidance Learning 
SP has been shown to induce an impairment in avoidance learning 
by rats after its injection into the substantia nigra or amygdala, but 
a facilitation in learning when injected into the lateral hypothalamus 
(Huston and Staubli, 1978, 1979). SP infusions into the nucleus basal-
is magnocellularis have been found to facilitate retention of a step-up 
avoidance task (Kafetzopoulos et al., 1986). The N-terminal fragment 
of SP, SPl-4, has been reported to enhance avoidance retention when 
injected into the lateral ventricles (i.c.v.) of mice, but similar 
infusions of SP or its C-terminal portion, SP7-ll, are without effect 
(Pelleymounter et al., 1986). SP also has been found to facilitate the 
acquisition of an appetitively motivated learning task (Schlesinger et 
al., 1986). 
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Reinforcing Properties 
Staubli and Huston (1985) have suggested that SP may be involved 
in rewarding processes. Infusions of SP into the lateral hypothalamus 
(Ul) of rats produce positively reinforcing effects in a conditioned 
place preference paradigm (Holzhauer-Oitzl et al., 1987). The posi-
tively reinforcing properties of SP injected into the LH may be due to 
a local vasodilatory action (Klugman et al., 1980). Others have repor-
ted that intra-LH infusions of SP leads to a reduction in operant 
responding for electrical stimulation of the LH (Goldstein and Malick, 
1977), and that intra-cortical or intra-ventricular infusions of SP 
decrease self-stimulation of the prefrontal cortex (Mora and Ferrer, 
1984). It also has been reported that injections of DiMe-C7 into the 
lateral ventricles may produce aversive effects (Elliott and Iversen, 
1983), whereas injections of DiMe-C7 into the MR may produce rewarding 
effects (Lee, J. et al., 1987). The reinforcing properties of SP and 
DiMe-C7 need to be further examined in order to determine which neuro-
kinin receptor and which site(s) is (are) involved. 
Spinally-Mediated Behavioral Effects 
The effects of intrathecally administered SP and other tachy-
kinins on nociception (Yashpal and Henry 1982, 1983, 1984; Cridland and 
Henry 1986, 1988; Henry and Salter, 1987; Sawynok and Nance, 1987) and 
cardiovascular function (Couture et al., 1985, 1987, 1988; Delbro, 
1987; Hassessian et al., 1987; Helke et al., 1987) have been thoroughly 
studied. Behavioral responses following intrathecal and intracisternal 
administration also have been observed. In mice, intrathecal ad-
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ministration of SP and ELE induces biting and scratching (Hylden and 
Wilcox, 1981; Rackham et al., 1981; Share and Rackham, 1981). More 
recently, Stoessl and colleagues (1987 a, b) demonstrated that ·intra-
cisternal (or subcutaneous) administration of senktide induces wet dog 
shakes and forepaw treading in both mice and rats, presumably by a 
serotonergic mechanism. 
Sexual Behavior 
SP also has been implicated in sexual behavior. Infusions of SP 
into the midbrain central gray has been observed to facilitate lordosis 
(Dornan et al., 1987). Anatomically, SP has been localized in the bed 
nucleus of the stria terminalis, a region known for its role in sexual-
ly differentiated brain function (Valcourt and Sachs, 1979; Malsbury 
and McKay, 1987). Also, infusions of SP into the lateral ventricles 
have been reported to inhibit ovulation in rats (Potargowicz and Trac-
zyk, 1987). 
Neurokinin - 5-HT Interactions in the CNS 
The behavioral and neurochemical effects of neurokinin admin-
istration suggest that these neuropeptide and 5-HT systems interact. 
Neurokinin/5-HT interactions have been deduced by observing the effects 
of drugs which alter 5-HT transmission. The intrathecal administration 
of SP in mice induces hind limb scratching (similar to 5-HT), and the 
effect of intrathecally administered 5-HT can be blocked by an SP an-
tagonist (Fasmer and Post, 1983; Fasmer et al., 1983; Hylden and Wil-
cox, 1981). Ogren et al. (1985) have suggested that SP may modulate 5-
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hydroxytryptophan- induced head twitching. It has been demonstrated 
that i.c.v. administration of 5,7-DHT potentiates the responses to in-
trathecally applied SP (Eide et al., 1988) and decreases SP content and 
immunoreactivity in the medulla and spinal cord (Singer et al., 1979; 
Towle et al., 1986; Pare et al., 1987). Using mice and rats, Stoessl 
and colleagues (1987 a,b) have demonstrated that the intracisternal or 
subcutaneous administration of senktide induces a "5-HT syndrome" 
consisting of head twitches, forepaw treading, hind limb splaying, and 
wet dog shakes, which can be blocked by 5-HT2 antagonists. In addit-
ion, it has been shown that the dose-dependent hyperactivity produced 
by intra-MR infusions of DiMe-C7 can be prevented by prior administra-
tion of PCPA or intra-MR 5,7-DHT administration (Paris and Lorens, 1987 
a,b). The 5-HT3 antagonist, GR38032F, furthermore, has been demonstra-
ted to attenuate both the locomotor hyperactivity and the increase in 
DA turnover in the nucleus accumbens induced by intra-VTA administra-
tion of DiMe-C7 (Hagan et al., 1987). 
Reisine et al. (1982) have reported that SP applied to the sub-
stantia nigra in the cat releases 5-HT in the contralateral caudate 
nucleus. Similarly, SP infusions into the MR increase 5-HT turnover in 
the hippocampus (Forchetti and Meek, 1982). Recently, it has been 
demonstrated that both SP and NKB stimulate basal and potassium-evoked 
5-HT release in rat frontal cortex slices, presumably by distinct 
receptors (Solti and Bartfai, 1987). 
Chronic treatment with the antidepressant drugs, imipramine and 
zimelidine, increases SP concentration in the dorsal and ventral spinal 
cord (Iverfeldt et al., 1986). Imipramine, but not zimelidine, also 
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increases potassium-stimulated SP release in a spinal cord-slice prep-
aration. This is thought to be mediated by 5-HT receptors (Iverfeldt 
et al., 1986). In contrast to imipramine, chronic treatment (14· days) 
with the selective 5-HT reuptake inhibitors, zimelidine and alaproco-
late, has been reported to increase SP-like immunoreactivity (SPLI) in 
the ventral spinal cord, and both SPLI and NKA/NKB-like immunoreactiv-
ity in the periaqueductal gray (Brodin et al., 1985, 1987). Repeated 
administration of imipramine leads to decreases in SPLI and NKA/NKB-
like immunoreactivity in the frontal cortex, whereas alaprocolate pro-
duces opposite effects (Brodin et al., 1987). Cocaine has been report-
ed to increase SPLI in the DR and to decrease pontomedullary 5-HT con-
centrations (Pradhan et al., 1981). 5-Hydroxytryptophan administration 
has been observed to decrease SPLI in the DR (Pradhan et al., 1981). 
Thus, the interactions between 5-HT and the neurokinins are diverse and 
clearly site-dependent. One area which deserves more study is the 
electrophysiological relationship between these two neurotransmitters. 
Conclusions 
Since von Euler and Gaddum's (1931) initial discovery of SP, a 
great deal of information has been generated concerning the anatomy, 
physiology, biochemistry, and molecular biology of the neurokinins in 
both the CNS and periphery. Three distinct binding sites for the 
neurokinins have been identified which has led to the development of 
metabolically stable selective agonists. A variety of behavioral ef-
fects have been observed following neurokinin administration into the 
CNS. However, specific, non-toxic antagonists are required in order to 
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better characterize the functions of the distinct neurokinin recog-
nition sites. A more thorough electrophysiological examination of 
neurokinin effects in the CNS is necessary as well. An anatomical 
analysis of the distribution of neurokinin cell bodies and neuronal 
pathways likewise is needed. 
This dissertation project was designed to elucidate the origin 
and function of the neurokinin projections to the midbrain raphe. The 
objectives were: 1) the differentiation of the behavioral effects pro-
duced by the distinct neurokinin agonists; 2) to determine whether the 
neurokinin-induced behavioral effects depended on the integrity of 5-HT 
neurons; 3) to determine the origin of the neurokinin innervation of 
the raphe; and, 4) to demonstrate the functional significance of MR-
neurokinin-induced behavioral arousal. 
CHAPTER III 
METHODS 
A. Behavioral Studies 
Animals 
Male Sprague-Dawley rats (Sasco-King, Orange, WI), 90-120 days 
old and 27S-32S g at the time of surgery, were used. The animals were 
housed individually in an illumination (12 hr light-dark cycle, lights 
on at 07: 00 h), temperature (22 ± 2°c), and humidity (SO ± S%) con-
trolled facility. Food and water were available ad libitum. Following 
their arrival, the animals were acclimated to their new environment for 
at least one week prior to surgical intervention. 
Cannula Implantation 
The rats were anesthetized with sodium pentobarbital (60 mg/kg, 
i.p.), and treated with atropine sulfate (0.4 mg/kg, i.m., in 0.9% 
saline) and sodium ampicillin (SO mg/kg, i.m., in 0.9% saline). The 
rats were secured in a Kopf stereotaxic frame with the top of the 
incisor bar positioned 3.3 mm below the interaural plane according to 
the atlas of Paxinos and Watson (1986). Thimersol (1:1000), an anti-
septic, was applied topically to the scalp. An incision was made, the 
skull exposed, and a craniotomy performed. A sterile stainless steel 
guide cannula (0.46 mm, o.d. and 0.25 mm, i.d.; Plastic Products, 
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Roanoke, VA) was lowered at an angle 25° lateral to the midsagittal 
plane, 3.2 mm lateral, 7.8 mm ventral and 7.5 mm caudal from bregma. 
The guide cannula contained a sterile stainless steel stylet (0:23 mm, 
o.d.) which extended 0.5 mm beyond its tip. The cannula was secured to 
the skull by means of acrylic cement and stainless steel screws. The 
wound margin was infiltrated with 2.0% lidocaine hydrochloride to min-
imize post-operative pain. The wound was closed with clips, and 1.0% 
chloramphenicol ointment, an antibiotic, was applied topically around 
the wound. Post-operatively the rats were kept warm on a heating pad 
until they regained their righting reflex. All animals were allowed to 
recover for at least one week prior to the initiation of behavioral 
testing. 
Neurotoxin Lesions 
The rats were prepared for surgery as described above. Briefly, 
the subjects were anesthetized with sodium pentobarbital (60 mg/kg, 
i. p.) and pretreated with the norepinephrine (NE) and dopamine (DA) 
reuptake inhibitor, nomifensine maleate (15 mg/kg/2.0 ml 0.9% saline, 
i.p.), 30-40 min prior to the neurotoxin infusion. One group of rats 
(n - 11) was first implanted with intra-MR cannulae. They then re -
ceived an infusion of 5,7-DHT (8.0 µg, as the base, in 2.0 µl of 0.1% 
ascorbate in 0.9% saline) directly through the cannula. The drug was 
infused by a microsyringe pump (Model CMA/100, Carnegie Medic in AB, 
Solna, Sweden) over 10 min (0.2 µl/min). The internal cannula was left 
in situ an additional 3-5 min to allow adequate spread of the solution 
away from the tip. The stylet then was replaced and the animal allowed 
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to recover. In addition, two small burr holes were drilled in the 
skull at the point of entry for the medial forebrain bundle (MFB) 
injections (see below). 
The second group of rats (n = 11) received a bilateral infusion 
of 5,7-DHT (8.0 µg, as the base, in 3.0 µl/side in the ascorbate ve-
hicle) into the MFB via 28 gauge stainless steel tubing. Using bregma 
(p) as the reference point, the coordinates were: anteroposterior, P-
3.8 mm; mediolateral, p ± 1.7 mm; dorsoventral, p - 8.7 mm. The drug 
was infused over 10 min (0. 3 µl/min), and the injection cannula was 
left in situ an additional 3-5 min to allow adequate spread of drug. 
Immediately following the infusion of 5,7-DHT, an intra-MR cannula was 
implanted. 
Two separate groups of control rats were prepared. One group (n 
- 5) was implanted with MR cannulae, then infused with 2.0 µl of ascor-
bate vehicle in a manner identical to the MR 5,7-DHT lesion group. The 
second group of controls (n - 5) received a bilateral infusion of 
ascorbate vehicle (3.0 µl/side) into the MFB, as described above, prior 
to MR cannula implantation. 
Apparatus 
Locomotor activity measures were obtained using darkened, enclos-
ed, cylindrical photocell chambers (46 cm diam x 42 cm high; LVE Model 
#PAC-001) with wire mesh floors (n - 10). Activity counts were gener-
ated by interruption of any one of six photocell beams located at the 
base of the chamber and recorded on a digital counter. 
r 1 
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Open field activity was observed using a plywood arena (100 x 100 
cm) with 40 cm high unpainted walls. Illumination was provided by a 40 
w bulb centered 1.0 m above the floor. The floor was painted white and 
divided by thin black lines into 25 equal squares (20 x 20 cm). The 
floor of the open field was elevated 7. 5 cm above the floor of the 
testing room. Equidistantly spaced holes (3. 5 cm diameter) were lo-
cated in the four corner squares of the central nine squares to permit 
measurement of head pokes. A head poke was defined as the lowering of 
the animal's snout into a hole. The space directly below the arena 
(visible through the holes) was illuminated with a 25 cm, 20 W fluores-
cent tube. Each animal's behavior was videotaped for subsequent anal-
ysis. 
Handling and Habituation 
The rats were handled daily beginning 7 -10 days after surgery. 
After 2-3 days of handling, habituation to the photocell chambers was 
initiated. Each rat was placed individually into an apparatus. Thirty 
min later, the animal was removed, gently wrapped in a towel for 30-60 
sec, then returned to the chamber for 30 min. This procedure was 
repeated for five consecutive days (Days 1-5) in order to adapt each 
rat to the injection procedure. All behavioral testing was conducted 
between 09:00-14:00 h, and each rat was always tested in the same 
photocell cage. 
For the open field experiments, the rats were handled daily 
beginning 7 -10 days after surgery. For the studies which were con-
ducted in a novel open field, the rats were removed from their home 
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cage and adapted for 3 days to the injection procedures as described 
above. Later, on each of these 3 days, each rat was handled for 1-2 
min to further accustom the animal to the experimenter. The rats were 
exposed to the open field only once, on the day of drug testing. For 
the studies which involved habituation to the open field chamber, each 
rat was removed from its home cage, gently wrapped in a towel as de-
scribed above, then placed in the center of the open field arena. The 
rat was allowed to explore the arena for 30 min, after which time it 
was removed and returned to its home cage. This procedure was repeated 
for five consecutive days. Drug effects were examined on the sixth 
day. The chamber was thoroughly cleaned with warm water and dried 
after removal of each rat. All testing was conducted between 09:00-
14:00. Each rat's behavior was videotaped for subsequent analysis. 
The following beha~iors were quantified: the number of wall and center 
squares entered, rears (rat stands on hind limbs and sniffs), and head 
pokes. 
Drug: Testing: 
Drug testing for the LMA experiments began on the day (Day 6) im-
mediately following the last day of habituation. Vehicle or different 
drug doses were administered every other day, in a randomized fashion. 
The animals were placed in the chambers daily for 60 min, but no data 
were collected on non-drug days. Total activity counts for the 30 min 
of post-drug testing were recorded. 
The injection procedure consisted of removing the animal after 
the 30 min pre-drug habituation period, and gently wrapping it in a 
... 
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towel. The stylet was removed and replaced with the internal cannula 
which was connected, via polyethylene tubing, to a 25 µl Hamilton syr-
inge driven by a microsyringe pump (Model CMA/100, Carnegie Medic.in AB, 
solna, Sweden). The drugs and vehicle were administered at a rate of 
1.0 µl/min. The volume of all infusions was 1.0 µl and the total time 
for each infusion was 1.0 min. Upon completion of the injection, the 
internal cannula was left in situ for an additional 30 sec, after which 
time it was removed and the stylet replaced. 
For the open field studies, the rats were removed from their home 
cages, gently wrapped in a towel, and infused with a neurokinin or 
vehicle as described above. Following completion of the drug infusion, 
the rat was immediately placed in the center of the open field arena, 
and its behavior videotaped for 24 or 30 min. 
turned to its home cage. 
The rat then was re-
DiMe-C7 [ (pGlu5, MePhe8, Sar9)substance P 5-11], neurokinin A 
(NKA), substance P (SP), neurokinin B (NKB), eledoisin (ELE), kassinin 
(KAS), physalaemin (PHY) (Peninsula Laboratories, Belmont, CA), and 
senktide [(succinyl-Asp6, MePhe8)substance P 6-11] (Bachem, Torrance, 
CA) were prepared according to the method of Stewart (1982). The ly-
ophilized peptides were dissolved in 0.01 M acetic acid and diluted to 
a stock concentration with phosphate buffered saline (PBS; pH 7. 4) . 
The stock solutions (DiMe-C7: 6.0 µg/µl; NKA: 6.0 µg/µl; SP: 3.3 µg/µl; 
senktide: 2.0 µg/µl; ELE: 3.3 µg/µl; KAS: 3.5 µg/µl; PHY: 6.0 µg/µl) 
then were aliquoted and kept frozen (-20°C). On each drug day, an 
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aliquot was thawed and diluted with vehicle (PBS with 0.01 M acetic 
acid added, pH 7.2). 
NKB first was dissolved in 88% formic acid, then diluted to a 
stock concentration (4.4 µg/µl) with phosphate buffer (pH 11.8). The 
stock solution was aliquoted and kept frozen ( - 20°C) . On each drug 
day, an aliquot was thawed and diluted with vehicle (PBS with 88% 
formic acid added, pH 3.8). 
All peptide solutions were kept dark and cold until used. Care 
was taken throughout to avoid the use of glass or polystyrene which 
will bind the peptide and dramatically alter the amount delivered 
(Stewart, 1982, 1983). 
Peptide doses were calculated as moles/µl. In order to account 
for differences in purity which can affect the desired drug concentra-
tion (Stewart, 1982), analyses were obtained from each manufacturer for 
each batch of peptide received. These can be found in Appendix I. The 
purity of all peptides was greater than 80%. The molar concentrations 
used took into consideration the purity of the peptide, and stock 
solutions were appropriately prepared. These calculations also can be 
found in Appendix I. 
Sodium pentobarbital was obtained from Butler (Columbus, OH); 
thimersol (MerthiolateR) from Eli Lilly (Indianapolis, IN); lidocaine 
hydrochloride (XylocaineR) from Astra (Worchester, MA); chloramphenicol 
(ChloromycetinR 1.0% ophthalmic ointment) from Parke-Davis (Morris 
Plains, NJ); atropine sulfate, sodium ampicillin and 5,7-dihydroxy-
tryptamine-creatinine sulfate were purchased from Sigma (St. Louis, 
MO). 
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Neurochemical Measurements 
The animals were sacrificed by decapitation, their brains re-
moved, and dissected on a brass plate over ice. The amygdala, hippo-
campus, hypothalamus, medial frontal cortex, nucleus accumbens and 
striaturn were obtained using a modification of the method described by 
Heffner et al., (1980). The tissue was immediately frozen on dry ice, 
then placed in microcentrifuge tubes and stored at -80°C. Tissue 
levels of 5-HT, 5-hydroxyindoleacetic acid (5-HIAA), DA, dihydroxy-
phenylacetic acid (DOPAC), norepinephrine (NE), and homovanillic acid 
(HVA) were determined within 1-2 weeks in each of the brain areas by 
high performance liquid chromatography (HPLC) with electrochemical 
detection. 
The frozen brain samples were weighed and sonicated in 0.1 N per-
chloric acid (PCA) containing 0 .1 mM ethylenediaminetetraacetic acid 
(EDTA), 2. 0 mM sodium metabisulfite (an antioxidant), 50 ng of the 
internal standard, N-methyl-5-hydroxytryptamine (NMS-HT), and/or 10 ng 
of the internal standard, 3, 4-hydroxybenzylamine (DHBA). The homog-
enate then was centrifuged at 15,000 x g for 10 min. 
For brain regions which did not require concentration of the 
amines and metabolites (nucleus accumbens and striaturn), the resulting 
supernatant was aspirated, added to minivials, then placed into a Beck-
man 504 autosampler at room temperature. The mobile phase consisted of 
0.15 M monochloroacetic acid, 0.8 mM EDTA, 18% methanol and 100 mg/L of 
octanylsulfonic acid (OSA). The retention times for these conditions 
were: DA, 5.2 min; DOPAC, 6.5 min; 5-HIAA, 9.9 min; 5-HT, 11.2 min; 
NMS-HT, 13.3 min; HVA, 15.2 min. 
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For brain regions which required concentration of the amines and 
their metabolites (amygdala, hippocampus and medial frontal cortex), an 
alumina extraction was performed. The supernatant (100 µl) from the 
initial centrifugation was added to 50 mg activated alumina. To this 
suspension, 50 µl of 3.0 M Tris-HCl (pH 8.4) was added and shaken 
vigorously for 10 min. Then, 40 µl 0.1 N PCA was added and the suspen-
sion centrifuged for 2.0 min. The supernatant was aspirated, added to 
mini vials, and loaded into the autosampler at room temperature. The 
mobile phase consisted of 0.15 M monochloroacetic acid, 0.8 mM EDTA, 
20% methanol, and 10 mg/L of OSA. The retention times for the substan-
ces contained in the supernatant were: 5-HT, 5.7 min; NMS-HT, 6.9 min; 
5-HIAA, 9.9 min. 
The alumina pellet from the above extraction was washed twice in 
200 µl of 2.0 mM Tris-HCl containing 2.0 mM sodium metabisulfite, 
vortexed, then centrifuged for 5.0 sec. Following the second wash, 50 
µl of 0. 2 N PCA containing 2. 0 mM sodium metabisulphite was added to 
the alumina pellet. The samples then were shaken vigorously and cen-
trifuged for 5.0 sec. The resulting supernatant was aspirated, added 
to minivials and loaded into the autosampler. The mobile phase consis-
ted of 0.15 M monochloroacetic acid, 0.8 mM EDTA, 15% methanol, and 750 
mg/L of OSA. The retention times for the substances contained in the 
supernatant were: NE, 5.1 min; DOPAC, 6.4 min; DHBA, 8.6 min; and DA, 
12.4 min. 
All mobile phases were filtered (0.2 µm), degassed under a vac-
uum, and delivered via a Beckman solvent delivery system (Model llOB). 
The flow rate for all separations was 0.9 ml/min. Aliquots of tissue 
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samples or standards were injected (20 µl) onto a reverse-phase column 
(S.0 µm 4.6 mm x 15 cm Beckman column. Rainin Co., Woburn, MA) equipped 
with a guard column [Bioanalytical Systems (BAS), West Lafayette·, IN]. 
The effluent from the analytical column was passed through a BAS LC-4 
electrochemical detector using a glassy carbon electrode with an ap-
plied potential of +0.74 V. The electrical output was quantified using 
a Beckman integrator (Model 427; Spectra-Physics, Santa Clara, CA). 
Sacrifice 
The animals used in the 5,7-DHT lesion study were sacrificed by 
decapitation. Rats used in all other experiments were injected with an 
overdose of sodium pentobarbital (90 mg/kg, i.p.) and perfused trans-
cardially with isotonic saline (100 ml) followed by 10% buffered form-
alin (100 ml). The brain stems were stored in formalin for at least 
two weeks prior to histological analysis. 
Histology 
Frozen coronal sections (50 µm) through the cannula placements 
were cut on a sliding microtome. Every fourth section was float mount-
ed from cold phosphate buffered saline (PBS) onto gelatin-chrome alum 
coated "subbed" slides, and subsequently stained with cresyl violet 
acetate. A representative cannula placement is depicted in Fig. 1 
(p.62). 
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Statistical Analysis 
All data were subjected to the appropriate analysis of variance 
(ANOVA). Post-hoc comparisons of means were made with Duncan's multi-
ple range test (Winer, 1971). For the repeated measures analyses, 
post-hoc comparisons were made only on the factors which were deter-
mined by the ANOVA to be significant at the 0. 05 probability level. 
Data from the NKB injection study were analyzed with a Student's t-test 
(two-tailed). The neurochemical data were analyzed by ANOVA or Stu-
dent's t-test where appropriate. In order to compare the relative 
potencies of the various tachykinins for eliciting hyperactivity, the 
data were analyzed by means of a regression analysis of the log-doses 
of the peptide versus the total activity. Tests for parallelism were 
performed on the various regression lines (Kenakin, 1987; Tallarida and 
Jacob, 1979) utilizing the computer programs of Tallarida and Murray 
(1979). 
B. Anatomical Studies 
Animals 
Rats were obtained and housed as described above (p. 44). 
!" 
' 
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Retrograde Tracing 
Iontophoresis 
Glass micropipettes with a tip diameter of 15-20 µm were made 
from glass tubing (100 µm outside diameter) using a Narashige electrode 
puller. 
The rats were anesthetized with sodium pentobarbital (60 mg/kg, 
i.p.); treated with sodium ampicillin (50 mg/kg, i.m.) and atropine 
sulfate (0.4 mg/kg, i.m.); and, placed in a Kopf stereotaxic apparatus. 
An incision was made and a craniotomy performed. Fluoro-Gold (FG) was 
iontophoresed into the MR, with the aid of a dissecting microscope, 
using the following coordinates: anteroposterior, bregma (p) - 7.5 mm; 
mediolateral, p ± 3.4 mm; dorsoventral, p - 7.7 mm. These were deter-
mined empirically by iontophoresing the dye, fast green. A Midguard 
constant current generator (Harvard Apparatus Inc., South Natick, MA) 
supplied 7.0 sec pulses of a 6.0 µA positive current every 7.0 sec for 
20 min. The current was applied to the solution in the pipette by 
means of a silver wire, and the circuit was completed by attaching an 
alligator clip to the wound margin. Following iontophoresis, the 
pipette was retracted from the brain, the wound margin closed with 
clips, and the animal placed on a heating pad until it recovered. The 
rats were sacrificed 7-14 days post-operatively. 
Perfusion 
The rats were administered an overdose of sodium pentobarbital 
(90 mg/kg, i.p.) and perfused transcardially with 200 ml of phosphate 
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buffered saline (0.1 M, pH 7.4, 700 ml/hat 4°C) followed by 400 ml of 
4.0% paraformaldehyde in 0.1 M phosphate buffer (600 ml/h at 4°C). 
Immediately prior to infusing the first solution, a bolus of heparin 
sulfate (300 U in 300 ul) was administered through the aortic cannula. 
Prior to the infusion of the fixative, the rat was placed on ice. The 
brain was removed, blocked and post-fixed for 60 min at room temper-
ature. In one rat (FLG-I3), the lower medulla and spinal cord also 
were removed. The brain then was transferred to a solution containing 
20% sucrose and 0.01% bacitracin in 0.1 M phosphate buffer, and stored 
for 1-7 days at 4°c. 
Tissue Sectioning and Processing 
The brains were frozen onto cryostat chucks with O.T.C embedding 
mediwn and sectioned in a microtome-crytostat (Hacker-Bright Model 
5031, Fairfield, NJ) maintained at -20°c. Coronal sections (18-25 µm) 
were obtained and placed in ice-cold PBS. Two series of adjacent sec-
tions were saved every 100 µm, and float-mounted onto gelatin-chromiwn 
potassiwn sulfate-coated ("subbed") slides. One series was processed 
for the visualization of Fluoro-Gold labeling and counterstained with 
0. 01% ethidiwn bromide (Schmued et al., 1982), while the other was 
stained with cresyl violet acetate. 
Immunocytochemistry 
Colchicine Pretreatment 
In order to visualize neurokinin perikarya, colchicine pretreat-
ment was used (Dahlstrom, 1971; Cuello et al., 1983; Skirboll and Hok-
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felt, 1983). Bilateral intracerebroventricular (i.c.v.) injections of 
colchicine (60 µg in 10 µl 0.9% saline) were made stereotaxically, un-
der pentobarbital anesthesia (60 mg/kg, i.p.). The coordinates. were: 
anteroposterior, ~ + 1.0 mm· 
' 
mediolateral, ~ ± 1.0 mm; dorsoventral, ~ 
- 4.3 mm. In one rat, an intrathecal injection of colchicine (100 
µg/10 µl) was made via PE-10 tubing introduced through the dura at the 
level of the first cervical vertebra, and gently lowered to the thor-
acic level. Colchicine infusions were performed 24-48 h prior to 
sacrifice. 
Perfusion 
The rats were administered an overdose of pentobarbital and 
perfused transaortically with 200 ml of calcium-free Tyrodes solution 
(700 ml/h at 4°C) followed by 400 ml of 4.0% paraformaldehyde in 0.1 M 
phosphate buffer, containing 0. 4% saturated picric acid ( 600 ml/h at 
4°c). 
Antisera 
The following primary antisera were used: rabbit anti-SP (Inc-
star, Inc., Stillwater, MN); rabbit anti-SP (SP2); and, rabbit anti-NKA 
(NKA2). The SP2 and NKA2 antisera were generously provided by Dr. 
Ernst Brodin of the Karolinska Institute. (Sweden), and have been char-
acterized with respect to their specificity and cross-reactivity (Bro-
din et al., 1986). All lyophilized antisera were rehydrated in double-
distilled water, aliquoted, and stored at -80°C. Thawed antisera were 
diluted in PBS which contained 0.2-0.3% Triton-X-100 (a detergent which 
r 
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enhances antibody penetration into tissue) and 0. 01% bacitracin (as a 
bacteriostat). This solution served as the diluent for the secondary 
antisera as well. The concentrations of primary antisera which p"rovid-
ed the best staining were: SP-Incstar, 1:500; SP2 and NKA2, 1:100. 
Two different secondary antisera were used. One was a swine 
anti-rabbit irnrnunoglobulin G (IgG) conjugated to fluorescein-isothio-
cyanate (FITC; Dakopatts, Sweden) diluted 1:10. The other was a bio-
tinylated goat anti-rabbit IgG (Vector Labs, Burlingame, CA) diluted 
1:200. This latter antibody required the use of an avidin-FITC con-
jugate diluted 1:200 in 10 mM HEPES buffer in 0.9% saline (pH 8.6). 
Tissue Sectioning and Processing 
The tissue was placed in the cryostat at -20°C, and sectioned as 
described above. Coronal sections (20 µm) were placed into culture 
dishes (3-4 per well) and processed free-floating. The 10 µm sections 
were thaw-mounted onto "subbed" slides prior to processing. The thaw-
mounted sections were brought to room temperature and rehydrated in PBS 
(10 min). All sections first were incubated in the antibody diluent 
(PBS with 0.2-0.3% Triton X-100 and 0.01% bacitracin) for 20-30 min. 
When the avidin-biotin method was used, the diluent also included 5-10% 
normal goat serum in order to block non-specific avidin binding. 
Following 3 x 10 min washes in PBS, the sections were incubated in the 
primary antisera at the appropriate dilution for 24-48 h at 4°C. The 
sections then were washed in PBS (3 x 10 min) and incubated with the 
secondary antibody at 37°C (FITC labeled swine anti-rabbit IgG) or room 
temperature (biotinylated goat anti-rabbit IgG) for 60 min. Following 
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3 x 10 min washes in PBS, the sections were mounted onto "subbed" 
slides, air dried, and covers lipped with DePex mounting media which 
contained 2.0% ~-mercaptoethanol to retard fluorescent fading (Dr. C. 
Saper, University of Chicago, personal communication). Prior to the 
final washes, the sections which had been processed with the biotin-
ylated secondary antibody were incubated with the FITC labeled-avidin 
for 60 min at room temperature. 
Microscopy 
A Leitz Dialux 20 microscope equipped with a 35 mm camera was 
used to visualize the FG, FITC, and ethidium bromide staining. Photo-
micrographs were obtained using epi-illumination and Ploemoptics with 
the appropriate filter combination. FG labeled cells were examined 
using a "blue" filter combination (Leitz cube A; 340-380 nm excitation 
and 430 nm barrier filters). FITC positive material was observed using 
a "green" filter combination (Leitz cube 12; 450-490 nm excitation and 
515 nm barrier filters). Ethidium bromide staining was visualized 
using a "red" filter combination (Leitz N2 cube; 530-560 nm excitation 
and 580 nm barrier filters). Photomicrographs were obtained with 
either black and white print (T-Max; ASA 400) or color slide (Ekta-
chrome; ASA 400; Eastman Kodak Co., Rochester, NY) film. 
CHAPTER IV 
RESULTS 
A. Behavioral Studies 
Experiment I: DiMe-C7 Dose-Response 
Procedure 
In the first experiment we replicated and extended our earlier 
findings that intra-MR DiMe-C7 dose-dependently increases LMA (Paris 
and Lorens, 1987 a,b), using a wider range of doses. Following five 
days of habituation to the apparatus, the rats (n - 10) received seven 
intra-MR injections, each separated by 48 h. Vehicle (1.0 µl) and six 
doses (11.4, 34.2, 114, 342, 1140 and 3420 pmol) of DiMe-C7 were ad-
ministered once according to a randomized design. 
Results 
The cannulae placements in the 10 rats used in this study are 
shown schematically in Appendix II (Fig A). As we have discussed 
previously (Paris and Lorens, 1987 a), the repeated drug administration 
protocol used in the present studies (one injection every other day) 
not only yields very reproducible behavioral effects with no apparent 
tolerance development, but minimal glial scarring (Fig. 1). 
In agreement with our previous reports (Paris and Lorens, 1987 
a,b), intra-MR infusions of DiMe-C7 produce dose-dependent increases in 
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LMA (Fig. 2). An ANOVA revealed a significant drug treatment effect 
[F(6,54) - 28.8, p < 0.001]. A post-hoc comparison of means indicated 
that I.MA was significantly (p < 0.01) elevated following all doses of 
DiMe-C7 except the 11. 4 pmol dose. The effects of the two highest 
doses, 1140 and 3420 pmol, were not significantly different from each 
other, but were significantly greater than those of the lower doses. 
In addition, the effects of the 342 pmol dose were significantly great-
er than those after the 34.2 pmol dose. 
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Fig. 1. MR Cannula Placement: Photomicrograph (x25) of a 50 µm coronal 
section (cresyl violet stain) showing a cannula tip (arrow) 
which terminated in the ventral part of the median raphe nu-
cleus (MR) in an animal from Experiment II. The cannula tracks 
in all rats were associated with glial scarring which approxi-
mated 0.5 mm in diameter. 
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Fig. 2. DiMe-C7 Dose-Response: Total activity for 30 min post-injec-
tion of vehicle (Veh) and different doses of DiMe-C7. Data 
represent mean ± SEM for n - 10 rats. Significant difference 
from corresponding Veh: * p < 0.05 (ANOVA followed by Duncan's 
multiple range test). X-axis is a log scale. 
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Experiment II: Non-Mammalian Tachykinin Dose-Responses 
Procedure 
In this experiment, the non-mammalian tachykinins, ELE, KAS and 
PHY, were tested. Three separate groups of rats (n - 7 - 10 per group) 
were used, one for each peptide tested. 
A linear regression analysis of the results from the first ex-
periment indicated that three doses of DiMe-C7 produced increases in 
activity which were approximately 30, 50 and 90% of the maximal respon-
se. These doses were: 30, 230 and 1140 pmol, respectively. The same 
three doses of the tachykinins were selected in order to compare their 
effects on LMA. In addition, all rats received an injection of a sub-
maximal dose of DiMe-C7 (230 pmol) for purpose of comparison. 
Following the five day habituation period, the rats received five 
intra-MR injections, each separated by 48 h. Vehicle (1.0 µl), a test 
dose of DiMe-C7 (230 pmol), and the three doses of the particular pep-
tide (30, 230 and 1140 pmol) were administered according to a ran-
domized design. 
Results 
The cannulae placements for the 24 rats used in this study are 
depicted schematically in Appendix II (Fig. A). 
Fig. 3 shows the effects of the non-mammalian tachykinins on LMA. 
An initial analysis confirmed that there were no significant group 
differences in the activity levels following the injections of vehicle 
[F(2,21) - 2.23, p > 0.10] or DiMe-C7 [F(2,21) - 2.95, p > 0.10]. 
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Therefore, for the sake of simplicity, the vehicle and DiMe-C7 scores 
were combined for all three groups for both statistical and graphical 
purposes. 
Further analysis of the 30 min post-drug activity scores indi-
cated a significant group effect [F(2,21) - 23.48, p < 0.001] and a 
significant effect of peptide dose [F(4,84) - 24.60, p < 0.001]. The 
interaction between the group and dose factors also was significant 
[F(S,84) - 2.19, p 0. 05]. 
All doses of ELE significantly elevated LMA. The activity levels 
observe.d following infusions of the 30 and 230 pmol doses were not 
significantly different from each other, but were significantly less 
than after infusions of the 1140 pmol dose. The effect produced by 
1140 pmol of ELE was equivalent to that produced by the 230 pmol test 
dose of DiMe-C7. 
A post-hoc comparison revealed that only the two highest doses of 
KAS tested, 230 and 1140 pmol, significantly elevated LMA compared to 
vehicle. In addition, the activity levels following all doses tested 
were significantly less than those induced by the DiMe-C7 test dose 
(230 pmol). Although only the two highest doses tested produced LMA 
effects which were significantly different from those following the 
vehicle injections (p < 0.05), the LMA effects after these three doses 
of KAS did not significantly differ from each other. 
For PHY, only the two highest doses, 230 and 1140 pmol, signif-
icantly elevated LMA in comparison to vehicle injections. The LMA fol-
lowing infusions of all doses tested was significantly less (p < 0.05) 
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than that produced by DiMe-C7 (230 pmol). The effects of the three PHY 
doses, furthermore, did not significantly differ from each other. 
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Fig. 3. Tachykinin Dose-Response: Total activity for 30 min post-
injection of vehicle (Veh), DiMe-C7 and three doses of ele-
doisin (ELE), kassinin (KAS) and physalaemin (PHY) in separate 
groups of rats (n - 7-9 per group). Data represent mean± SEM. 
Significant difference from Veh: * p < 0.05 (ANOVA followed by 
Duncan's multiple range test). 
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Experiment III: Mammalian Neurokinin Dose-Responses 
Procedure 
This experiment was conducted identically to Experiment II except 
for the peptides tested. The mammalian tachykinins, neurokinin A and 
substance P, and the neurokinin B agonist, senktide, were tested. 
Results 
The cannula placements for the 21 rats used in this study are 
depicted schematically in Appendix II (Fig A). 
An initial analysis of the 30 min post-drug total activity scores 
following vehicle [F(2,18) - 1.02, p > 0.3] and DiMe-C7 [F(2,18) -
0. 46, p > 0. 3] injections confirmed that there were no significant 
differences between the three groups of rats. Therefore, both the 
vehicle and DiMe-C7 scores for all three groups were combined for 
statistical and graphical purposes. 
Fig. 4 shows that all three of the neurokinins increased LMA. An 
ANOVA indicated that there was a significant effect of the dose of the 
particular peptide [F(4,72) = 26.14, p < 0.001], as well as a signif-
icant difference between the three groups [F(2,18) - 9.60, p < 0.001]. 
The interaction between dose and group also was significant [F(8,72) -
8.59, p < 0.01]. 
For the senktide group, all three doses (30, 230, and 1140 pmol), 
significantly increased LMA compared to the effects of both vehicle and 
DiMe-C7. Further analysis indicated that the LMA increases produced by 
the 230 pmol dose was significantly greater than that produced by 30 
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pmol dose, and that the hyperactivity produced by the 1140 pmol dose 
was significantly greater than that following the 30 and 230 pmol 
doses. 
All three doses of NKA significantly elevated I11A compared to 
vehicle. The hyperactivity produced by 1140 pmol was significantly 
greater than that induced by the 30 and 230 pmol doses, as well as the 
DiMe-C7 test-dose (230 pmol). The increases in I11A produced by the 30 
and 230 pmol doses of NKA did not differ significantly from each other, 
or from those observed following DiMe-C7 (230 pmol) administration. 
For the SP group, only the highest dose tested (1140 pmol) sig-
nificantly increased I11A compared to vehicle. The increase in I11A pro-
duced by the 1140 pmol dose was significantly greater than that ob-
served following the 30 pmol SP dose, but did not differ from the 
increase in activity produced by the DiMe-C7 test-dose. 
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Fig. 4. Neurokinin Dose-Response: Total activity for 30 min post-
injection of vehicle (Veh), DiMe-C7 and three doses of senktide 
(SENK), neurokinin A (NKA) and substance P (SP) in separate 
groups of rats (n - 8 per group). Data represent mean± SEM. 
Significant difference from Veh: * p < 0.05 (ANOVA followed by 
Duncan's multiple range test). 
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Experiment IV: NKA Low Dose-Response Study 
Procedure 
Following the five day habituation period, the rats (n = 7 per 
experiment) received five intra-MR injections each separated by two 
days. Vehicle (1.0 µl) and four doses (1.0, 3.0, 10 and 30 pmol) of 
NKA were administered according to a randomized design. Prior to 
sacrifice and histological analysis, some of the rats were used in 
Experiment VI. 
Results 
The cannulae placements for the eight rats used in this study are 
shown schematically in Appendix II (Fig. A). 
Fig. 5 shows that NKA dose-dependently increased LMA. An ANOVA 
indicated that there was a significant effect of NKA on LMA [F(4,28) ~ 
13. 8' p < 0. 001] . A post-hoc comparison of means revealed that only 
the 30 pmol dose significantly elevated LMA compared to the vehicle 
injections. The increase in LMA produced by the 30 pmol NKA dose was 
equivalent to that observed in Experiment III (Fig.4). As seen in Fig. 
5, injections of 1.0 and 3.0 pmol of NKA decreased LMA, however, this 
was not statistically significant (0.05 < p < 0.10). 
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Fig. 5. Neurokinin A Low Dose-Response: Total activity for 30 min 
post-injection of vehicle (Veh) and varying doses of neurokinin 
A. Data represent mean ± SEM for n - 8 rats. Significant 
difference from corresponding Veh: * p < 0.05 (ANOVA followed 
by Duncan's multiple range test). X-axis is a log scale. 
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Experiment V: Senktide Low Dose-Response Study 
Procedure 
This experiment was conducted identically to Experiment IV except 
for the peptide studied. Senktide was tested at the same four doses 
used in the previous experiment. 
Results 
The cannulae placements for the 8 rats used in this study are 
schematically represented in Appendix II (Fig. A). 
Fig. 6 shows that senktide dose-dependently increased l.MA. An 
ANOVA indicated that there was a significant effect of senktide on l.MA 
[F(4,28) - 16.5, p < 0.001]. Post-hoc comparisons of means showed that 
all of the senktide doses tested, except 1.0 pmol, significantly eleva-
ted l.MA. The increase in l.MA produced by the 30 pmol dose was equiv-
alent to that observed in Experiment III (Fig. 4). Further analysis 
showed that the increasing doses of senktide each produced significant-
ly greater effects on l.MA than the immediately lower dose. Thus, the 
l.MA effect of the 30 pmol dose was significantly greater (p < 0. 05) 
than that following 10 pmol, which was greater than that following 3.0 
pmol, which was greater than that following the 1. 0 pmol dose, which 
was equal to that following vehicle injections. 
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Fig. 6. Senktide Low Dose-Response: Total activity for 30 min post-
injection of vehicle (Veh) and varying doses of senktide. Data 
represent mean ± SEM for n - 8 rats. Significant difference 
from corresponding Veh: * p < 0.05 (ANOVA followed by Duncan's 
multiple range test). X-axis is a log scale. 
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Re&ression Analysis 
Fig. 7 shows the regression analysis performed for the .tachy-
kinins and analogues studied. An initial analysis of activity follow-
ing vehicle infusions showed that there were no significant differences 
between the groups of rats [F(8,62) - 2.02; p > 0.05]. The grand mean 
± SEM for all the vehicle scores was 624 ± 24. Analysis of the DiMe-C7 
test scores also did not reveal any significant group differences 
[F(5,39) - 1.95; p > 0.10]. The grand mean± SEM for all DiMe-C7 test 
scores was 1220 ± 43. 
Tests for parallelism indicated that the senktide and DiMe-C7 
regression lines were not significantly different (t - 0.56, df - 8; p 
* > 0.05). Both the senktide and DiMe-C7 slopes, however, were signif-
icantly different from the SP and NKA lines. The SP and NKA regression 
lines, moreover, did not differ significantly (t - 1.54, df - 2; p > 
0.05). The relative positions of the lines indicate that senktide was 
more potent than DiMe-C7, and NKA was more potent than SP. 
Analysis of the regression lines for the non-mammalian tachy-
kinins indicated that they were parallel, and that their slopes were 
significantly different from those of senktide and NKA, but not SP. It 
should be noted, however, that the slopes for the non-mammalian com-
pounds were relatively flat indicating a lack of dose-dependent effects 
within the range of doses tested. 
* For the sake of clarity, only the most relevant t-values are 
given. 
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Fig. 7. Regression Analysis: Regression lines of total activity for 30 
min post-injection versus tachykinins dose in pmol (log scale). 
Regression lines: senktide: 
DiMe-C7: 
NKA: 
SP: 
ELE: 
KAS: 
PHY: 
y - 585(x) 
y - 622(x) 
y - 345(x) 
y - 128(x) 
y = 87(x) 
y - 22(x) 
y = 89(x) 
+ 608 
+ 138 
+ 393 
+ 578 
+ 781 
+ 751 
+ 566 
Veh = grand mean of vehicle activity scores; DiMe-C7 (230 pmol) 
- grand mean of test dose activity scores. 
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Experiment VI: Intra-MR NKB Injections 
Procedure 
Rats from Experiments IV (n = 4) and V (n = 5), as well as two 
naive rats, were habituated to the testing apparatus for five days. On 
the sixth day the rats received an injection of either the formic acid 
vehicle (1.0 µl) or NKB (3.0 pmol). They were sacrificed by decapita-
tion immediately following removal from the testing chamber. 
Results 
The cannulae placements in the rats which received injections of 
either the formic acid vehicle or NKB are included in Appendix II (Fig. 
A). The cannulae placements for the two additional rats (not shown) 
were comparable. 
Fig. 8 shows the 30 min total activity following either formic 
acid vehicle or NKB (3.0 pmol) injections. NKB significantly elevated 
LMA (t = 3.31, df = 9, p < 0.01). For the purpose of comparison, the 
activity levels obtained in Experiment V following injections of ve-
hicle or senktide (3.0 pmol) are presented in Fig. 8. NKB elevated Ll1A 
to a level equivalent to that seen with an equimolar dose of senktide 
(t 1.94, df - 11, p > 0.05). 
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Fig. 8. Neurokinin B Infusions: Total activity for 30 min post-injec-
tion of vehicle (Veh), neurokinin B (NKB) and senktide (SENK; 
from Experiment V). Data represent mean ± SEM. Significant 
difference from corresponding Veh: * p < 0. 05 (Student's t-
test). 
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Experiment VII: 5.7-Dihydroxytryptamine (5.7-DHT) Lesions 
Procedure 
Beginning 14 days post-operatively, and following two days of 
handling, the animals were habituated to the testing apparatus for five 
days, 60 min per day. The day immediately following the last day of 
habituation, drug testing was begun. At 48 h intervals, each rat (n -
32) received intra-MR injections of vehicle (1.0 µl), DiMe-C7 (1140 
pmol), NKA (230 pmol) and senktide (30 pmol). These doses were selec-
ted on the basis of our previous dose-response analysis which showed 
that they produced sub-maximal but equivalent increases in LMA (see 
Fig. 2 and 3). Each drug was administered only once, according to a 
randomized design. 
Results 
The cannulae placements in the 21 rats used in this study are 
shown schematically in Appendix II (Fig. B). 
The 5,7-DHT injections into the MR produced some cell loss (pre-
sumably 5-HT neurons) with minimal glial scarring in the region sur-
rounding the cannula tip. No extensive scarring or cavitation was 
observed. Analysis of the MFB injection sites revealed that the 5,7-
DHT and vehicle infusions did not cause any destruction of perikarya in 
the region, or any cavitation at the tip of the injection needle. No 
evidence of retrograde degeneration in the MR was obtained. 
An initial analysis of the data (not shown) indicated that the 
two groups of control animals did not differ either in their response 
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to the neurokinin infusions or neurochemically, therefore their data 
were combined for subsequent analysis. 
Fig. 9 shows the total activity counts for the 30 min following 
the inj ec ti on of DiMe - C7, NKA and senktide for the three groups of 
rats. An ANOVA revealed significant lesion [F(2,24) - 6.18; p < 0.01] 
and drug [F(3,72) - 24.91; p < 0.001] effects. The lesion x drug in-
teraction also was significant [F(6,72) - 4.63; p < 0.001]. A post-hoc 
analysis indicated that for the control group, administration of all 
three peptides significantly elevated LMA compared to vehicle, but that 
the activity levels produced by these infusions did not significantly 
differ from each other. Further analysis indicated that the LMA fol-
lowing vehicle infusions was equivalent for all three groups. The 
activity levels produced by infusions of senktide and DiMe-C7 were 
equivalent between the control and MFB lesion groups. 
The MR 5, 7-DHT lesions completely blocked the LMA produced by 
infusions of DiMe-C7, NKA and senktide. In contrast, the MFB 5,7-DHT 
lesions did not affect the locomotor hyperactivity produced by intra-MR 
administration of DiMe-C7 and senktide, but appeared to attenuate the 
effects of NKA. The hyperactivity produced by infusions of NKA was 
significantly lower than that produced by both senktide and DiMe-C7 in 
rats with MFB lesions. In addition, the hyperactivity produced by 
infusions of NKA in the MFB lesion group was intermediate to that 
produced by similar infusions in the control and MR lesion groups. 
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Fig. 9. MR/MFB 5.7-DHT Lesions: Effects of intra-median raphe (MR) 
infusions of senktide (30 pmoles), neurokinin A (NKA; 230 
pmoles), DiMe-C7 (1140 pmoles) and vehicle (1. 0 µl PBS with 
acetic acid, pH 7.2) in rats which had sustained either MR or 
MFB 5,7-dihydroxytryptamine lesions, or vehicle control injec-
tions, two weeks previously (n - 9 per group). Data represent 
mean ± SEM total activity counts for 30 min post-injection. 
Significant difference from corresponding vehicle infusion: * -
p < 0.05. 
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The MR 5,7-DHT injections significantly reduced the 5-HT and 5-
HIAA concentrations in all five brain regions assayed (Table II). The 
MFB 5, 7-DHT injections produced virtual depletion of 5-HT and 5-HIAA 
concentrations in all the brain regions. In all cases, the MFB lesions 
produced reductions greater than 86% from control levels. 
Table III shows the effects of the MR and MFB 5,7-DHT lesions on 
forebrain DA, NE and metabolite levels. The MFB lesions produced 
significant reductions in NE levels in both the MFC and hippocampus. 
These lesions also produced significant reductions in DA levels in all 
brain regions analyzed, except the amygdala. DOPAC levels were af-
fected by the MFB lesions only in the striatwn and nucleus accwnbens. 
HVA concentrations were significantly reduced only in the nucleus 
accwnbens of rats with MFB lesions. 
The only effect of the MR lesions on DA levels was an increase in 
the amygdala. Similarly, DOPAC levels were significantly increased in 
both the amygdala and MFC in rats with MR 5,7-DHT lesions. 
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Table II: 
EFFECTS OF INTRA-MEDIAN RAPHE (MR) AND MEDIAL FOREBRAIN BUNDLE (MFB) 
5.7-DIHYDROXYTRYPTAMINE LESIONS ON FOREBRAIN 
SEROTONIN LEVELS 
Region 
Group 
Amygdala 
5-HT 
(ng/g) 
Control 1114 ± 58 
MR-Lesion * 292 ± 74 (-74%) 
MFB-Lesion * 60 ± 29 (-95%) 
Medial Frontal Cortex 
Control 792 ± 44 
MR-Lesion * 222 ± 71 (-72%) 
MFB-Lesion * 42 ± 16 (-95%) 
Stria tum 
Control 794 ± 47 
MR-Lesion * 429 ± 68 (-46%) 
MFB-Lesion * 114 ± 8 (-86%) 
Nucleus Accumbens 
Control 1157 ± 83 
MR-Lesion + 652 ± 155 (-44%) 
MFB-Lesion N.D. (- >98%) 
Hippocampus 
Control 583 ± 37 
MR-Lesion 
* 
67 ± 13 (-89%) 
MFB-Lesion 
* 
53 ± 16 (-91%) 
5-HIAA 
(ng/g) 
255 ± 17 
+ 89 ± 19 (-65%) 
N.D. (- >96%) 
192 ± 11 
* 49 ± 17 (-74%) 
N.D. (- >97%) 
319 ± 23 
* 158 ± 32 (-50%) 
N. D. ( - >94%) 
327 ± 18 
* 167 ± 38 (-49%) 
N. D. ( - >94%) 
278 ± 17 
* 
61 ± 9 (-78%) 
* 
30 ± 9 (-89%) 
--m-=------
N - 7-9 per group; data represent mean ± SEM; numbers in paren-
thesis - % change from corresponding Control; significant 
difference from corresponding Control: + - p < 0. 05; * - p < 
0.01. 
N.D. - Not detectable; less than limits of sensitivity: amyg-
dala, < 10 ng/g; medial frontal cortex, < 5 ng/g; striatum, < 
20 ng/g; and nucleus accurnbens, < 20 ng/g wet weight of tissue. 
F··~-
Region 
Group 
Amygdala 
Control 
MR-Lesion 
Table Ill: 
EFFECTS OF INTRA-MEDIAN RAPHE {MR) AND MEDIAL FOREBRAIN BUNDLE CMFB) 
5.7-DIHYDROXYTRYPTAMINE LESIONS ON FOREBRAIN DOPAMINE AND 
NOREPINEPHRINE LEVELS 
NE DA DO PAC 
(ng/g) 
597 ± 34 381 ± 42 30 ± 3 
659 ± 36 * 503 ± 21 (+32%) * 43 ± 4 (+43%) 
MFB-Lesion 476 ± 22 299 ± 22 29 ± 2 
HVA 
--------------------------------------------------------------------------------------------
Medial Frontal Cortex 
Control 
MR-Lesion 
MFB-Lesion 
Stria tum 
Control 
MR-Lesion 
MFB-Lesion 
353 ± 17 
351 ± 18 
* 268 ± 16 (-24%) 
105 ± 9 
130 ± 11 
* 83 ± 9 (-21%) 
7678 ± 346 
7543 ± 358 
* 5737 ± 406 (-25%) 
18 ± 1 
* 29 ± 3 (+61%) 
16 ± 2 
887 ± 67 
1003 ± 29 
* 533 ± 60 (-40%) 
352 ± 26 
412 ± 26 
264 ± 40 
00 
\J1 
W''-
Nucleus Accumbens 
Control 
MR-Lesion 
MFB-Lesion 
Hippocampus 
Control 
MR-Lesion 
MFB-Lesion 
---
---
---
808 ± 31 
831 ± 53 
* 590 ± 45 (-27%) 
Table III (cont'd) 
7222 ± 332 1109 ± 49 378 ± 27 
6251 ± 371 1088 ± 101 372 ± 45 
* 5682 ± 141 (-21%) * 760 ± 78 (-31%) * 231 ± 31 
(-39%) 
N - 7-9 per group; data represent mean ± SEM; numbers in parenthesis - % change from cor-
responding control; significant difference from corresponding control: * - p < 0.01. 
00 
O'I 
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Experiment VIII: DiMe-C7 Dose-Response in a Novel Open Field 
Procedure 
Rats (n = 30 from Experiment II) were handled daily for 3 days. 
They then were tested (10 rats per day for three days) following an 
infusion of either vehicle (1.0 µl) or three doses of DiMe-C7 (30, 230, 
and 1140 pmol). Each animal was injected with drug or vehicle and im-
mediately placed in the center of the arena. The behavior of the an-
imal was videotaped for 30 min for subsequent analysis. Following the 
testing period, each rat was removed, transported to another room and 
swiftly decapitated. The brain was removed and placed in buffered 
formalin for subsequent histological analysis. 
Results 
The effects of DiMe-C7 on behavior in a novel open field are 
shown in Fig. 10. An analysis of the total activity (wall squares 
entered + center squares entered + rears + head pokes) indicated that 
DiMe-C7 did not affect activity in a novel open field [F(3,21) = 0.55; 
p > 0.3]. Further analysis of each component behavior (Fig. 11) demon-
strated no significant effects of DiMe-C7: wall squares entered [F(3, 
20) - 0.07; p > 0.3]; center squares entered [F(3,20) - 1.32; p > 
0.05]; rears [F(3,20) - 2. 78, p > 0.05]; and head pokes [F(3,20) -
0.74; p > 0.3]. There were significant effects of time (Fig. 11) 
within the chamber for wall squares entered [F(9,27) - 3.72; p < 0.01], 
center squares entered [F(9,180) - 3.65; p < 0.05], and head pokes 
[F(9,180) - 5.53; p < 0.01]. The only significant drug x time inter-
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actions were for rears [F(27,180) - 1.58; p - 0.05] and head pokes 
[F(27,180) - 2.08; p < 0.01]. Analysis of the time effects indicated 
that the greatest contribution came from the highest dose of DiMe-C7 
(1140 pmol). There was a general increase in activity over the 30 min 
testing period. 
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Fig. 10. DiMe-C7 Novel Open Field: Total Activity: Total activity 
(wall squares + center squares + rears + head pokes) for 30 min 
following infusion of varying doses of DiMe-C7. N - 7/9 rats 
per dose; data represent mean ± SEM. No significant differen-
ces from vehicle infusions were observed. 
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Fig. 11. DiMe-C7 Novel Open Field: Component Behaviors: Nwnber of 
wall squares, center squares, rears and head pokes per 3 min 
block for 30 min following infusion of varying doses of DiMe-
C7. N - 7 /9 rats per dose; data represent group mean; error 
bars were omitted for clarity. No significant differences from 
vehicle infusions were observed. 
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Experiment IX: Neurokinin Effects on Novel Open Field Behavior 
Procedure 
Rats (n = 30 from Experiment III) were handled daily for three 
days beginning eight days following the completion of Experiment III. 
This experiment was conducted identically to Experiment VII, except for 
the drugs tested. In this study, each rat was infused with either 
vehicle (1.0 µl), NKA (230 pmol) or senktide (30 pmol). Following the 
completion of the experiment, all rats received an overdose of sodium 
pentobarbital and were transcardially perfused with normal saline 
followed by buffered formalin. The brain stems were removed and stored 
in formalin for at least one week prior to histological analysis. 
Results 
The effects of NKA (230 pmol), senktide (30 pmol) and vehicle 
(1.0 µl) on behavior in a novel open field are shown in Fig. 12 and 13. 
An analysis of the total activity (wall squares entered + center 
squares entered + rears + head pokes) indicated that there was a sig-
nificant drug effect [F(2,18) - 8.71; p < 0.01]. A post-hoc analysis 
indicated that the activity levels of the animals injected with senk-
tide were significantly greater than that following infusion of vehicle 
and NKA. Analysis of each component behavior (Fig. 13) demonstrated 
significant drug effects for wall squares entered [F(2,18) - 6.49; p < 
0.05] and center squares entered [F(2,18) - 5.40; p < 0.01]. Signif-
icant time effects also were observed for wall squares entered [F(9, 
162) - 14.5; p< 0.01], center squares entered [F(9,162) - 3.45; 
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p < 0.01], head pokes [F(9,162) - 3.49; p < 0.01), and rears [F(9,162) 
- 8.79; p < 0.01). 
Post-hoc analysis showed that the significant effects on compo-
nent behaviors were due to the increases on these measures among the 
rats which had received infusions of senktide. As can be seen in Fig. 
13, the senktide treated group was more active than the other two 
groups for the entire 30 min period. This is in contrast to the ve-
hicle and NKA infused rats which showed significant reductions in 
squares entered during the last 12-15 min of the testing period. 
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Fig. 12. Neurokinin Effects in a Novel Open Field: Total Activity: 
Total activity (wall squares + center squares + rears + head 
pokes) for 30 min following infusion of vehicle, NKA (230 pmol) 
or senktide (30 pmol). N - 7/9 rats per dose; data represent 
group means ± SEM. * - significant difference from vehicle 
infusions, p < 0.05 (ANOVA +Duncan's multiple range test). 
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Fig. 13. Neurokinin Effects in a Novel Open Field: Component Behaviors: 
Number of wall squares, center squares, rears and head pokes 
per 3 min block for 30 min following infusion of vehicle, NKA 
(230 pmol) or senktide (30 pmol). N - 7/9 rats per dose; data 
represent group means; error bars were omitted for clarity. 
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Experiment X: Neurokinin-Habituated Open Field 
Procedure 
In order to test the effects of habituation on a rat's behavioral 
response to an intra-MR neurokinin infusion, rats were tested in an 
open field arena to which they had been adapted. Rats (n - 19) were 
implanted with intra-MR cannulae. Following 7 days recovery, the rats 
were adapted to the injection procedure and placed in the open field 
apparatus for 30 min a day for 5 consecutive days. On the sixth day, 
each rat was removed from its home cage, infused with either vehicle 
(1.0 µl), NKA (230 pmol) or senktide (30 pmol), and immediately placed 
in the open field arena for 30 min. The experiment was conducted over 
a two week time period with approximately half the rats from each group 
tested during each week. Following completion of the experiment, the 
rats were perfused with saline and formalin and their brain stems 
removed for histological analysis. 
Results 
The cannulae placements are shown schematically in Appendix II 
(Fig. C). An initial analysis comparing the activity measured on the 
first and last days of habituation indicated a significant reduction in 
total activity [F(l,15) = 37.6; p < 0.001], wall squares entered [F(l, 
15) - 32.5; p < 0.001], center squares entered [F(l,15) - 31.2; p < 
0.001], rears [F(l,15) - 15.2; p < 0.001], and head pokes [F(l,15) 
8.63; p < 0.01]. This reduction in activity indicates that the animals 
96 
habituated to the open field chamber during the five days of adapta-
tion. 
The total activity following administration of either vehicle 
(1.0 µl), NKA (230 pmol) or senktide (30 pmol) is shown in Fig. 14. An 
analysis of the total activity on the test day indicated a significant 
effect of the neurokinins [F(2,16) - 4.41; p < 0.05]. Post-hoc com-
parisons showed that both NKA and senktide significantly elevated 
activity compared to vehicle infusions. 
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Fig. 14. Neurokinin Effects in an Habituated Open Field: Total Activ-
ity: Total activity (wall squares entered + center squares en-
tered + rears + head pokes) for 30 min following infusion of 
vehicle, NKA (230 pmol) or senktide (30 pmol). N = 7/9 rats per 
dose; data represent group means ± SEM. * = significant differ-
ence from vehicle infusions, p < 0.05 (ANOVA + Duncan's multiple 
range test). 
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The effects of vehicle, NKA and senktide on wall and center 
squares entered, rears and head pokes are shown in Fig. 15. An ANOVA 
revealed a significant drug effect on wall squares entered [F(2,15) -
10.5; p < 0.001], center squares entered [F(2,15) 8.38; p < 0.01], 
and rears [F(2,15) - 6.52; p < 0.01]. Significant time effects and 
drug x time interactions also were noted for the number of wall squares 
entered [F(7,105) - 11.8; p < 0.01 and F(l4,105) - 2.82; p < 0.01, 
respectively]. 
The animals which had been infused with either NKA or senktide 
entered a significantly greater number of squares than the vehicle 
treated group during the first 15-18 min (Fig. 15). Interestingly, 
further analysis indicated that the rats infused with NKA entered more 
center squares and emitted more rears than the other two groups. In 
contrast, animals injected with senktide tended to enter more wall 
squares than those injected with NKA over the 24 min test period. 
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Fig. 15. Neurokinin Effects in an Habituated Open Field: Component 
Behaviors: Number of wall squares, center squares, rears and 
head pokes per 3 min block for 30 min following infusion of 
vehicle, NKA (230 pmol) or senktide (30 pmol). N - 7/9 rats 
per dose; data represent group means; error bars were omitted 
for clarity. 
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B. Anatomical Studies 
Experiment I: Retrograde Tracing of MR Afferents 
The Fluoro-Gold (FG) injection sites are shown in Fig. 16. All 
were localized within the MR and were approximately 1.0 mm in diameter. 
The center of each injection site was associated with a small glial 
scar (approximately 0. 25 mm in diameter) which is characteristic of 
iontophoretic FG administration (Schmued and Fallon, 1986). The number 
and extent of FG retrogradely-labeled cell bodies were virtually iden-
tical in all animals. Fig. 17 schematically portrays the loci of the 
FG labeled cell bodies observed in a representative animal (FLG-I2). 
The injection site in case FLG-I2 is pictured in Fig. 18f. Photomicro-
graphs of labeled perikarya in different brain regions are shown in 
Fig. 18. The description which follows summarizes the results which 
were consistently obtained in the six rats. Certain exceptions to the 
labeling pattern will be pointed out. 
Telencephalon 
Retrogradely labeled neurons were found in the following telen-
cephalic areas: frontal and cingulate cortices, septal area, ventral 
pallidurn, and the magnocellular preoptic area. No labeled cells were 
observed in the caudate-putamen, the nucleus accurnbens, the hippocampal 
formation, or the amygdaloid complex at any anteroposterior level. 
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Cortex 
As shown in Fig. 17a-g and 18a, a high density of labeled n~urons 
was found throughout the medial aspects of the frontal and cingulate 
cortices. In two rats (FLG-H3 and I1), a few retrogradely labeled 
cells (not shown in Fig. 17) were found in the insular cortex. Labeled 
neurons were not observed in other cortical regions. 
Septal Area 
The septal area (Fig. 17d-f) was found to contain a number of 
retrogradely labeled neurons. Most notable in this region was the high 
density of labeled neurons in the nucleus of the horizontal limb of the 
diagonal band (Fig. 18b). Fewer labeled cells were observed in the 
vertical limb and in the medial septal nucleus. Cells also were en-
countered within the lateral septal nuclei, more within the inter-
mediate division than in the dorsolateral septum. Adjacent to the 
septal area, a few labeled neurons were observed in the bed nucleus of 
the stria terminalis (Fig. 17f). 
Ventral Pallidum. Preoptic Area. and the Substantia Innominata 
The ventral pallidum and substantia innominata (Fig. 17e,f) were 
found to contain a number of retrogradely labeled cells. A large num-
ber of FG-labeled cells were observed within the magnocellular preoptic 
area (Fig. 17f) spread over its medial and lateral subdivisions. It 
also should be noted that the cells which were found in the horizontal 
limb of the diagonal band and those found within the ventral pallidum 
tended to form a continuous band of perikarya. 
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Fig. 16. Fluoro-Gold Injection Sites: Fluoro-Gold injection sites in 
the six rats used in this study. Drawings of coronal sections 
(designated a-f in upper left of schematic) are adapted from Pax-
inos and Watson (1986). Numbers at lower left of each drawing 
indicate distance in mm from the interaural plane. Colchicine-
treated rats are indicated below with an asterisk. 
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Fig. 17. Localization of Retrogradely Labeled Cells Following MR 
Fluoro-Gold Infusions: The loci of neurons which were labeled 
bilaterally following an FG injection into the MR in rat FLG-12 
(colchicine treated) are plotted on drawings of coronal sections 
(designated a-t in upper left of schematic) are adapted from Pax-
inos and 'Watson (1986). Numbers at lower left of each drawing 
indicate distance in mm from the interaural plane. The injection 
site is indicated by the blackened area in the MR (see sections 
m-o) and illustrated in Fig. 16 c-e and 18 f. 
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Fig. 18. Representative Photographs of Fluoro-Gold Labeled Neurons: 
Photomicrographs (x250; except in f where magnification was xl60) 
of: a) medial frontal cortex; b) horizontal limb of the diagonal 
band of Broca; c) lateral habenular nucleus; d) laterodorsal 
tegmental nucleus; e) medial nucleus of the cerebellum; and, f) 
injection site. Representative Fluoro-Gold labeled cells in each 
section are indicated with arrows. Drawings of coronal sections 
are adapted from Paxinos and Watson (1986). 
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Diencephalon 
Fluoro-Gold labeled neurons were found be distributed discretely 
within the following diencephalic regions: the lateral habenular nu-
cleus, the ventromedial thalamic nucleus, and the hypothalamus. 
Epithalamus 
The diencephalic region which contained the greatest number of 
retrogradely filled cells was the lateral habenular nucleus (Fig. 
17h,i; Fig. 18c). No FG-labeled neurons were observed in the adjacent 
medial habenular nucleus. An occasional labeled cell was found em-
bedded within the stria medullaris, just dorsal to the habenular com-
plex. 
Dorsal Thalamus 
The ventromedial nucleus was the only dorsal thalamic nucleus 
found to contain retrogradely labeled neurons (Fig. 17h-j). Most of 
these cells were clustered around the mammillothalamic tract. This 
group of labeled neurons also seemed to be continuous with those found 
more posteriorly in the prerubral fields. 
Sub thalamus 
A number of FG- labeled cells were encountered within the zona 
incerta (Fig. 17g-j) and the area immediately surrounding the mammillo-
thalamic tract. 
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Hypothalamus 
A number of areas within the hypothalamus (Fig. 17g-j) were. found 
to contain retrogradely labeled neurons. These included the anterior, 
lateral, ventromedial, dorsomedial, paraventricular, and mamrnillary 
nuclei. The densest number of labeled cells were localized throughout 
the lateral hypothalamic area and the mammillary region. A number of 
cells were found surrounding the fornix. 
Mesencephalon 
FG filled neurons were observed in the region just dorsal and 
lateral to the posterior commissure (Fig. 17j). Cells were observed 
ventral to the posterior commissure, immediately lateral to the third 
ventricle and dorsal to the nucleus of Darkschewitsch. This latter 
nucleus also was found to contain a few labeled neurons (Fig. 17k). 
The ventral tegmental area (Fig.17j-l) contained a large number 
of labeled cells. A few FG-filled neurons also were found in the 
substantia nigra, pars compacta (Fig. 17j,k). 
A large number of retrogradely labeled cells were found more 
caudally in the midbrain (Fig. 17i-o), especially in the central gray, 
the superior colliculus, the deep mesencephalic nucleus lateral to the 
red nucleus, and the interpeduncular nucleus. A few labeled cells also 
were found in the medial geniculate, the anterior pretectal nuclei, and 
the inferior colliculus. 
The rostral rubral field contained FG filled neurons, as did the 
rostral and caudal linear raphe nuclei. The dorsal raphe (DR) nucleus 
contained FG-labeled neurons as did all portions of the MR surrounding 
116 
the injection site. A few labeled cells were seen in the ventral 
tegmental nucleus of Gudden. 
Metencephalon 
At pontine levels a large number of retrogradely labeled cells 
were found in the nucleus raphe pontis, and in both the oral and caudal 
parts of the pontine reticular nucleus (Fig. 17m-q). Scattered cells 
could be seen in the ventral nucleus of the lateral lemniscus, and in 
the reticulopontine tegmental, and subpedunculotegmental nuclei. Some 
FG-filled neurons were found in the cuneiform nucleus and in the pedun-
culopontine and adjacent microcellular tegmental nuclei. 
More caudally, the laterodorsal tegmental nucleus (LDTg) con-
tained a prominent number of FG-filled cells (Fig. 17p,q; Fig 18d). 
Labelled cells also were found in the motor, motor nucleus, and most 
notably, in the principal sensory nucleus (ventrolateral part) of the 
trigeminal complex (Fig. 17p,q). In colchicine treated rats, these 
labeled neurons were observed to send dendri tic processes into the 
adjacent dorsal tegmental nucleus of Gudden and trigeminal nuclei. 
Cerebellum 
A number of retrogradely labeled cells were detected within the 
medial nucleus of the cerebellum (Fig. 17s; Fig. 18e). This was the 
only cerebellar region found to contain FG-filled cells. 
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Myelencephalon 
At medullary levels (Fig. 17q-t), scattered FG-filled ~eurons 
were detected in the nucleus raphe magnus, pallidus, and obscurus; the 
medial and lateral vestibular nuclei; and the prepositus hypoglossal 
nucleus. Within the medullary reticular formation, labeled cells were 
found in the gigantocellular and lateral paragigantocellular nuclei. 
Lower Medulla and Spinal Cord 
FG-labeling in the lower medulla and spinal cord was investigated 
in only one rat (FLG-13). A few (1-3/nucleus) labeled cells were found 
in: the rostroventrolateral reticular nucleus; the dorsal and ventral 
medullary reticular field; the nucleus of the solitary tract (bordering 
the dorsal motor nucleus of the vagus); the dorsal and paramedian ret-
icular nuclei; the lateral reticular nucleus; layers 3, 5, 7, 8 of the 
cervical cord; the central cervical nucleus; layers 2 and 8 of the 
thoracic cord; and, along the border of layers 4 and 10 of the lumbar 
spinal cord. 
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. Experiment II: Neurokinin Fiber Staining 
Representative sections depicting immunocytochemical staining for 
neurokinin fibers are shown in Fig. 19. SP- and neurokinin-like im-
munoreactivity (SPLI and NKLI, respectively) were found within the MR, 
the DR, the interpeduncular nucleus, and within the principal sensory 
trigeminal nucleus. Results with the anti-SP and anti-NKA antisera 
were virtually identical. 
Controls 
In order to test the specificity of the primary antibodies used, 
sections through the interpeduncular nucleus, which contains a very 
dense neurokinin fiber network, were incubated with primary antibody 
and with primary antibody which had been preabsorbed with the respec-
tive antigen (SP and NKA; 100 µg/ml of diluted antibody). Fig. 20 
shows the immunocytochemical staining obtained with the unabsorbed 
antisera (a) and the absence of staining with the preabsorbed primary 
antisera (b). 
Previous cross-absorption studies with the SP2 and NKA2 primary 
antibodies indicated that the immunoreactivity was still observed 
following preabsorption of the SP2 antiserum with NKA or NK.B. Pre-
absorption of the NKA2 antibody with SP did not affect the fiber label-
ing, but preabsorption with NK.B did eliminate it (Brodin et al., 1986). 
Cross-absorption studies with the commercially obtained anti-SP anti-
body indicated a 5-10% cross-reactivity with NKA and no apparent cross-
reactivity with NKB (Dr. Mary Frick, Incstar, Inc., personal communi-
cation, 1988). Substitution of the primary antibodies with diluent 
(omit controls), eliminated all staining. 
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Fig. 19. Neurokinin-Like Immunoreactive Fibers: Photomicrographs 
(x250) of sections through a) the median raphe nucleus (MR), and, 
b) the principal sensory trigeminal nucleus (PrSVL). The MR sec-
tion was incubated with the rabbit anti-NKA primary antibody, 
whereas the PrSVL section was incubated with the rabbit anti-SP 
antiserum. 
b 
121 
Fig. 20. Preabsorbed Control: Photomicrographs (x250) of sections 
through the interpeduncular nucleus (IPN) stained with a rabbit 
anti-SP antibody without preabsorption (a), and following absorp-
tion overnight with SP. 
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Experiment III: Neurokinin Perikarya Staining 
In order to determine whether our immunocytochemical proeedures 
would enable us to visualize neurokinin immunoreactive cell bodies, 
sections through the rat dorsal root ganglia were processed for study. 
Ganglia were obtained from an untreated and an intrathecally colchicine 
pretreated rat. Fig. 21 shows the localization of both SPLI and NKLI 
within the dorsal root ganglia. 
The results of the immunocytochemical staining of neurokinin cell 
bodies in the CNS are shown in Fig. 22. SPLI and NKLI-perikarya were 
observed in a number of regions previously reported to contain SP or NK 
reactive perikarya. The best staining was found in the following re-
gions: the rostral central gray, the interpeduncular nucleus, the dor-
sal raphe nucleus, and the laterodorsal tegmental nucleus. Fig. 22 
shows immunoreactive cells in the medial habenular nucleus, interpedun-
cular nucleus, the rostral central gray, and the laterodorsal tegmental 
nucleus. Occasional SPLI and NKLI cells also were encountered within 
the septum, the paraventricular nucleus, the caudate-putamen, and the 
lateral hypothalamus. 
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Fig. 21. Neurokinin-Like Immunoreactivity in Dorsal Root Gan~lia: 
Photomicrographs (x250) of SP-immunoreactive cells and fibers in 
the dorsal root ganglia following incubation with the rabbit an-
ti-SP antibody in a colchicine-treated (a), and an untreated rat 
(b). Photomicrograph (x250) of an NKA-immunoreactive cell fol-
lowing incubation with the rabbit anti-NKA antiserum is shown in 
(c). 
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Fig. 22 (a-d). Neurokinin-Like Immunoreactive Perikarya : Photomicro-
graphs (xl60 in a and b; x250 in c and d) of SP-immunoreactive 
cells, from colchicine-treated rats, following incubation of the 
tissue sections with the rabbit anti-SP antibody. Sections are 
through: a) the medial habenular nucleus (MHb); b) the inter-
peduncular nucleus (IPN); c) the rostral central gray (CG); and, 
d) the laterodorsal tegmental nucleus (LDTg) . 
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Combined Fluoro-Gold and Neurokinin Immunocytochemistry 
The brains from two rats which had received an infusion of FG 
into the MR, and colchicine treatment one week later, were processed 
for immunocytochemistry. Sections were saved through regions which had 
been found to give adequate staining for neurokinin perikarya: the 
medial habenular nucleus, the interpeduncular nucleus, the dorsal 
raphe, the rostral central gray, and the laterodorsal tegmental nu-
cleus. With the exception of the medial habenular nucleus, all of 
these regions were found to be the source of MR afferents. By using 
the appropriate filter combination, separate populations of either FG 
or FITC labeled cells could be discerned in each region. There were no 
clear cut cases of doubled-labeled neurons. In one case, initial 
viewing of a section through the laterodorsal tegmental nucleus sug-
gested the possibility of a doubled-labeled cell which was not verified 
upon subsequent viewing. Although it is possible that the fluorescence 
may have faded, staining of the laterodorsal tegmentum in another ani-
mal did not reveal any double-labeled neurons. Fig. 22 (e,f) shows a 
section through the dorsal raphe photographed using the filter combina-
tions for visualization of FG and FITC. 
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Fig. 22 (e,f). Combined Retrograde Labeling and Neurokinin Irnrnunocyto-
chemistry: Section through the dorsal raphe (DR) showing SP-
irnrnunoreactive and FG-filled neurons. Section was photographed 
(x250) to visualize FITC (e) and FG-labeled cells (f). Note that 
the FG-labeled cells (black arrows in f) are not visible in e. 
Although some "bleed-through" of the fluorescence can be seen, 
the FITC labeled cells (white arrows in e) are not visible in f. 

CHAPTER V 
DISCUSSION 
The purpose of this dissertation project was to investigate the 
functional relationships between neurokinin and 5-HT neuronal processes 
within the median raphe nucleus (MR) of the rat midbrain. The first 
series of experiments studied the behavioral effects following tachy-
kinin injections into the MR. It was found that activation of two dif-
ferent neurokinin receptors (NK-2 and NK-3) could elicit locomotor hyp-
eractivity, and that agonists (NKB and senktide) selective for the NK-3 
site were ten times more potent than agonists (NKA) selective for the 
NK-2 site. Lesions made with 5,7-DHT confirmed that the hyperactivity 
produced by neurokinin injections into the MR depend on the integrity 
of MR 5-HT neurons. The hyperkinesis produced by activation of NK-2, 
but not NK-3, sites may be mediated, at least in part, by 5-HT projec-
tions to the forebrain. Analyses of animals' behavior in an open field 
suggested, furthermore, that the behavioral changes elicited by MR in-
jections of the neurokinins depend on the degree of familiarity or 
novelty of the environment. 
Using a retrograde tracing technique and immunocytochemistry, the 
second series of experiments examined the origin of the neurokinin 
innervation to the MR. The MR was found to receive afferent projec-
tions from many discretely localized brain structures. Immunocytochem-
ical studies confirmed that the MR contains SP-like and neurokinin-like 
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immunoreactive fibers. Analyses of the combined immunocytochemical and 
retrograde labeling data suggested, furthermore, that the forebrain is 
the source of the neurokinin innervation to the MR. 
A. Behavioral Studies 
Dose-Response Analysis of Intra-MR Neurokinin Infusions 
The first series of experiments were undertaken in order to 
determine the relative rank order of potency for intra-MR injected 
tachykinins to induce locomotor hyperactivity. The dose-response 
analyses suggest that hyperkinesis can be elicited by activation of two 
different neurokinin receptors. At the NK-2 site, NKA was more potent 
than SP and the non-mammalian tachykinins, while at the NK-3 site, 
senktide was more potent than DiMe-C7. Importantly, the hyperactivity 
produced by intra-raphe infusions of neurokinin B (3.0 pmol) was equiv-
alent to that produced by an equimolar dose of senktide. The results 
suggest that activation of NK-2 and NK-3 receptors in the MR lead to 
elevations in the level of behavioral arousal. Intra-MR neurokinin-
induced hyperactivity, moreover, may provide a novel in-vivo model for 
studying NK-2 and NK-3 receptor activation in the central nervous 
system of the rat. 
Stoessl et al. (1987 a,b) have reported that peripheral or intra-
cisternal infusions of senktide produce the classical "serotonin-syn-
drome" (head twitching, forepaw treading, hind limb splaying) in both 
rats and mice. The experimental procedure used for measuring LMA in 
the present study (a darkened photocell chamber) does not permit one to 
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differentiate photocell breaks produced by locomotion from those pro-
duced by stereotypic movements. However, the analyses of the rats' be-
havior in an open field following the intra-MR injection of DiMe-C7, 
NKA and senktide indicated that the animals were not engaged in any of 
these "serotonin-mediated" or other types of stereotypies. In con-
trast, the animals exhibited an increase in a variety of exploratory 
behaviors, such as walking, rearing, sniffing, and head poking. 
The non-mammalian tachykinins, ELE, KAS, and PHY, all produced 
increases in LMA, although ELE was the most potent and the most effi-
cacious. Binding studies indicate that radiolabeled ELE labels NK-3 
binding sites in rat brain (Bergstrom et al., 1987; Glowinski et al., 
1987). Isolated peripheral tissue preparations, such as the rat portal 
vein, are sensitive to low doses of both NKB and ELE (Drapeau et al., 
1987; Mastrangelo et al., 1986). However, this assay also is sensitive 
to KAS, suggesting that this in-vitro preparation does not necessarily 
reflect binding potencies or pharmacodynamic interactions within the 
CNS. 
Senktide was the most potent (minimum effective dose: 3.0 pmol) 
and the most efficacious neurokinin analogue to elicit hyperactivity. 
The relative potencies of the neurokinin agonists were: senktide (-
NKB) > DiMe-C7, and NKA >>SP. Radiolabeled senktide was developed as 
a selective NKB agonist (Laufer et al., 1986a; Wormser et al., 1986), 
and binds to NK-3 sites in rat brain. Thus, the data suggest that the 
intra-raphe effects of senktide on LMA are mediated by NK-3 receptors. 
Infusions of 3.0 pmol NKB, equimolar to the lowest dose of senk-
tide which produced a significant increase in LMA, induced locomotor 
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hyperactivity which was equivalent to that of senktide. Since it was 
necessary to dissolve NKB in a formic acid vehicle, the experiment was 
limited to a single injection. The morphology of the cells immediately 
surrounding the cannula tips in rats which received either the formic 
acid vehicle or NKB infusions was identical to that seen in rats in-
fused with other compounds. However, in a few instances, a thin "halo" 
(approximately 0. 2 mm thick) , devoid of perikarya, was observed sur-
rounding the cannula tips. Nevertheless, the formic acid vehicle 
infusions alone did not affect I.MA (see Fig. 8). These results cor-
roborate those obtained with senktide. 
Activation of an.NK-2 or NK-3 receptor in the MR of the rat leads 
to an increase in behavioral arousal. Neurokinin-like fibers (but not 
cell bodies) and receptors have been observed in the MR. The effects 
of the neurokinins, in contrast to those of intra-MR infused muscimol, 
depend upon intact 5-HT neurons (Paris and Lorens, 1987 a,b; and pres-
ent study). This suggests that NKA and NKB projections to the raphe 
modulate 5-HT neuronal activity. 
Although MR NK-2 receptor activation leads to locomotor hyper-
activity, it should be noted that the presence of NK-2 receptors in the 
CNS has been questioned (Glowinski et al., 1987; Saffroy et al., 1988). 
It must be emphasized, furthermore, that without the availability of 
non-neurotoxic neurokinin antagonists, one can only utilize the rela-
tive potencies of the various agonists to identify the possible recep-
tor(s) involved. 
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MR and Medial Forebrain Bundle 5.7-DHT Lesions 
Infusion of the SP analogue, DiMe-C7, into the MR produces dose-
dependent increases in LMA which can be blocked by pretreatment with 
~ the tryptophan hydroxylase inhibitor, PCPA, and by MR 5,7-DHT lesions 
(Paris and Lorens, 1987 a,b). One of the objectives of the present 
study was to determine if 5, 7-DHT lesions of the MR would similarly 
r block the effects of intra-raphe infusions of senktide and NKA. Doses 
~· t: which previously were determined to produce equivalent increases in LMA 
(see Fig. 4), were administered to rats two weeks following 5, 7-DHT 
lesions of the MR. These lesions completely blocked the hyperactivity 
t- .. 
1 produced by the intra-raphe neurokinin infusions. 
,, 
In order to test 
whether 5-HT projections to the forebrain mediate the LMA effects of 
intra-MR infused neurokinins, 5,7-DHT was injected bilaterally into the 
medial forebrain bundle (MFB), anterior to the DA cell bodies of the 
rostroventral midbrain tegmentum. These lesions, in contrast to the 
5,7-DHT lesions of the MR, did not block the hyperactivity produced by 
the intra-raphe injections of senktide and DiMe-C7, although they 
appeared to attenuate the hyperactivity produced by NKA. These results 
indicate that intra-raphe neurokinin induced hyperactivity produced by 
activation of NK-3 receptors depends on the integrity of 5-HT neurons 
in the MR, but not on the 5-HT fibers which ascend through the MFB to 
innervate the forebrain. On the other hand, NK-2 receptor mediated 
hyperactivity may depend in part upon 5-HT fibers which innervate 
forebrain regions. 
Since the MFB 5, 7-DHT lesions were placed in the lateral hypo-
thalamus, rostral to the DA cell bodies in the ventral tegmental area 
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(VTA) and substantia nigra (SN), it is possible that 5-HT projections 
to these structures are critical for intra-MR neurokinin induced ef-
fects on LMA. The DA neurons in the substantia nigra (A9) and rostro-
ventromedial mesencephalon (AlO), and the forebrain regions they inner-
vate, have been implicated in the regulation of motor function (Le Moal 
et al., 1975; Koob et al., 1981; Bannon and Roth, 1983; Oades et al., 
1986; Oades and Halliday, 1987). The DA neurons in the VTA, futher-
more, are innervated by neurons of the MR, and have been shown by elec-
tron microscopy to receive synaptic contacts from 5-HT axon terminals 
(Herve et al., 1987; Oades and Halliday, 1987). Thus, a neurokinin---
5-HT---DA circuit which mediates behavioral arousal can be postulated. 
In fact, we have unpublished data which shows that a low dose of the DA 
antagonist, haloperidol (200 µg/kg, i.p.), can block the LMA effects of 
intra-MR DiMe-C7. 
This system is distinct from the direct neurokinin-VTA projection 
which modulates LMA (Stinus et al., 1978; Kelley et al., 1979, 1985; 
Kalivas et al., 1985; Elliott and Iversen, 1986). Since the hyperac-
tivity produced by intra-raphe infusions of neurokinins can be blocked 
by ibotenic acid lesions of the MR, the neurokinin-raphe induced in-
creases LMA is not due to diffusion of the neurokinins to the adjacent 
VTA. In order to determine whether a MR-5-HT---VTA-DA link is critical 
for intra-MR neurokinin induced hyperactivity, it would be necessary to 
perform lesions of the VTA with the catecholamine neurotoxin, 6-hydrox-
ydopamine (60HDA). These studies are in progress. 
Alternatively, it is possible that the intra-raphe neurokinin 
induced increase in LMA is mediated by a descending 5-HT projection. 
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The MR has been shown to send 5-HT as well as non-5-HT projections to 
the nucleus raphe magnus and obscurus in the rat, and the reticular 
formation and raphe pallidus in the cat (Brodal et al., 1960 a, b; 
Bobillier et al., 1975; Gallager and Pert, 1978; Beitz, 1982). No 
direct spinal projections from the MR have been observed, although 
projections to cervical levels originating in the reticular formation, 
just lateral to the MR, have been reported (Bowker et al., 1981). 
The MR 5, 7-DHT lesions led to increases in amygdaloid DA and 
DOPAC levels and to increased DOPAC levels in the medial frontal cortex 
(Table III). No changes in DA or DOPAC levels were found in the nucle-
us accumbens or neostriatum. These observations suggest that damage to 
MR 5-HT neurons results in enhanced DA utilization in select forebrain 
regions and support the view that 5-HT fibers modulate the activity of 
mesencephalic DA neurons. The increases in DOPAC levels in the medial 
frontal cortex are in contrast to those observed following electrolytic 
lesions of the MR (Herve et al., 1981). This discrepancy, however, may 
be due to the non-specificity of electrolytic lesions as a technique to 
deplete 5-HT concentrations (Lorens, 1978). Although 5-HT neurons are 
known to innervate the basal ganglia, the MR 5, 7 -DHT lesions did not 
affect the DA and DOPAC levels in the neostriatum. This observation is 
in agreement with results obtained following electrolytic lesions 
(Dray, 1981; Soubrie et al., 1984). In fact, only electrolytic lesions 
of both the dorsal and median raphe nuclei have been observed to pro-
duce transient changes in striatal DOPAC levels (Juorio and Greenshaw, 
1986). 
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The 5,7-DHT injections into the MFB, following pretreatment with 
the NE and DA reuptake inhibitor, nomifensine, produced falls in the 
DA, DOPAC, and NE levels in all the areas assayed, except the amygdala, 
suggesting incomplete protection of catecholamine neurons. The de-
creases in catecholamine parameters were between 20-40% and not nearly 
as great as those for 5-HT and 5-HIAA. The decreases in catecholamine 
levels, however, were not as extensive as that observed with MFB les-
ions with no pretreatment (Waddington and Crow, 1979). Baumgarten et 
al. (1981) have suggested that a combination of nomifensine and des-
methylimipramine may provide optimal selectivity of 5, 7-DHT for 5-HT 
neurons. However, it is important to point out that although the MFB 
lesions did produce 20-40% falls in forebrain catecholamine and metab-
olite levels, these lesions did not block the I.MA effects of intra-
raphe infusions of the neurokinins. 
The data from the present study indicate that raphe NK-2 and NK-3 
receptor mediated hyperactivity depends upon 5-HT neurons. The results 
suggest that a 5-HT projection to the DA cell bodies of the ventral 
tegmental area may be important. Alternatively, a 5-HT projection to 
other brain stem sites cannot be ruled out. NK-2 mediated hyperac-
tivity, on the other hand, may depend, in part, upon ascending 5-HT 
fibers. 
B. Anatomical Studies 
The present series of experiments were undertaken in order to 
thoroughly examine the origin of the afferents to the MR with the 
eventual goal of determining the source of its neurokinin innervation. 
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The optimal method for accomplishing these goals is to use a retro-
gradely transported fluorescent dye, in combination with the indirect 
immunofluorescence method of Coons (1950, 1958; Bjorklund and Skager-
berg, 1979; van der Kooy and Steinbusch, 1980; Skirboll and Hokfelt, 
1983; Skirboll et al., 1984; Shiosaka and Tohyama, 1986). Fluorescent 
tracers have been shown to provide the most sensitive method for vis-
ualizing retrogradely labeled neurons (Skirboll et al., 1984). The 
fluorescent dye chosen to study the afferent projections to the MR was 
Fluoro-Gold (FG). This dye can be visualized following ultraviolet 
excitation, is intensely fluorescent, extremely resistant to fading, 
has a high signal-to-noise ratio, does not leak from cells, produces 
excellent dendritic filling, and can be readily combined with other 
fluorescent dyes and tracing methods (Schmued and Fallon, 1986; Wes-
sendorf et al., 1987; Reep et al., 1988). Initially, we dissolved FG 
in double-distilled water and injected small (25-75 nl) volumes using 
30 gauge tubing and a microsyringe pump. Despite the small volumes 
infused, this method resulted in extensive diffusion of the dye out of 
the MR and along the injection tubing. Therefore, the method of appli-
cation adopted was to iontophorese the FG solution. This procedure 
produced very small, well demarcated injection sites (see Fig. 17f) 
with no diffusion along the micropipette track or into adjacent struc-
tures. 
FG can be taken up and retrogradely transported by cut or damaged 
neuronal processes but not by intact fibers (Schmued and Fallon, 1986). 
Since fiber systems pass through and just lateral to the MR, it is pos-
sible that the FG may have been taken up by fibers damaged by the 
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micropipette. However, this type of non-specific uptake was probably 
very minimal because the concentration of the FG solution was low 
(2.0%) and the injection sites were very discrete (Schmued and Fallon, 
1986). Nevertheless, the sources of the afferent projections to MR 
observed in the present study should be corroborated by employing an 
anterograde tracer, such as Phaseolus vulgaris leucoagglutinin (PHA-L). 
Little attention has been focussed on the afferent inputs to the 
MR in the rat. In fact, only one systematic retrograde tracing study 
has been reported (Aghajanian and Wang, 1977). This was the first and 
only attempt we are aware of to document the source of the afferents to 
the midbrain raphe nuclei. However, this study qualitatively compared 
the afferents to the MR with those to the DR and pontine reticular 
formation. The present study differs from the work of Aghajanian and 
Wang (1977) in a number of respects. We employed a more sensitive 
retrograde marker (Schmued and fallon, 1986; Shiosaka and Tohyama, 
1986) and used a semi-quantitative approach to map the perikaryal 
origins of MR afferents in coronal sections obtained throughout the 
brain. The density of the various projections was inferred from the 
number of labeled cells found within a given structure. The data are 
diagrammed in Fig. 17 and are discussed below by region. 
The regions found to contain to greatest numbers of retrogradely 
labeled cells included: the medial frontal and cingulate cortices, the 
septal area, the ventral pallidum/substantia innominata, the lateral 
habenular nucleus, the zona incerta, the lateral habenular nucleus, the 
lateral hypothalamus, the interpeduncular nucleus, the central gray, 
and the laterodorsal tegmental nucleus. Retrogradely labeled neurons 
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were conspicuously absent from a number of major forebrain structures, 
including: the caudate-putamen, the nucleus accumbens, the amygdaloid 
complex, the hippocampal formation, and entorhinal cortex. 
Cortical Afferents 
The only FG-labeled cells found in the cerebral cortex were 
located in the medial frontal cortex, and in the medial wall of the 
cingulate gyrus. Projections from these areas to the raphe have been 
described previously (Leonard, 1969; Aghajanian and Wang, 1977; Dr. E. 
J. Neafsey, personal communication, 1988). Pre-frontal cortical stimu-
lation also has been reported to affect the firing rate of raphe neur-
ons (Hardy and Haigler, 1985). Since an aspartatergic projection from 
the frontal cortex to the ventral tegmental area has been suggested 
(Christie et al., 1985), it is possible that the corticoraphe projec-
tion also may be aspartatergic. Al though the MR has been shown to 
project extensively to other areas of the cerebral cortex, including 
the parietal and occipital regions, only the medial frontal and cingu-
late cortices were found to send fibers back to the MR (O'Hearn and 
Molliver, 1984; Parnavelas et al., 1985; Waterhouse et al., 1986; 
Kosofsky and Molliver, 1987; Molliver, 1987). Notably, the number of 
FG-labeled cells in these regions was very large (see Fig 17a-g). The 
possible function of cortical-raphe interactions will be discussed 
below (see pp. 179-180). 
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Septal Afferents 
FG filled cells were found in the dorsal and intermediate parts 
of the lateral septal area, in the medial septal nucleus, in the vert-
ical and horizontal limbs of the diagonal band of Broca, and in the bed 
nucleus of the stria terminalis. These observations confirm previous 
reports of efferents from these structures to the MR as demonstrated by 
the retrograde transport of the fluorescent tracer true blue, and by 
the anterograde transport of PHA-L and [3H]leucine (Swanson and Cowan, 
1979; Swanson, 1982; Tomimoto et al., 1987). In the present study, the 
largest number of labeled cells observed in the septa! region were lo-
calized in the horizontal limb of the diagonal band, with minor contri-
butions from the remaining septa! nuclei. This observation appears to 
disagree with the results obtained by Aghajanian and Wang (1977). 
These authors reported a minor projection from the diagonal band to the 
MR, and an apparently insignificant projection from the bed nucleus. 
Basal Forebrain 
The results indicate that afferents to the MR originate in the 
ventral pallidum, lateral preoptic area, and the rostral portion of the 
substantia innominata. Afferents to the MR from this portion of the 
rat forebrain have been observed by some but not all authors. For 
instance, Swanson et al. (1987) reported afferents to the MR from the 
medial preoptic area. However, their PHA-L injection included parts of 
the nucleus of the diagonal band and lateral pre-optic area which may 
have confounded their results (Swanson et al., 1987). An injection of 
PHA-L confined to the substantia innominata, as well as an injection 
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into the caudal portion of the lateral preoptic area resulted in lab-
eled fibers and terminals in the region of the MR (Swanson et al. , 
1984). These observations have been confirmed by several other labor-
atories (Aghajanian and Wang, 1977; Tomimoto et al., 1987). A projec-
tion to the MR which originates in the ventral pallidal region also has 
been described by Haber et al. (1985) using the anterograde transport 
of tritiated amino acids. These authors also observed a few fibers 
along the outermost lateral border of the MR and adjacent pontine 
reticular formation following an injection of tritiated amino acids 
into the globus pallidus (dorsal pallidum; Haber et al., 1985). Retro-
gradely labelled neurons in these regions were not observed in the 
present study, perhaps due to the discrete FG infusions into the MR. 
The lack of retrogradely labelled neurons in the globus pallidus also 
has been noted by others (Aghajanian and Wang, 1977). 
Habenular Complex 
The results confirmed that a large number of cells in the lateral 
habenular nucleus project to the MR. These projections, which comprise 
a portion of the dorsal diencephalic conduction system (Sutherland, 
1982), reach the midbrain via the fasciculus retroflexus (Akagi and 
Powell, 1968; Pasquier et al., 1976; Aghajanian and Wang, 1977; Herken-
ham and Nauta, 1979). These habenuloraphe fibers may pass through or 
around the interpeduncular nucleus (Akagi and Powell, 1968; Herkenham 
and Nauta, 1979). The principal target for medial habenular nucleus 
efferents is the interpeduncular nucleus (Herkenham and Nauta, 1979). 
Following an injection of tritiated amino acids into the medial 
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habenular nucleus, Herkenham and Nau ta ( 1979) also found fibers and 
terminals within the MR. This observation is in disagreement with the 
present and other studies (Pasquier et al., 1976; Aghajanian and Wang, 
1977). It should be noted, however, that in the present study, in all 
cases, one or two weakly labelled cells were found in the very dorso-
lateral portion of the medial habenular nucleus, bordering on the 
lateral nucleus. Therefore, it is possible that a few neurons in the 
medial habenular nucleus project to the MR as suggested by Herkenham 
and Nauta (1979), but not to the extent to which they describe. 
Dorsal Thalamus 
The only dorsal thalamic region found to project to the MR was 
the ventromedial nucleus. Although earlier studies have reported a 
projection from the DR to the ventromedial thalamic nucleus (Herkenham, 
1979), there are no reports of any connections between this nucleus and 
the MR. Shammah-Lagnado and colleagues (1987), however, observed 
afferents to the pontine reticular formation from a group of cells 
bordering the zona incerta and the ventromedial thalamic nucleus. 
Zona Incerta 
A significant projection from the zona incerta to the MR was 
identified. Although efferents from the midbrain raphe to the zona 
incerta have been described (Shammah-Lagnado et al., 1985), efferents 
from this region to the raphe have not been observed, except for a 
projection to the nucleus raphe magnus (Carlton et al., 1983). 
, 
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Hypothalamus 
In the present study, FG-filled neurons were visualized in the 
following hypothalamic regions: the anterior hypothalamic area; the 
lateral nucleus; the paraventricular nucleus; the dorsomedial nucleus; 
the ventromedial nucleus; the posterior hypothalamic area; and, the 
mammillary complex. Aghajanian and Wang (1977) described afferents 
which originate in the anterior hypothalamic nuclei and terminate in 
the midbrain reticular formation but not in the MR. Hypothalamic 
afferents to the pontine reticular formation also have been reported by 
other investigators (Shammah-Lagnado et al., 1987). Saper and col-
leagues (1979) demonstrated lateral hypothalamic projections to the MR 
in the rat. Labeled fibers have been observed in the MR following the 
injection of tri tiated amino acids into the dorsomedial hypothalamus 
and into the premammillary region (Krieger et al., 1979; Swanson et 
al., 1984). Tritiated amino acid injections into the ventromedial 
hypothalamus labeled fibers in the DR but not in the MR (Krieger et al, 
1979). Projections from the paraventricular nucleus to the brain stem 
also have been reported (Armstrong et al., 1980; Conrad and Pfaff, 
1976), but paraventriculoraphe connections have not. 
FG-labeled perikarya were visualized throughout the mammillary 
complex. Following the injection of tritiated amino acids into the 
mammillary nuclei, Cruce (1977) observed labeled fibers in the lateral 
border of the MR, as well as in the ventral and dorsal nuclei of Gud-
den, but found no evidence for synaptic terminals. These mammillary 
projections appear to be reciprocated (Shibata, 1987). 
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Substantia Nigra and Ventral Tegmental Area 
A projection to the MR from the pars compacta of the substantia 
nigra, which contains the A9 DA cell group (Dahlstrom and Fuxe, 1964), 
was identified in the present study. Nigroraphe connections have been 
reported previously (Pasquier et al., 1977; Fallon and Loughlin, 1985). 
In comparison to its projection to the DR, however, the nigral projec-
tion to the MR appears to originate in only a few cells (see Fig. 
17j,k). 
In contrast to the substantia nigra, the ventral tegmental area, 
which contains the AlO DA cell group (Dahlstrom and Fuxe, 1964), was 
found to send a significant projection to the MR. Ventral tegmental DA 
and non-DA projections to the MR have been reported by others (as re-
viewed in Oades and Halliday, 1987). 
The retrorubral field, which includes the AS DA cell group (Dahl-
strom and Fuxe, 1964), the rostral and caudal linear nuclei, and the 
interfascicular nucleus also are the source of afferents to the MR. 
These projections have been observed previously and most likely are DA 
and non-DAergic in nature (Fallon and Loughlin, 1985). 
Central Gray and Cuneiform Nucleus 
Projections from the periaqueductal gray and adjacent cuneiform 
nucleus were noted in the present study. Although these regions have 
been reported to receive projections from the midbrain raphe, recip-
rocal connections have not been observed (Conrad et al., 1974; Andrezik 
and Beitz, 1985). However, both of these regions appear to project to 
the nucleus raphe magnus (Beitz, 1982; Carlton et al., 1983; Lakos and 
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Basbaum, 1988). Some of these fibers may contain neurotensin (Beitz, 
1982). Since the midbrain raphe contains neurotensin fibers and bind-
ing sites (Kessler et al., 1987; Shipley et al., 1987), it is possible 
that afferents to the MR which originate in the central gray are neuro-
tensinergic. 
Interpeduncular Nucleus 
The interpeduncular nucleus (IPN) is a major source of afferent 
fibers to the MR. Recently, Groenewegen and colleagues (1986) detailed 
the cytoarchitecture and fiber connections of the IPN. They reported 
that the MR is one of the major targets for IPN efferents. These raphe 
projections originate in distinct IPN subnuclei (Groenewegen et al. , 
1986). In the present study, retrogradely labeled neurons were found 
throughout the IPN. There also is some evidence that the projection 
from the IPN to the MR is excitatory (Maciewiez et al., 1981). 
Gudden's Tegmental Nuclei 
In the present study, numerous FG-labeled perikarya were found in 
the ventral tegmental nucleus of Gudden (VTG). This observation is in 
agreement with reports which describe reciprocal connections between 
the MR and the VTG (Morest, 1961; Petrovicky, 1973, 1985 a,b). Al-
though the dorsal tegmental nucleus of Gudden (DTG) has been reported 
to project to the MR (Morest, 1961; Petrovicky, 1973), we failed to 
observe any retrogradely labeled neurons in the DTG. However, as 
described below, the adjacent laterodorsal tegmental nucleus does send 
a massive projection to the MR. The DTG and VTG, however, both project 
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to the adjacent pontine reticular formation (Petrovicky, 1985 a,b; 
Shammah-Lagnado et al., 1987). 
Reticulotegmental Nucleus 
Based on the number of labeled cells discerned, the pontine 
reticulotegmental nucleus (RTg) is the source of a minor projection to 
the MR (see Fig. 17m-o). The major target of RTg efferents is the 
cerebellum (Flumerfelt and Hrycyshyn, 1985). RTg projections to the MR 
have not been described previously. 
Pedunculopontine and Microcellular Tegmental Nuclei 
The pedunculopontine tegmental nucleus (PPTg) was found to send 
projections to the MR. The PPTg is located in the "mesencephalic 
locomotor region" (Skinner and Garcia-Rill, 1984; Garcia-Rill et al., 
1987). Although it has been reported to project to other mesencephalic 
structures, such as the ventral tegmental area, the substantia nigra, 
the superior colliculus, and periaqueductal gray (Steeves and Jordan, 
1984; Garcia Rill et al., 1987), PPTg projections to the MR have not 
been previously described. The PPTg contains cholinergic neurons which 
innervate the substantia nigra as well as the IPN (Armstrong et al., 
1983; Woolf and Butcher, 1985, 1986; Paxinos and Butcher, 1985; Clarke 
et al., 1987; Beninato and Spencer, 1987; Jones and Beaudet, 1987; Rye 
et al., 1987). It thus is possible that the PPTg may be a source of a 
cholinergic projection to the MR. 
The microcellular tegmental nucleus (Paxinos and Butcher, 1985), 
which lies dorsolateral to the PPTg, also was found to project to the 
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MR (see Fig. l 7m, n). Although this nucleus is intensely stained by 
acetylcholinesterase histochemistry, and evidences SP-like immunoreac-
tivity, relatively little is known about its connectivity or physiology 
(Paxinos and Butcher, 1985). 
Laterodorsal Tegmental Nucleus 
Another major source of afferent projections to the MR is the 
laterodorsal tegmental nucleus. This nucleus contains a large number 
of cholinergic neurons, and is the origin of an ascending cholinergic 
system, the dorsal tegmental pathway (Armstrong et al., 1983; Shute and 
Lewis, 1967). Using the PHA-L anterograde tracing technique, Satoh and 
Fibiger (1986) were the first to demonstrate a projection from this 
region to the MR. These authors suggest that this projection may be 
cholinergic because of the high levels of choline acetyltransferase 
activity in the MR (Kobayashi et al., 1975). However, it is also 
possible that this pathway may contain SP or one of the other neuro-
kinins, since SP-like immunoreactive perikarya have been discerned in 
the laterodorsal tegmental nucleus (Sakanaka et al., 1982; Vincent et 
al., 1983). 
Raphe Nuclei 
MR afferents from the dorsal (DR) and pontine raphe nuclei, and 
from the nucleus raphe magnus and obscurus, were observed. A projec-
tion to the MR from the DR, but not from the other raphe nuclei, has 
been reported (Bobillier et al., 1975). These findings suggest that 
raphe-raphe connections may provide a means for 5-HT neurons in the MR 
to be regulated by 5-HT neurons in other raphe nuclei. 
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Medial Nucleus of the Cerebellum 
The medial cerebellar nucleus, the rat equivalent of the fas-
tigial nucleus (Beitz and Chan-Palay, 1979 a,b), was found to project 
..- to the MR. The only previous report of a cerebellar input to the 
midbrain raphe was based on the degree of retrograde degeneration 
observed following lesions of the fastigial nucleus in the cat (Brodal 
et al., 1960b). In the present study, retrogradely labeled neurons in 
the medial nucleus were detected in all rats (see Fig. 17s and Fig. 
18e.). 
cells. 
No other cerebellar regions were found to contain FG-filled 
Visual System Afferents 
Afferents to the MR were found to originate in the superior 
colliculus and anterior pretectal nucleus. Both of these regions are 
involved in the processing of visual information. It should be noted 
that MR afferents from the lateral geniculate body and occipital cortex 
were not observed. Although the midbrain raphe sends 5-HT and non-5-HT 
fibers to various components of the visual system, including the super-
ior colliculus, lateral geniculate body, and retina (Beitz et al., 
1986; Dolabela de Lima and Singer, 1987; Villar et al., 1987), these 
areas have not been reported to innervate the raphe (for a review, see 
Sefton and Dreher, 1985). However, fibers emanating from these areas 
descend just lateral to the MR in the tectospinal tract (Papez and 
Freeman, 1930; Waldron and Gwyn, 1969). It is possible that collateral 
branches from this system synapse upon cells within the raphe. Alter-
natively, it is possible that FG may have been taken up by fibers in 
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the tectospinal tract which may have been damaged by the glass micro-
pipette. An anterograde tracing study utilizing PHA-L iontophoresed 
into the superior colliculus and pretectal nucleus would help clarify 
this issue. 
Trigeminal Nuclei 
Two nuclei in the trigeminal complex were found to project to the 
MR: the principal sensory nucleus, and the motor nucleus of the trigem-
inal nerve. The trigeminal region may receive 5-HT and enkephalinergic 
projections from the midbrain raphe (Travers, 1985; Beitz et al., 
1987), but trigemino-MR projections have not been described [see Trav-
ers (1985) and Tracey (1985) for reviews]. Ascending and decussating 
fibers emanating from the trigeminal complex pass immediately dorso-
lateral to the MR. It thus is possible that some synapse upon cells in 
the raphe (Huerta et al., 1983; Smith, 1973). Alternatively, it is 
possible that these trigeminal cells were labeled because of uptake of 
FG by fibers damaged by the micropipette. 
Auditory Afferents 
The present study localized afferents to the MR which originated 
in areas that make up part of the auditory system in the rat (Webster, 
1985) : the medial geniculate nucleus, inferior colliculus, and the 
ventral and lateral nuclei of the lateral lemniscus. Interconnections 
between these areas and the MR have not been reported previously. 
1S3 
Vestibular Inputs 
Three nuclei associated with the vestibular system in the rat 
(Mehler and Ruberstone, 198S) were found to project to the raphe: the 
lateral and medial vestibular nuclei, and the prepositus hypoglossal 
nucleus. Connections between the vestibular complex and the MR have 
not been previously described. 
Noradrenergic Afferents 
Projections to the MR were observed to originate in areas con-
taining norepinephrine (NE) cell groups: A4 and A6 of the locus cerule-
us, and AS and A7 of the lateral brain stem reticular formation (Dahl-
strom and Fuxe, 1964). Previous reports have indicated that the MR re-
ceives its primary noradrenergic innervation from the lateral tegmental 
system which arises in the Al, AS and A7 cell groups. The DR and MR 
appear to receive only a minor contribution from the locus ceruleus (A4 
and A6; Levitt and Moore, 1979). WGA-HRP injections into the region of 
the AS-NE containing cells did not result in labeled fibers in the DR 
or MR (Byrum and Guyenet, 1987). However, dopamine-P-hydroxylase 
immunocytochemistry has confirmed the presence of noradrenergic fibers 
and terminals in the mesencephalic raphe (Swanson and Hartman, 197S). 
Regions adjacent to the MR, including the dorsal tegmental nucleus of 
Gudden, the VTA, and the pontine reticular formation receive afferents 
from the LC (Levitt and Moore, 1979; Shammah and Lagnado et al., 1987). 
154 
Reticular Formation 
A number of reticular structures were found to send efferent 
projections to the MR including the deep mesencephalic nucleus, the 
oral and caudal parts of the pontine reticular formation, and the 
gigantocellular and lateral gigantocellular reticular nuclei. These 
regions have been shown to receive projections from the MR (see review 
by Steinbusch and Niewenhuys, 1983) , but have not been previously 
reported to send efferents to the MR. Interconnections between the 
reticular formation and the raphe are not surprising in light of the 
similarity of their afferent and efferent connections (Andrezik and 
Beitz, 1985; Shammah-Lagnado et al., 1985). In fact, in their original 
description, Taber et al. (1960) considered the raphe nuclei as forming 
the medial extension of the reticular formation. 
C. Immunocytochemical Findings 
Localization of Neurokinin-like Immunoreactivity in the 
Midbrain Raphe and Surrounding Regions 
The first step in determining the neurokinin innervation of the 
MR was to characterize the SP-like (SPLI) and neurokinin-like (NKLI) 
immunoreactivity. This was accomplished utilizing antibodies directed 
against SP and NKA/NKB (antisera SP2 and NKA2; Brodin et al., 1986), as 
well as anti-SP antisera obtained commercially (< 10% cross-reactivity 
with NKA and NKB; Dr. Mary Frick, Incstar, Inc, personal communication, 
1988). These antibodies produced SPLI and NKLI staining which was 
similar in distribution (see Fig. 19). These observations are consis-
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tent with those of other investigators who found SPLI in the MR and the 
trigeminal complex (Ljungdahl et al., 1978 a; Cuello and Kanazawa, 
1978; Shults et al., 1984). Because of the cross-reactivity of the 
NKA/NKB antisera employed, and because of the similar distribution and 
probable co-localization of NKA and SP in the CNS, the immunoreactive 
methods used were unable to distinguish between SPLI and NKLI. 
In order to confirm the presence of the neurokinins in the mid-
brain raphe, a collaborative study was undertaken with Dr. Ernst Brodin 
(Karolinska Institute, Stockholm). In brief, adult male Sprague-Dawley 
rats were sacrificed, and tissue punches (1.5 mm in diameter and 1.0 mm 
thick; average weight - 3 .4 mg/punch) were obtained from the MR, DR, 
IPN and rostral central gray. The tissue was frozen on dry ice, pooled 
into three samples for each area (one sample - 4-5 punches), then 
stored at -40°c until analyzed by reverse-phase HPLC and radioimmuno-
assay (Brodin et al. , 1986) . The samples were assayed for SP with 
antisera SP2 (cross-reactivity with NKA/NKB and NPK, negligible) and 
for NKA/NKB with antisera NKA5 and E7 (which cross react with NKB, 90 
and 240%, respectively; and, with NPK, 54 and 93%, respectively; Brodin 
et al., 1986; Lindefors et al., 1985 b; Dr. E. Brodin, personal com-
munication, 1988). The SP-like and NKA-like concentrations, as well as 
the NKA/NKB and NKA/NPK ratios in each brain area are presented in 
Table IV. 
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Table IV: HPLC-RIA ANALYSIS OF MIDBRAIN TISSUE PUNCHES 
B.egion SPLI NKALI NKA NKA 
NKB . NPK 
Antisera SP2 NKA5 E7 
(fmol/sample) (fmol/sample) 
----------------------
--------------------------- -----------------
MR 1971 2679 2337 4.3 9.0 
± 324 ± 388) ± 331) 
DR 1904 2503 2666 4.4 8.2 
± 418 ±567 ± 413 
CG 5630 3784 4350 5.4 6.4 
± 2430 ± 572 ± 922 
IPN 2518 3526 4343 1. 9 5.0 
± 1591 ± 809 ± 1044 
--Data represent mean ± SEM for three samples. Each sample represents 
punches from 4-5 animals. Cross-reactivities of the antisera were 
accounted for in the calculation of the ratios. 
These data confirm that each of the four brain regions contain 
SP, NKA, NKB, as well as small amounts of NPK. It would appear that 
the three neurokinins exist within the raphe in roughly equal con-
centrations. These results, furthermore, underscore the need for 
utilizing biochemical methods in order to substantiate immunocytochem-
ical findings. 
Problems Associated With Peptide Immunocytochemistry 
One of the objectives of the dissertation project was to deter-
mine the origin of the neurokinin innervation of the MR. To accomplish 
this goal, retrograde tracing using the fluorescent dye, Fluoro-Gold 
(FG), was combined with immunocytochemical techniques to localize the 
neurokinins. This method is recognized as a sensitive and useful 
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procedure for visualization of neurotransmitter-specific afferents to a 
particular brain region (van der Kooy and Steinbusch, 1980; Hokfelt et 
al., 1983; Skirboll and Hokfelt, 1983; Skirboll et al., 1984): The 
first step in this procedure is to identify perikarya which accumulate 
the dye by retrograde transport. The second step involves the visual-
ization of neurons which contain the neurotransmitter. The final step 
involves the successful combination of the two. 
Visualization of a particular transmitter can be accomplished by 
immunocytochemistry (Coons, 1950, 1958; Sternberger, 1979; Shiosaka and 
Tohyama, 1986). The immunocytochemical demonstration of a substance, 
however, is associated with a number of problems. These include: the 
sensitivity and specificity of the primary antisera; modification or 
loss of antigenic binding sites due to fixation or sectioning; lack of 
antibody penetration; choice of buffers; steric hindrance preventing 
antibody binding; and the so-called "Bigbee" effect (Bigbee et al., 
1977), in which high concentrations of antigen and primary antibody 
prevent the binding of the secondary antibody (Larsson, 1983; Sof-
reniew, 1983; Van Leeuwen, 1986). All of these factors can be the 
source of false-negative/positive results, and must be eliminated 
during the development of a staining procedure for a given substance. 
Peptide immunocytochemistry, furthermore, involves some unique 
obstacles which must be overcome. Since neuropeptides are synthesized 
from large precursor molecules which originate in the soma and are 
transported and processed enroute to the nerve terminal, the concen-
tration of the peptide in the cell body is typically very low (Hokfelt 
et al. , 1980). In order to visualize peptide-containing perikarya, 
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animals usually must be pretreated with colchicine so that the peptide 
accumulates within the soma (Dahlstrom, 1971; Cuello et al., 1983; 
r.arsson, 1983). The charge of the peptide during the processing ·steps, 
determined by the pH of the buffer system employed, also is critical to 
the success of the staining procedure (Van Leeuwen, 1986). 
Another problem associated with peptide immunocytochemistry is 
that the antibodies employed may cross-react with the precursor or 
similar molecules which contain the antigenic site against which the 
antibodies are directed (Larsson, 1983; Hokfelt et al., 1980; Block and 
Hoffman, 1987). Thus, the antibodies may enable the visualization of a 
particular group of immunoreactive cells, but subsequent studies util-
izing more specific antisera may give conflicting results. This has 
been the case for somatostatin as well as the opioid neuropeptides 
(Hokfelt et al., 1980). Because of the similarity in the structure of 
members of a related group of peptides, cross-reactivity can be a 
significant problem. In fact, the high cross-reactivity of the anti-
bodies utilized in some of the first SPLI mapping studies has precluded 
a definitive localization of SP-specific neurons and processes (Dr. To-
mas Hokfelt, personal communication, 1986). Another problem associated 
with peptide immunocytochemistry is that antisera directed against a 
particular antigenic site may not always be recognized in tissue sec-
tions because of the three-dimensional structure of the peptide in-vivo 
(Larsson, 1983), or because of its membrane binding properties. This 
particular problem is not typically encountered with other techniques, 
such as radioimmunoassay or HPLC (Brodin et al., 1986; Larsson, 1983). 
Since these procedures are performed on peptides extracted from tissue, 
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more of the molecule is accessible to the antibody, thus allowing a 
better opportunity for binding, and increased specificity for antisera 
directed against the unique portions of the peptide chain (Larsson, 
1983; Brodin et al., 1986). 
Neurokinin Immunoreactivity in Dorsal Root Ganglia 
In order to control for the ability of our procedures to localize 
SPLI and NKLI cell bodies, SPLI and NKLI were first demonstrated in 
spinal dorsal root ganglia (DRG), a tissue known to be rich in neuro-
kinin cell bodies (Hokfelt et al., 1975; Dalsgaard et al., 1982, 1985; 
Fuxe et al., 1983; Leach et al 1985; Gibbins et al., 1987). Sections 
through the DRG from both intrathecally colchicine-treated and untreat-
ed rats were processed as described in Chapter III, Methods. Using 
this procedure, we were able to visualize both SPLI and NKLI cell 
bodies and fibers in the DRG. Although intrathecal administration of 
colchicine was used to arrest axonal transport and increase the cel-
lular concentration of the peptides (Dahlstrom, 1971; Cuello et al., 
1983; Dalsgaard et al., 1985), contrary to our expectations, more 
perikarya were stained in the untreated rat (Fig. 20), whereas better 
fiber staining was seen in the colchicine-treated rat. It is possible 
that the accumulation of material in the soma following colchicine 
treatment causes swelling and distention which hinders the binding of 
the antibody to the peptides. This physical disruption also could lead 
to better antibody penetration of individual fibers and hence better 
axonal staining. 
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Localization of Neurokinin Cell Bodies in the CNS 
The mapping of SP-like immunoreactive cell bodies in the adult 
rat CNS was first reported in the seminal studies of Ljungdahl et al. 
(1978 a,b) and Cuello and Kanazawa (1978) and subsequently by Shults et 
al. (1984). Their findings, as well as those obtained in the present 
study, are summarized in Table V. As can be seen, the results overall 
are in general agreement. 
Although neurokinin-like cell body staining was obtained in 
sections through the dorsal root ganglia (see Fig. 20), CNS perikaryal 
staining following colchicine pretreatment was not observed consis-
tently in every brain region examined. In general, the best cell body 
staining was obtained in the brain stem, particularly in the central 
gray, IPN, DR and laterodorsal tegmental nucleus. With the exception 
of the IPN, this might be explained by the proximity of these regions 
to the ventricular system and, thus, their accessibility to the colchi-
cine administered into the lateral ventricles (Ljungdahl et al., 1978 
a). SPLI cell bodies in the IPN can be easily visualized in untreated 
rats (Cuello and Kanazawa, 1978; Ljungdahl et al., 1978 a; Artymyshyn 
and Murray, 1985; Contestable et al., 1987). 
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Table V: SUBSTANCE P-LIKE IMMUNOREACTIVE CELL BODIES IN THE CNS 
B,egion 
Rhinencephalon 
-;,lfactory tubercle 
Telencephalon 
nucleus accumbens 
septal nuclei 
medial 
lateral 
diagonal band of Broca 
caudate-putamen 
medial forebrain bundle areas 
interstitial nucleus of the 
anterior commissure 
globus pallidus 
bed nucleus of the stria 
terminal is 
amygdala 
preoptic area, medial 
hypothalamus 
suprachiasmatic nucleus 
anterior hypothalamic nucleus 
paraventricular nucleus 
ventromedial nucleus 
dorsomedial nucleus 
lateral hypothalamic 
premammillary nucleus 
posterior hypothalamic nucleus 
Diencephalon 
subthalamic nucleus 
medial habenular nucleus 
zona incerta 
Mesencephalon 
central gray 
nucleus of Darkschewitsch 
interpeduncular nucleus 
mesencephalic reticular 
formation 
superior colliculus 
laterodorsal tegmental nucleus 
dorsal raphe 
pontine reticular formation, 
caudal 
Ljungdahll Shults2 Cuello3 Present4 
+ 
++ 
+++ 
++++ 
+++ 
+++ 
++ 
++++ 
++++ 
+++ 
++++ 
++ 
+ 
+ 
++++ 
+++ 
++++ 
++++ 
+++ 
+ 
++++ 
++ 
++++ 
+++ 
++++ 
++ 
+++ 
+++ 
++ 
+ 
++ 
+++ 
++++ 
++ 
+ 
++ 
++++ 
++ 
+++ 
+ 
+++ 
+++ 
+++ 
++++ 
++++ 
++++ 
++++ 
++++ 
+ 
+++ 
+ 
+ 
+ 
+ 
+ 
++ 
+ 
+ 
+ 
+ 
+++ 
+++ 
++++ 
+++ 
+ 
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Table V (cont') 
Mesencephalon (cont') 
cuneiform nucleus +++ 
dorsal parabrachial nucleus6 ++ 
raphe pontis ++ 
Myelencephalon 
raphe magnus 
raphe obscurus 
raphe pallidus 
++++ 
+++ 
+++ 
++++ +++ 
+ 
+ 
1 
2 
3 
4 
5 
6 
medullary reticular formation 
spinal vestibular nucleus 
nucleus of the solitary tract 
spinal trigeminal nucleus 
caudal trigeminal nucleus 
lateral cuneate nucleus 
++++ 
+ 
+ 
+ 
+ 
++++ + 
+ 
+ 
+ 
+ 
Adapted from Ljungdahl et al. (1978): + - l; ++ - 2-5; +++ - 6-20; 
++++ - > 20 SP-immunoreactive cell bodies. 
Adapted from Shults et al. (1984): + - "low"; ++ - "moderate"; +++ 
- "high"; ++++ - "highest" number of SP-immunoreactive cells bod-
ies. 
Adapted from Cuello and Kanazawa (1978). Since these authors were 
primarily interested in immunoreactive fibers and terminals, they 
did not use colchicine pretreatment and did not attempt to quantify 
the number of immunoreactive cell bodies encountered. 
Present study: the rating scheme of Shults et al. (1984) was used. 
The "magnocellular preoptic nucleus" of Paxinos and Watson (1986). 
The "lateral parabrachial nucleus" of Paxinos and Watson (1986). 
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In the present study, SPLI cell bodies were observed in the 
septum, diagonal band of Broca, hypothalamus, and medial habenular 
nucleus, but not in every rat. Ljungdahl et al. (1978 a) also were 
unable to discern SPLI perikarya in a given area in every rat studied. 
!hey reported, furthermore, that intracerebral infusions of colchicine 
were necessary in order to visualize SPLI perikarya in certain areas 
(Ljungdahl et al., 1978 a). In addition, SPLI cell bodies were more 
easily seen and in some cases, exclusively, in young (1-3 week old) 
rats (Ljungdahl et al., 1978 a). These observations emphasize the 
importance of using optimal conditions for each brain region under 
study. 
The problems (reviewed above pp. 156-159) encountered with neuro-
kinin staining probably explain why most immunocytochemical studies of 
this family of peptides have focussed upon individual brain regions. 
Table VI provides a list of reports in which neurokinin- like cell 
bodies have been visualized in the CNS. 
The lack of perikaryal neurokinin-like staining in certain CNS 
regions could be due to the low concentration of the peptide in the 
soma, even after colchicine pretreatment. This may be especially true 
for neurons with long and/or highly collateralized axons. An example 
is the striatonigral neurokinin system. This is probably the most 
extensively studied neurokinin system in the CNS (Jessel et al., 1978; 
Kanazawa et al., 1980; Bolam et al., 1983, 1986; Gerfen, 1985; Ritter, 
1985; Arai et al., 1987; Bannon et al., 1987; Chesselet et al., 1987; 
Kawai et al., 1987; Li et al., 1987; Nylander and Terenius, 1987; Sivam 
et al., 1987; Voorn et al., 1987; Diez-Guerra et al., 1988). 
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Table VI: SUBSTANCE P-LIKE IMMUNOREACTIVITY IN SELECTED AREAS 
Regionl 
nucleus accumbens 
caudate (cat and ferret) 
(cat) 
arcuate nucleus & 
median eminence 
tuberomammillary nucleus 
medial habenular & 
interpeduncular nuclei 
hippocampus 
(human) 
dorsal raphe 
interpeduncular nucleus 
Visualization 
Method2 
PAP 
PAP 
PAP 
PAP 
PAP 
PAP and 
colloidal gold 
FITC and 
PAP 
PAP 
PAP 
(SP and NKA) 
FITC and 
PAP 
FITC 
PAP 
PAP 
PAP 
PAP 
PAP 
FITC 
Source 
Pickel et al., 1988 
Izzo et al., 1987 
Beckstead, 1987 
Penny et al., 1986 
Bolam et al.,1983 
Tsuruo et al. , 1987 
Kohler et al., 1985 
Contestabile, et al., 
1987 
Shults et al., 1987 
Davies and Kohler, 
1985 
Del Fiacco et al., 
1987 
Magoul et al., 1986 
Groenewegen et al., 
1986 
Vu and Hamill, 1988 
Barr et al., 1987 
Artymyshyn and 
Murray, 1985 
Huitinga et al., 1985 
Table VI (cont') 
parabrachial nuclei 
nucleus of the solitary tract 
(monkey) 
medullary raphe & 
reticular formation 
brain stem (human) 
ventrolateral medulla 
(cat) 
PAP 
FITC 
PAP 
PAP 
PAP 
PAP 
FITC 
PAP 
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Block and Hoffman, 
1987 
Thor and Helke, 1987 
Maley et al., 1987 
Menetry and Basbaum, 
1987 
Hancock, 1984 
Nomura et al. , 1987 
Pilowsky et al., 1986 
Ciriello et al., 1988 
1 Species used is the rat, unless otherwise noted. 
2 Method of visualization: PAP - peroxidase antiperoxidase (light 
microscopy); FITC - fluorescein isothiocyanate (fluorescence micro-
scopy) 
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Some investigators have had difficulty visualizing SP-like immunoreac-
tive cell bodies in caudate nucleus (Ljungdahl et al., 1978 a; Bolam et 
al, 1983), while others presumably have had no difficulty, even without 
colchicine pretreatment (Cuello and Kanazawa, 1978). In contrast to 
the caudate nucleus, the IPN, with its relatively shorter projections 
and high concentrations of SP, is a structure in which SPLI cell bodies 
are readily stained under a variety of conditions. 
Alternatively, it is possible that there is differential process-
ing and expression of neurokinins in distinct pathways. The density 
and distribution of SP binding sites, cell bodies and fibers fluctuates 
during the pre-and post-natal period (Inagaki et al., 1982; Sakanaka et 
al., 1982; Quirion and Dam, 1986). This could explain why cell bodies 
in some brain regions are only visualized in very young (l-3 week old) 
rats (Ljungdahl et al., 1978 a). 
It is worth noting that a number of recent studies have utilized 
the PAP or avidin-biotin-PAP technique for visualizing neurokinin cell 
bodies. These methods do not require specialized fluorescence micros-
copy and may be more sensitive because of the low concentrations of 
primary antibody which can be used (Hsu et al., 1981; Larsson, 1983; 
Vandersande, 1983; Van Leeuwen, 1986). A fluorescence immunocytochem-
ical technique was used in the present study because of the sensitivity 
of the retrogradely transported fluorescent dyes which are available 
(Hokfelt et al., 1983; van der Kooy and Steinbusch, 1980; Skirboll and 
Hokfelt., 1983; Skirboll et al., 1984). Although other neuronal trac-
ers, such as horseradish-peroxidase (HRP) and wheat-germ agglutinin 
(WGA), are available (Schwab et al., 1978; Leehan et al., 1981; Mesu-
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lam, 1982), these suffer from the disadvantages of being taken up by 
fibers of passage and producing anterograde as well as retrograde 
labeling (Leehan et al., 1982; reviewed by Hokfelt et al., ·1983). 
Improvements in specificity have come through conjugation of WGA with 
HRP and gold complexes, and their careful iontophoretic application 
into the brain (Gonatas et al., 1979; Baker and Spencer, 1980; Basbaum 
and Mentery, 1987). A disadvantage, however, is that these techniques 
require a special development step not needed with the fluorescent 
tracers (Hokfelt et al., 1983). 
Combined MR Fluoro-Gold Injections with Neurokinin Immunocytochemistry 
Neurokinin-like staining of selected brain regions was attempted 
using two rats which had received FG injections into the MR 10 days 
earlier. Since our best SPLI and NKLI staining was observed in brain 
stem areas, these regions were concentrated on for the combined retro-
grade tracing and immunocytochemical studies. Both FG and FITC labeled 
neurons were discerned in several brain structures, but especially in 
the rostral central gray, the DR, the IPN, and the laterodorsal tegmen-
tal nucleus. Double-labeled cells, however, were not observed. In one 
case, there may have been one or two double- labeled neurons in the 
laterodorsal tegmental nucleus, but on re-examination, the fluorophore 
appeared to have faded. Fig. 22e,f shows FITC and FG but not double-
labeled cells in the same DR-section. Therefore, the neurokinin inner-
vation of the MR probably does not originate in these brain regions. 
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,EYture Considerations for Determining the Neurokinin Afferents to the MR 
Because of the inability to observe PG- labeling in neuro_kinin-
like perikarya, the origin of the neurokinin innervation of the MR was 
not demonstrated. Thus, alternative approaches should be adopted. One 
approach would be to concentrate on the brain regions which have been 
shown to send fibers to the MR. Neurokinin-like staining then could be 
optimized for those regions and eventually combined with retrograde 
labeling. For instance, it might be necessary to utilize intracerebral 
injections of colchicine in order to bring out neurokinin-like peri-
karya staining (Ljungdahl et al., 1978 a; Bolam et al., 1983; Groen-
ewegen et al., 1986). Alternatively, as suggested in recent articles 
(see Table VI), it may be necessary to utilize the PAP or avidin-biotin 
method of Hsu and colleagues (Hsu et al., 1981; Hsu and Reine, 1981), 
rather than fluorescent methods. 
Another approach would be to place lesions in putative neuro-
kinin-labeled nuclei or pathways which may innervate the MR, then 
analyze tissue punches of the raphe nuclei for neurokinin immunoreac-
tivity. This method has been used extensively to study the striato-
nigral neurokinin system (Jessel et al., 1978; Kanazawa et al., 1980; 
Arai et al., 1987; Sivam et al., 1987; Voorn et al., 1987). A bio-
chemical approach using HPLC coupled with RIA has been used success-
fully to determine the amount of neurokinin immunoreactivity in the MR 
and various other brain regions (see Table IV; Brodin et al., 1986; 
Lindefors et al., 1985). This approach has the advantage of being able 
to produce quantitative data concerning the neurokinin input to the 
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raphe and is being used in our collaborative study with Dr. Brodin's 
laboratory. 
In situ hybridization histochemistry has been recently employed 
to study neurokinin distribution in the CNS (Chesselet et al., 1987; 
warden and Young, 1988). This technique uses 35s-labeled probes spec-
ific for neurokinin mRNA transcripts. Although the probes are highly 
sensitive and avoid many of the problems encountered with immunocyto-
chemistry, at present the technique appears to suffer from a lack of 
resolution. For example, Warden's and Young's (1988) recent report, 
which compares the distribution of the mRNAs for SP and NKB in the rat 
CNS, localizes SP transcripts in regions not previously shown to con-
tain SP-like cell bodies. This would suggest that either there is a 
technical problem with their methods, or that some neurons in the CNS 
are inefficient with respect to gene transcription. The authors did 
not try to reconcile these discrepancies. Al though these techniques 
offer great potential for localizing neuronal neurokinin processes, 
Warden's and Young's results must be interpreted carefully. 
D. Function of Neurokinin-Induced Hyperkinesis 
The results from the present study raise some important ques-
tions. What is the functional relevance of the behavioral arousal 
produced by neurokinin infusions into the MR? Is the animal exploring, 
searching for food, seeking a means of escape, or simply locomoting? 
What anatomical circuits mediate intra-MR neurokinin induced activa-
tion? The following discussion will address these questions. 
~-
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What is the Function of Intra-MR Induced Hyperkinesis? 
Open Field Studies 
Measurement of LMA in enclosed photocell chambers does not permit 
an analysis of the animal's behavior. The animal could generate activ-
ity counts (photobeam breaks) by rotating, grooming, rearing, or biting 
(Dourish, 1987). Likewise, drug induced increases in activity could be 
manifested in several ways. For example, infusions of tachykinins into 
the ventral tegmental area induce increases in LMA as measured in pho-
tocell chambers, but when observed in an open field, the rat may be en-
gaging in grooming, rearing or scratching (Elliott and Iversen, 1986). 
Peripheral and intracisternal injections of senktide, furthermore, have 
been reported to produce stereotypic movements in rats (Stoessl et al., 
1987 a,b). Thus, we observed rats in an open field following neuro-
kinin infusions into the MR. 
It is generally accepted that exposure of an animal to a novel 
environment elicits both fear (neophobia) and curiosity. Immediately 
after placement in the center of the open field, a normal rat will move 
cautiously but directly to the wall and "freeze," defecate and urinate. 
The animal then will ambulate along the wall of the compartment seeking 
a means to escape . As the animal's fear attenuates, it begins to 
explore the apparatus. Eventually, the animal habituates to the cham-
ber, and tends to sit or lie quietly near the wall, occasionally saun-
tering to another part of the arena. A number of factors affect an 
animal's response to a novel open field. These include the intensity 
and type of illumination and background noise; the degree of food 
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and/or water deprivation, the strain and sex of the rat; time of day 
and year; handling and prior experience; the presentation of reinforc-
ing stimuli, such as electric shock, highly palatable foods, or. small 
furry objects; and, how the animals are normally housed (Gray, 1972, 
1982; Frankova et al., 1987). Although not well understood, pheromones 
also may play a role, especially when rats are tested sequentially in 
the same chamber. The open field used in the present study (see Meth-
ods, Chapter III) was designed to provide a mildly fearful environment 
with holes in the floor which could elicit exploratory responses. In 
addition, the animals were handled frequently and were well adapted to 
the injection procedure. 
The results of the first two open field experiments showed that 
vehicle treated rats exhibited high levels of activity, and that much 
of their time was spent exploring the chamber. This was evidenced by 
the high incidence of rearing, head pokes, and center squares entered 
(see Fig. 10 and 11). Intra-MR infusions of DiMe-C7 and NKA did not 
lead to further increases in activity. In contrast, senktide, as well 
as muscimol (unpublished observations), produced increases in LMA. 
In order to control for the effects of novelty on the behavioral 
arousal produced by neurokinin injections into the MR, the rats in the 
third open field experiment were adapted to the chamber prior to drug-
testing. Not surprisingly, the vehicle treated rats exhibited a much 
lower level of activity than similarly treated rats exposed to the 
novel chamber (compare Fig. 12 and Fig. 14). MR infusions of both NKA 
and senktide produced increases in activity in rats which had been 
adapted to the open field arena. The increases in activity were mani-
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fested predominantly as increases in wall squares entered during the 
first 15 minutes in the chamber. However, it is interesting to note 
that although both NKA and senktide produced significant increases in 
activity, NKA tended to increase exploratory behaviors: rears, head 
pokes, and center squares entered. Anxiolytic compounds produce simi-
lar effects (Gray, 1982). In contrast, senktide induced locomotion 
primarily along the periphery of the chamber. These observations 
suggest that the binding of senktide to an NK-3 receptor in the MR 
results in increased locomotion, whereas binding of NKA to an NK-2 
receptor leads to enhanced exploration. Thus, activation of NK-2 
receptors on 5-HT neurons in the MR may produce a mild anxiolytic 
effect. 
Punished Drinking 
The potential "anxiolytic" effects of intra-MR infusions of senk-
tide were examined using a punished drinking paradigm (unpublished ob-
servations). Anti-anxiety drugs increase the rate of punished respond-
ing (File, 1987; Treit, 1985). Senktide (0-30 pmol) did not affect 
punished or unpunished drinking. Thus, activation of a MR NK-3 recep-
tor does not appear to produce an anxiolytic effect. We are planning 
to examine the effects of NKA and the NK-1 agonist, septide, using this 
paradigm. 
Effects on Food and Water Intake 
To further investigate the functional significance of neurokinin 
induced LMA, we observed the effects of the peptides on food and water 
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intake. MR infusions of muscimol and the S-HT1A agonist, 8-0HDPAT, 
have been demonstrated to increase locomotion and to induce increases 
in food and water intake in non-deprived rats (Dourish et al., 1985 
a,b,c, 1986; Klitenick and Wirtshafter, 1986, 1987). Since the neuro-
kinins also increase LMA, it is possible that they could stimulate-
ingestive behaviors as well. Studies conducted in our laboratory, 
however, have revealed that senktide infusions into the MR or DR pro-
duce decreases in both food and water consumption in non-deprived rats. 
No effects were observed in deprived animals. These effects of senk-
tide on food intake are novel. Infusion of pmol doses of tachykinins 
into the lateral ventricles has been reported to produce an antidip-
sogenic effect in rats (Massi et al., 1986; De Caro et al., 1987). 
Thus, it is possible that the tachykinins may regulate water intake via 
the MR. It is interesting in this regard that Lorens et al. (1971) 
found that electrolytic midbrain raphe lesions produced transient 
increases in water consumption. 
Effects on Reinforcement Processes and Pituitary-Adrenal Axis 
Preliminary studies in our laboratory, using the conditioned 
place preference paradigm, suggest that intra-MR infusions of muscimol 
induce aversive effects, whereas DiMe-C7 injections may produce reward-
ing effects (Lee, J. et al., 1987). Infusions of muscimol into the MR, 
furthermore, were found to produce dose - dependent increases in the 
plasma levels of ACTH and corticosterone. These pituitary-adrenal 
hormones are secreted as a result of an animal's exposure to aversive 
or stressful stimuli (Bassett et al., 1973; File and Peet, 1980; Natel-
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son et al., 1987). In contrast, MR infusions of DiMe-C7 do not alter 
the plasma levels of these hormones. 
Neurochemical Effects 
Muscimol has been shown to produce several behavioral effects 
when infused into the midbrain raphe, including hyperkinesis, hyper-
phagia, and hyperdipsia, as well as endocrine and electrophysiological 
changes. It has been reported that raphe-GABAergic neurons modulate 
forebrain 5-HT and DA turnover (Forchetti and Meek, 1981; Nishikawa and 
Scatton, 1985 a,b; Nishikawa et al., 1986). 
The effects of intra-MR infusions of the neurokinins on 5-HT 
turnover have not been thoroughly examined. One study has reported 
that intra-MR administration of high doses of SP (4.0 and 10 µg) pro-
duces an increase in 5-HT turnover in the hippocampus, measured as an 
increase in 5-HIAA concentration (Forchetti and Meek, 1982). This 
study, as well as preliminary evidence obtained in our laboratory using 
DiMe-C7, supports the view that the neurokinins modulate the activity 
of 5-HT neurons. 
Neuroanatomical Considerations 
Locomotion is composed of a complex series of neuronal events 
which involve spinal and brain stem signals which are monitored by 
cortical and diencephalic messages. Spinal feedback, as well as sen-
sory input, can modulate any component of the circuit. Although the 
basic locomotor pattern generator involves a hard-wired spinal circuit, 
locomotion is dependent upon supraspinal influences (Carew, 1985; Arm-
r 
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strong, 1986). Some of the major supraspinal messages come from the 
mesencephalic and subthalamic locomotor regions, the nigrostriatal and 
mesoaccumbens DA systems, the pontomedullary locomotor sites, the red 
nucleus and rubrospinal tract, and the cerebellum (Armstrong, 1986) . 
. To implicate the MR in a complex series of neuronal connections, such 
as those involved in locomotion, requires anatomical documentation. 
The anatomical findings obtained in the present study will be discussed 
in relation to known locomotor circuits. 
Mesencephalic Locomotor Region 
A "mesencephalic locomotor region" has been localized in the 
posterior midbrain. Electrical stimulation of this region induces 
locomotion in cerveau isole cats (Grillner and Shik, 1973). The anat-
omy and physiology of this region had been studied extensively by Gar-
cia-Rill and colleagues (Garcia-Rill et al. , 1983 a, b; Garcia-Rill, 
1983; Garcia-Rill and Skinner, 1987 a,b). An homologous region, pri-
marily involving the pedunculopontine nucleus (PPTg), has been demon-
strated in the rat (Skinner and Garcia-Rill, 1984; Garcia-Rill et al., 
1987). GABA neurons appear to play an important role in the modulation 
of locomotor movements by this area (Imperato and DiChiara, 1981; 
Childs and Gale, 1983; Garcia-Rill et al., 1985). The mesencephalic 
locomotor area, furthermore, is reciprocally connected with the nucleus 
accumbens, entopeduncular nucleus, and motor cortex (Garcia-Rill et 
al., 1981, 1983, 1985; Saper and Lowey, 1982; Brudzynski and Mogenson, 
1985; Brudzynski et al., 1986; Yang and Mogenson, 1987; Swerdlow and 
Koob, 1987; Scarnati et al., 1987). The mesencephalic locomotor area 
r 
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and basal ganglia also appear to be functionally interconnected (Gar-
cia-Rill, 1986). 
There have been no reports, to our knowledge, concerning the 
relationship between the MR and the PPTg in the rat. The present 
anatomical study represents the first observation of a direct link 
between the PPTg and the MR. Previous studies have indicated that a 
number of cells in the PPTg contain choline acetyltransferase (Sofron-
iew, 1985 a, b) and NADPH-diphorase (a marker reputably specific for 
cholinergic neurons in the PPTg; Goldsmith and van der Kooy, 1988), 
suggesting that the PPTg may be the source of a cholinergic projection 
to the MR. Additional electrophysiological and lesion experiments are 
needed to verify the functional relationship between these brain stem 
nuclei. 
Subthalamic Locomotor Region Connections 
Another region which has been implicated in locomotion is the 
"subthalamic locomotor area" (Armstrong, 1986). This diencephalic area 
comprises the fields of Forel, the subthalamic nucleus, zona incerta, 
lateral hypothalamus, and the mammillary nuclei (see Armstrong, 1986). 
These structures have been shown anatomically and physiologically to 
project to and modulate neuronal activity within the PPTg (Swanson et 
al., 1984, 1987; Mogenson et al., 1985; Mogenson and Wu, 1986). As 
discussed previously (p. 143), several components of the subthalamic 
locomotor area have reciprocal connections with the MR, including the 
zona incerta, the lateral hypothalamus, and the mammillary nuclei. 
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Therefore, connectivity with the subthalamic locomotor area provides 
another means for MR neurons to communicate with motor circuits. 
Lateral Hypothalamic Locomotor Connections 
Electrical stimulation of the lateral hypothalamus has been shown 
to affect locomotion (Gross and Sinnamon, 1986; Sinnamon and Stopford, 
1987; Sinnamon et al., 1987). The relationships between this region 
and the ventromedial midbrain have been examined (Sinnamon et al. , 
1987; Sinnamon and Stopford, 1987). It would appear that the MR and 
adjacent structures may be involved in the locomotion induced by elec-
trical stimulation of the lateral hypothalamus. Lesions of the dorsal 
midbrain, including the PPTg, did not affect electrically stimulated 
lMA (Sinnamon and Stopford, 1987). Sinnamon and colleagues (1987) 
present evidence that electrical stimulation of the midbrain raphe can 
produce a variety of locomotor effects, ranging from facilitation to 
inhibition when observed in the presence or absence of concurrent 
hypothalamically-induced locomotion (Sinnamon et al., 1987). Two 
caveats apply to this type of research: 1) the effects were observed in 
anesthetized preparations and thus may not necessarily reflect loco-
motion in awake animals; and, 2) electrical stimulation produces both 
antidromic and orthodromic activation of fibers of passage, as well as 
stimulation of interstitial cell bodies. Thus, interpretation of these 
experiments can be quite difficult. 
r 
r 
-
178 
Association with the Mesotelencephalic DA Systems 
The mesotelencephalic DA system is composed of the mesostriatal 
and mesolimbocortical DA systems, originating in the A8-10 DA cell 
groups (Bjorklund and Lindvall, 1984). A vast amount of literature has 
accumulated in recent years implicating the mesencephalic DA cell 
groups and their terminal regions in locomotion. A number of inves-
tigators also have implicated MR-5-HT neurons in the regulation of 
these pathways (Chase, 1974; Jacobs, 1974; Dray et al 1976; Hery et 
al., 1980; Lee and Geyer, 1984 a,b; DiSimoni et al., 1987; Herve et al, 
1987; Lee, E.H.Y. et al., 1987; Mori et al., 1987). The mesencephalic 
DA regions are reciprocally connected with the MR. MR afferents orig-
inating in the ventral tegmental area, substantia nigra, retrorubral 
fields, and rostral and caudal linear nuclei were observed in the 
present study. The dopaminergic nature of these afferents remain to be 
elucidated. 
The dependence of the MR-neurokinin induced hyperactivity on 
ascending mesotelencephalic DA systems has yet to be evaluated. How-
ever, the behavioral evidence obtained in the present study suggests 
that the hyperactivity elicited is mediated by 5-HT--DA interactions in 
one of these systems. First, the hyperactivity produced by activation 
of an NK-3 receptor was not affected by destruction of ascending 5-HT 
fibers rostral to the mesencephalon, but was blocked by destruction of 
5-HT neurons within the MR. Therefore, a 5-HT projection to either the 
ventral tegmental area or substantia nigra may mediate intra-raphe 
neurokinin induced LMA. Secondly, pretreatment with the DA antagonist, 
haloperidol, can block the effects of DiMe-C7. The 5-HT innervation of 
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the substantia nigra has been proposed to originate in the MR (Dray et 
al., 1976, van der Kooy and Hattari, 1980; Mori et al., 1987). How-
ever, recent anatomical evidence suggests that the DR is the primary 
source of nigral 5-HT afferents (Wirtshafter et al., 1987 b). The 
-
available anatomical evidence indicates that 5-HT neurons innervate the 
VTA (Herve et al., 1987; Oades and Halliday, 1987). Therefore, MR 
neurokinin-induced hyperactivity may be mediated by a 5-HT projection 
to the ventral tegmental area. In order to test this hypothesis, one 
could use 6-0HDA to selectively destroy DA cell bodies of the ventral 
tegmental area, and substantia nigra, then evaluate the effects of 
intra-MR neurokinins. Such studies are in progress. 
Medial Frontal Cortical Projections and LMA 
The medial aspects of the prefrontal cortex have been implicated 
in a number of psychological processes, including spatial problem 
solving, drive inhibition, and the temporal sequencing of appropriate 
behaviors (Brutkowski, 1965; Kolb 1974, 1984; Fuster, 1985; Herrmann et 
al., 1985; Vives et al., 1986). This region, furthermore, has been 
associated with visceral motor function (Terrebery and Neafsey, 1983). 
Although lesion data suggest that the medial frontal cortex modulates 
LMA (Kolb, 1974), it would appear that this region probably is not 
involved in locomotion per se. Rather, it appears to be critical for 
integrating spatial, temporal and environmental stimuli (see Kolb, 
1984; Brutkowski, 1965; Herrmann et al., 1985; Fuster, 1985). Since 
the medial frontal cortex provides a rather substantial projection to 
the MR (this study and Leonard, 1965), it is possible that this cort-
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ical region plays an important role in the processing of external 
stimuli during physiological and drug-induced locomotion. 
The involvement of the medial frontal cortex in the regulation of 
an organism's response to significant environmental stimuli is further 
suggested by the widely reported, but little understood, stress-induced 
increases in frontal cortical DA metabolism (Thierry et al., 1976; Lav-
ielle et al., 1978; Blanc et al., 1980; Bannon and Roth, 1980; Reinhard 
et al., 1982; Herman et al., 19.82; Claustre et al., 1986; D' Angio et 
al., 1987). The neurokinins have been shown to regulate frontal corti-
cal DA turnover via their modulation of DA neurons in the rostromedio-
ventral mesencephalon (Bannon et al., 1983, 1986; Elliott et al., 
1986). These changes in DA turnover are not due to locomotion per se, 
since rats trained to run in a wheel exhibit increases in DA metabolism 
in the neostriatum but not in the frontal cortex (Speciale et al. , 
1986). As the LMA effects of intra-raphe neurokinin administration may 
be mediated by DA neurons within the ventral tegmental area, it is pos-
sible that intra-MR neurokinin administration will affect DA metabolism 
in the frontal cortex as well. 
Conclusions 
Anatomically, the MR is in a position both to modulate and to be 
modulated by a number of regions involved in the regulation of motor 
function. The heterogeneity of the locomotor responses observed in the 
present study reflects the complexity and diversity of the afferent 
modulation of MR neurons and their projections. 
SUMMARY 
The overall objective of the dissertation project was to inves-
tigate the origin and functional role of the neurokinin innervation of 
the median raphe nucleus (MR) in the rat. The neurokinins (SP, NKA, 
and NKB) are found in mammals and are members of a family of struc-
turally related bioactive peptides called tachykinins. The non-mam-
malian tachykinins include eledoisin, kassinin, and physalaemin. The 
neurokinins have a distinct distribution of binding sites (NK-1, NK-2, 
NK-3) in the CNS. The neurokinins and their recognition sites, fur-
thermore, have been localized within the midbrain raphe nuclei. The 
specific aims of the project were to determine: 1) the behavioral 
effects of direct injection of the neurokinins into the MR; 2) which 
neurokinin(s) is (are) involved; 3) if the behavioral effects depend on 
the integrity of raphe 5-HT neurons; and, 4) the origin of the neuro-
kinin innervation of the MR. 
Our laboratory was the first to show that intra-raphe injections 
of a neurokinin agonist, the metabolically stable SP analogue, DiMe-C7, 
produce dose-dependent increases in locomotor activity which are depen-
dent upon intact midbrain 5-HT neurons. This neurokinin induced be-
havioral activation can be blocked by administration of the dopamine 
(DA) antagonist, haloperidol. In the present study, the dose-dependent 
behavioral effects of the mammalian and non-manunalian tachykinins and 
the neurokinin B agonists, DiMe-C7 and senktide, were compared. Unfor-
tunately, non-neurotoxic antagonists currently are not available so 
181 
182 
that the neurokinin recognition site(s) involved could be further 
characterized. 
The dose-response analyses suggested that behavioral arousal can 
be induced by activation of MR NK-3 sites with senktide and DiMe-C7, 
and by activation of MR NK-2 sites with NKA. lntra-raphe injections of 
the serotonergic neurotoxin, 5,7-DHT, prevented the hyperactivity pro-
duced by infusions of DiMe-C7, NKA and senktide into the MR. In con-
trast, previous studies demonstrated that similar lesions did not block 
the hyperactivity induced by intra-raphe administration of the GABAA 
agonist, muscimol. 5,7-DHT lesions of the 5-HT fibers which ascend in 
the median forebrain bundle, rostral to the mesencephalic DA cell 
groups, however, did not block the increases in activity produced by 
senktide or DiMe-C7, but did attenuate the hyperactivity produced by 
NKA. These results suggest that the increases in locomotor activity 
induced by senktide may be mediated by a 5-HT projection to the ventral 
tegmental area and/or the substantia nigra, while the effects produced 
by NKA may be mediated, in part, by 5-HT fibers which innervate the 
forebrain. Additional studies are needed in order to confirm this 
hypothesis. 
Analysis of the animals' behavior in an open field arena led to a 
further differentiation of the effects of senktide and NKA following 
their injection into the MR. Senktide produced elevated activity 
levels when the animals were placed in a novel environment, while NKA 
induced an increase in exploration only in a familiar environment. 
Thus, it is possible that neurokinin--5-HT interactions in the MR may 
regulate emotional tone and motivational processes. The behavioral 
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arousal induced by intra-raphe muscimol administration is associated 
with feeding behavior and increases in plasma ACTH and corticosterone 
levels which are not dependent on intact 5-HT neurons. In contrast, 
the behavioral activation produced by infusions of either DiMe-C7 or 
senktide into the MR are not accompanied by either feeding or changes 
in plasma hormone concentrations. It remains to be seen if intra-raphe 
injections of NKA, or a specific NK-1 agonist, such as septide, would 
affect ingestive behaviors or pituitary-adrenal function. 
Retrograde tracing studies (utilizing the fluorescent dye, 
Fluoro-Gold) were performed in order to determine the origins of the 
afferent projections to the MR. Several of the brain regions found to 
project to the MR have been implicated in the regulation of motor func-
tion. Although further studies are necessary, these data provide an 
anatomical basis for the possible role of the MR in the initiation, 
sequencing, and maintenance of distinct behavioral patterns. 
Fluorescence immunocytochemistry and HPLC-RIA confirmed previous 
reports that fibers containing neurokinin-like substances are located 
within the midbrain raphe. However, combined neurokinin immunocyto-
chemistry with Fluoro-Gold retrograde tracing did not reveal the ori-
gin(s) of the neurokinin input to the MR. Brain stem regions were 
found which contained both retrogradely labeled cells and neurokinin 
immunoreactive neurons, namely, the dorsal raphe nucleus, the inter-
peduncular nucleus, the rostral central gray, and the laterodorsal 
tegmental nucleus. Unfortunately, clear-cut evidence for double label-
ing in these structures was not obtained. The neurokinin neurons which 
project to the MR remain to be demonstrated. 
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The imrnunocytochemical studies indicated, furthermore, the need 
to refine the approach used to visualize neurokinin cell bodies in var-
ious CNS regions. Further studies should include the use of intra-
cerebral injections of colchicine to arrest axonal transport, and the 
development of histochemical techniques which would optimize the stain-
ing of neurokinin-like substances in distinct brain regions. 
Future studies also should examine the electrophysiological ef-
fects of the neurokinins on 5-HT and non--5-HT neuronal activity in the 
midbrain raphe. This would allow a more complete understanding of the 
physiology of raphe neurokinin/5-HT interactions. 
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Peptide Analysis and Preparation 
Documentation concerning the purity and content of each peptide 
was supplied. Most of the batches contained > 84% of the peptide. In 
these cases, no corrections were made for determination of molar con-
centrations. One batch of neurokinin A, however, had a peptide content 
of only 76%. A correction was made to obtain the proper stock sol-
ution, as noted below. 
1.) Vehicle: 0 .1 M phosphate buffered saline (PBS) with 0. 01 M 
acetic acid added, pH 7. 2 (350 ml PBS and 150 ml 
0.01 M acetic acid) 
2.) Preparation of Stock Solutions: 
DiMe-C7 (MW 880.13): 
5.0 mg lyopholyzed peptide is dissolved in 250 µl 0.01 M acetic 
acid. Once dissolved, 585 µl PBS is added. 
Stock concentration - 6.0 ug/ul - 7.0 nmol/ul 
Senktide (MW 842.1): 
1.0 mg lyopholyzed peptide dissolved in 400 µl 0.01 M 
acetic acid, followed by 100 µl PBS. 
OR: 5. 0 mg dissolved in 2000 µl acetic acid followed by 
500 µl PBS. 
Stock concentration - 2.0 ug/ul - 2.4 nmol/ul 
Neurokinin A (MW 1133.48): 
Batch 1: 5.0 mg lyopholyzed peptide dissolved in 300 µl 0.01 
M acetic acid, followed by 535 µl PBS. 
Batch 2: Since the biochemical analysis provided by the 
manufacturer indicated< 80% purity (see below), a 
correction was made: 
5.0 mg supplied (0.76) - 3.8 mg actual, dissolved in 
200 µl 0.01 M acetic acid followed by 435 µl PBS. 
Stock concentration - 6.0 ug/ul - 5.3 nmol/ul 
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Substance P (MW 1347.80): 
5. 0 mg lyopholyzed peptide was dissolved in 1000 µl 0. 01 M 
acetic acid, followed by 500 µl PBS. 
Stock concentration - 3.3 ug/ul - 2.4 nmol/ul 
Eledoisin (MW 1188.57): 
5.0 mg lyopholyzed peptide dissolved in 1300 µl 0.01 M acetic 
acid, followed by 235 µl PBS. 
Stock concentration - 3.3 ug/ul - 2.8 nmol/ul 
Kassinin (MW 1334.74): 
5.0 mg lyopholyzed peptide dissolved in 1200 µl 0.01 M acetic 
acid, followed by 235 µl PBS. 
Stock concentration - 3.5 ug/ul - 3.1 nmol/ul 
Physalaemin (MW 1265.61): 
5. 0 mg lyopholyzed peptide was dissolved in 250 µl 0. 01 M 
acetic acid, followed by 535 µl PBS. 
Stock concentration - 6.0 ug/ul - 4.7 nmol/ul 
Neurokinin B (MW 1210.58): 
4. 0 mg lyopholyzed peptide dissolved in 100 µl, 88% formic 
acid, followed by 800 µl 9.8 mM PBS, pH 11.0 (final pH 3.8). 
Stock concentration - 4.4 ug/ul - 3.6 nmol/ul 
Vehicle: 10 ml 88% formic acid and 80 ml PBS (pH 11.0). 
Final pH - 3.8. 
Note: Peptide stock solutions were divided into aliquots and 
stored in polyethylene tubes frozen at o0 c. On a drug 
day, the peptides were thawed, and appropriate molar 
dilutions made. All solutions were kept cool and dark 
until used. 
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3.) Manufacturers Purification and Content Analysis: 
DiMe-C7 (Peninsula Laboratories, Belmont CA): All DiMe-C? used 
was from the same lot number, although purchased separately. 
c- 7473 m Loi 011045 ti 5rng !r : i 
·11 g. 
~ [pGlu 5 ,XePheB,sar9] i' -~ i! ,b 
!t. (Substance p 5-11) !~ \~ 
•11T.,...,.War a.- C. W001t•1•1Ht..._. ii 
PENINSULA LABORATORIES, INC. 
QUALITY CONTROL RECORD 
i 
PENINSULA LABORATORIES, INC. 
I 
I ::::g ~:~lu~:::_Phe8 , Sar9J Substance P (5-11) l ,-.... ~"u' p0>•-0>•-"•-<,,._,...,_,.,_._.._ .. ,_,., 
,
,.'.· LOT ANALYSIS: 
::_::_: :::c~YER CHROMATOGRAPHY 
_ F (nBuOH:Pyr:H0Ac:H2o, 15:10_:3:12) o-tol1dine 
_!:~· Result.s: Single spot running Yith the nandard. Rf • 0. 67_ 
L. Silica . Fm (nBuOH:Pyr:H(!Ac:H20, 15: 15: 3: 12) o-tolidine j;;~ .. 
~:;t Results: !,, 
!" 
Single spot running Yith the standard. Rf • 0.67 
i: ELECTROPHORESIS 
!· j .. l.'hatman 3 MM; pH 1.9(HCOOH:Acet); 1000 V, 1 hr.; o-tolidine 
Dale: September 29, 1986 
Lot No.: 011045 
M. W.: 880.13 
f 
I 
! 
Results: Single spot traveling Yith the standard toYard the cathode. 
Rf • 0.07 Yith reference to Arginine. 
AMINO ACID ANAI.YSIS 
Chromatogram I 63-1402 92. 6 : peptide 
Certified by· 
Theory 
NH Cl~ 
Met 
Leu 
Phe 
Sar 
N!':e-Phe 
c. 4~ p./$'0/ 
I 
2 
2 
I 
I 
I 
1 
I 
Ouahty Control Manager 
Found 
1. 81 
l. 94 
l.00 
0.99 
1. 06 
0.71 
* * The value of NHe-Phe is not de-
termined by Amino Acid Analysis. 
Note: All peptides should be stored in 
a cool & dry place until in use. 
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Senktide (Bachem, Torrance, CA): All Senktide used was from the 
same lot number, although purchased separately. 
BACHEM1NC. 
FINE CHEMICALS 
Certificate of Analysis 
PRODUCT: Senktide 
LOT NUMBER: 655C RELEASE DATE: December 1986 
STRUCTURE: Succinyl-Asp-Phe-N-MePhe-Gly-Leu-Met-NH 2 
MOLECULAR WEIGHT: 842.l 
APPEARANCE: White powder 
AMINO ACID ANALYSIS: 
Asx 0.95 
Glx 
Ala 
Met LOO 
'Tyr 
Lys 
Thr 
Pro 
Cys 
Ile 
Phe 0.97• 
Arg 
•N-MePhe • Present, but not quantitated 
PEPTIDE CONTENT: 83.8\ (~3\) 
Ser 
Gly 
Val 
Leu 
His 
Trp 
PEPTIDE PURITY: >99\ (See attached HPLC trace) 
AU~G/~ 
BACHEM, INC. Y 
.............. .._ .. 
LOO 
LOO 
1112 ~& n1llCIT. ~CA IOIOI 
11~1n TWl tteaMr-na a40tP' n.c 
•MOM l'TMl'T. a...n-o. w.w..oet, ...a ca,.,,.. 
ftL.L ,,.,..,...... 1U. ttDOl 9.ACfllll. 
' i. 
I 
j : 
/· 
I: 
I 
Pi;H(I 
I 
z 
Tl ni: A~£.:1 
2Z.032 
t2 .. ,;,. 67JOts 
lZS'e 
TOTAL -·-----£7;:~18 
hi;: 
.:i.:r . - --· . -----Gl'l!.~!Ei<"!" .:!!_~.=57.~--·--·-----
cc:.:.,;: .. ~:<:_~)'~ .!L~. '(f.~.~-''-----
s~: ::_'!.:.{£...:: : .... ?.rf/Lt..71;,:._r. _ _ 
J:.ii-1. i.;;"J.~~~--VV Fi.;:;:;;_L-3:_ __ ~.iliH. 
001'-:E Ei'f· ~ _;,~TC.: .R-~7J7, 
CC•llC 
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Neurokinin A (Peninsula and Bachem): 
1~ QUALITY CONTROL RECORD PENINSULA LABORATORIES, INC. 
•ft Calalog No. 
Name: 
! 
7359 Date:June 17, 1986 
a-Neurokinin (Neuromedin L, Substance K) Lot No.: 010251 
\ Sequence: His-Lys-Thr-Asp-Ser-Phe-Val-Cly-Leu-Het-NH 2 M. W.: 1133. 48 
I 
I 
· .. r; 
. ,j· 
LOT ANALYSIS: 
Thin Layer Chroll"1tographv: 
Cellulose F: nBuOH:Pyr:H0Ac:H20 15:10:3:12 
Silica nBuOH:Et0Ac:HOAc:H20 1:1:1:1 
Silica Fm: nBuOH:Pyr:HOAc:H20 6:6:1.2:4.8 
Reaulta: Fm: Single spot. Rf • 0.56 
F: &ingle •pot. Rf• 0.75 
Electrophoresis: 
llhatman 3HM Pyr:Acet.,pH3.S; lSOOV., 1 hr. 
Ninhydrin 
Ninhydrin 
Ninhydrin 
Ninhydrin 
Results: Single spot traveling towards the cathode. 
Rf • 0.60 with reference to arginine. 
A~INO ACID ANALYSIS: 
Chro111atogram No. ~ % of Peptide 88.7% 
Theory· Found Theory Found 
Lys 1 1.00 
His 1 0.81 
:>H3 l 1.09 
Asp 1 1.02 
Thr l 0.95 
S.:r 1 1.04 
Cly 
Val 
Mt!t 
Leu 
Phe 
1 
1 
l 
l 
1 
0.98 
0.91 
1.07 
l. 08 
0.95 
Carlified by: __ 6._._c:._·6_w-=-~..:.;;;.,f"·'----
Quality Control Manager 
.... 010251 
Smg 
Neurokiu;.~"1 A (Neuro111~l::..n L, 
!Jubstauc1~ K) 
w a a: 11aw1 •.1 •.q.1 ;r.s i·MPfJ m 
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b BACHEM,H;. FINE CHEM.ICALS 
·_ Certificate of Analysis 
PROD•JC'l:,: Substance JC (alpha-Neurokinin) 
LOT ~UMBER: 5468 RELEASE DATE: December 19€5 
STRUCTURE: H 2 N-His-Lys-Thr-Asp-Ser-Phe-:Val-Cly-Leu-Met-l~?.2 
:~OLECULAR WEICHT: 1133.S 
APPEARANCE: White powder 
AMINO ACID ANALYSIS; 
ASX 1.00 Tnr l.00 Ser 0.68* 
Cl.JC Pro' Cly l.01 
Ala 
Met 098 
' Tyr 
Lys l.02 
Cys 
Ile 
Phe 1.00 
Arg 
Val 1.04 
Leu 0.!9 
His 0.99 
Trp 
*Partially destroyed during acid hydrolysis 
PEPTIDE CONTENT: 76.48\ 
-PEPTIDE PURITY: >99\ 
........... 
1,N ........... ITllU'f. ~CA -
., ...... ,,, TWl., ..... ,.,....~n.c 
HA CHEM/Ne. NE CHEMICALS 3132 Kasruwa Strttel Torrance. Cattt. 90505 
OTY SMG LOT• 5468 
l!,3\ I 
(See attached HPLC trace) 
./ 
_.,. . 
..... ~ . ..,..,.,..~Dau QI" 1M 
Ta.Lcnwt ..... TUl1TIM~e 
a-Neurokinin {Substance K, 
Neurornedin L) 
HOT "OR HUMAN USE 
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,,/ 
J oloha-Neuroklnln,Substance K,Neromed!n L 
1 at#546B 
START 00.00.00.00. 
C-RlB 
S~IPL II 
FILE II 
P.EPT ll 
METHOD 
AT"TEH 
11.63 
STOP 
(10 
1 
5(•65 
41 
II HAME TIME 
e:. 10.% 
e 11.63 
TOTAL 
12/3/85 
COHC MK 
,9.•442 
0.5557 y 
100 
Dr. Cioud 
...( Nciu.tu.W'lllcl.:~ 
as' 
-tel) IS-~ 
F1REA 
122219 
602 
122902 
• 1.~ FJ.cW /·;;......,_ 
.110"-~ 
A-IUP ?·11 .9·3 
S· C.Y.:!.CtJ • 
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Substance P (Peninsula): 
QUALITY CONTROL RECORD 
PENINSULA LABORATORIES, INC. 
111 TA.YLOll; WAY. HLWONT, ~L"· lotOOJ • tu.a HloUll • IMOJ 1n.1111 • TILU NO. uun 
Catalog No. 7451 Date: February 17, 1987 
.Name: Substance P 
Sequence: Arg-Pro-Lys-Pro-Cln-Cln-Phe-Phe-Cly-Leu-Het-NH2 
LOT ANALYSIS; 
THIN LAYER CHROMATOGRAPHY: 
Silica F (nBuOH:Pyr:HOAc:H20, 15:10:3:12) Ninhydrin 
Silica Fe (nBuOH:Pyr:H0Ac:H20,21:12:2:15) Ninhydrin 
Silica Fm (nBuOH:Pyr:HOAc:H20, 15:15:3:12) Ninhydrin 
P.esults: F Single spot running •lightly behind the standard. 
Fe Single spot running •lightly behind the standard. 
Fm Single spot running vith the standard. 
ELECTROPHOP.ESIS: 
llhat11&n 3HH, pH 3.S(Pyr:Acet.); lSOOV. lhr. Ninhydrin 
Lot No.: 011989 
M.W.: 1347.80 
R! • 0.36 
Rf • 0.29 
Rf • 0.54 
Results: Single spot running vith the standard toward the cathode. 
Rf•0.76 vith reference to Arginine. 
AMINO ACID ANALYSIS: 
Chromatogram No. 63-2775 % of peptide 86.3% 
Theory Found 
Lys l l.04 
NHJ 3 2.91 
Arg l l.18 
Clu- 2 2.08 
Pro 2 l. 97 
Cly l 0.91 
Met l 0.85 
L•u 1 l.01 
Phe 2 l.94 
Certified by: t:· awt.c;t 
Ou.alily Control Manager Note: All peptides should be stored in 
a cool & dry place until in use, 
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Subs-::iince P 
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Neurokinin B (Peninsula): 
QUALITY CONTROL RECORD 
PENINSULA LABORATORIES, INC. 
111 TA.YLO« WA'f, lfl.MOMT, (;AL". '6001 • f4U.J ff2..UH • ,.., ID·U11 • nu:x NO. """ 
Catalog No. 7357 
. Name: Neurokinin 8 (Neuromedin K, Neurokinin s) 
Date: Much 28, 1985 
Lot No.: 0074 72 
! i Sequence: Asp-Met-Hi s-Asp-Phe-Phe-Va 1-Gly-Leu-Met-NH2 M. W.: 1210. 58 I Note: Dissolve in ss:.fonaic acid and dilute with desired buffer. 
LOT ANALYSIS: 
Thin Layer Chromatography: 
Silica n8uOH:EtOAc:HOAc:H 20 (1 :1 :1 :1) Ninhydrin 
Results: Single spot migrating the same as the standard. 
Electrophoresis: 
Whatman 31111 HCOOH:Acet.,pHl.9; lOOOV., 1 hr. 
Results: Main spot with tailing. 
Rf • 0.42 with reference to arginine. 
AMINO ACID ANALYSIS: 
Chromatogram No. CL-7108 % of Peptide 94: 
Theory "Found 
His 1 1.04 
NH3 1 1.28 Asp 2 1. 98 
Gly 1 1.02 
Val 1 1.03 
Met 2 2.08 
Leu 1 0.93 
Phe 2 2.06 
Ninhydrin 
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(Neurornedin K) 
... 007472 
Smg 
., ' ,.,,_ .. ..,. ~ c. .. oot .. ,., •• , .. :.., 
-~pr3~1~!Mi"'i'f~jri1~1ri1.,.1ri1ri.,~,~!~·")"!';'f~.\l"~,"!'.')'!";l"l'"{~ii•"'i"'i"! .. •g 
Eledoisin (Peninsula) 
Catalog No. 7101 Oa~:october 9, 1986 
Name: Eledoisin Loi No.: 011073 
Sequence: pClu-Pro-S~r-Lys-Asp-Ala-Phe-Ile-Cly-Leu-Het-NH2 M.W.: 1188.57 
LOT ANALYSIS: 
i Thin Laver Chrom.Hographv: 
J Cellulose Fe: nBuOH:Pyr:H0Ac:H20 42:24:4:30 o-tolidine 
~ 
l 
·I 
I 
\ 
Silica Fm: nBuOH:Pyr:HOAc:H20 6:6:1.2:4.8 o-tolidine 
Results: Fe: Single spot running slightly ahead of the standard. Rf• 0.71 
Fm: Single spot running with the standard. Rf • 0.64 
Electrophnresis: 
\Jhatman )HM HCOOH:Acet •• pHl.9; lOOOV.,l hr. o-tolidine 
Results: single spot running vith the standard towards the cathode. 
Rf • 0. 24 with reference to Arginine. 
AH I NO ACID ANALYSIS: 
Chromatogram No. 6,-1439 % of Peptide 90.5% 
Theory Found Theory Found 
Lys l 0.98 Cly l l. 05 
NH3 l l. 60 Ala l l.03 Asp l 0.95 Het l 0.99 
Ser· l 0.93 Ile l l.00 
Clu l l.04 Leu l l.04 
Pro l 0.96 Phe l 0.95 
Certified by: __ C_c,._·k,-"-1</-r_~_,,,.,'-----­z 
Quality Control Manager 
NOTE: Peptides should be stored in a 
cool & ~ry area until in use. 
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Kassinin (Peninsula) 
QUALITY CONTROL RECORD 
PENINSULA LABORATORIES, INC. 
i Catalog No. 7111 
\ 
Date: September 19, 1986 
I 
l 
l 
f 
f 
J 
t 
' 
Name: Kassinin 
Sequence: Asp-Val-Pro-Lys-Ser-Aip-Cln-Phe-Val-Cly-Leu-Het-NK2 
LOT ANALYSIS: 
Silica Fm: nBuOK:Pyr:HOAc:K20 6:6:1.2:4.8 
Silica nBuOK:Et0Ac:HOAc:H20 l:l:l:l 
Ninhydrin 
Ninhydrin 
Lot No.: 010902 
M. W.: 1334. 74 
Results: Fm: Main spot running vith the standard vith a faint lover and 
negligible upper spot. Rf ~ 0.54 
1:1:1:1 Main spot running with the standard with a faint lover spot. Rf • 0.50 
Electrophoresis: 
\lhatman 3MM KCOOH:Ac,,t.,pK 1.9; lOOOV.,l hr. Ninhydrin 
Results: Single spot running Yith the stand~rd towards the cathode. 
Rf • 0.36 vi ~h reference to Arginine. 
AHINO ACID ANALYSIS: 
Chromatogram No. ~ .. of Peptide 95.1% . 
Theory Found Theory Found 
Lys l l.07 Pro l l.09 
NK 3 2 2.05 Cly l l.00 Asp 2 l. 78 Val 2 2.00 
Ser l 0.89 Met l l.10 
Clu l l.06 Leu l l.08 
Phe l 0.99 
Certified by· __ C_. _e..,_·tc_IV--'~-'-.,.._-..,--
NOTE: Peptides should be stor"d in a 
cool & dry Area until in u~e. Ou•lily Conlrol Manager 
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~ QUALITY CONTROL RECORD PENINSULA LABORATORIES, INC. 
Catalog No. 
Name: 
7110 
J>hysalaemin 
Date: April 16, 1986 
Lot No.: 0098 70 
Sequence: pGlu-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NH2 
LOT ANALYSIS: 
Thin Laver Chromatographv: 
Silica nBuOH:Et0Ac:HOAc:H20 l:l:l:l 
Silica F: nBuUH:Pyr:HOAc:H 20 ·15:10:3:12 
Silica Fm: nBuOH:Pyr:HOAc:H20 6:6:1.2:4.8 
l'inhydrin 
Ninhydrin 
Ninhydrin 
Results: F: Single spot running with the standard. Rf • 0.49 
M.W.: 
Fm: Single spot running with the stand~rd. Rf • 0.63 
l:l:l:l Sini,:le ~pot.running with the standard. Rf• 0.60 
Electrophoresis: 
'I/batman 3HM Pyr:Acet.,pH6.4; 1500V., l hr. Ninhydrin 
Results: Sin~le spot runnin; v1th the standard in the neutral zone. 
Rf • 0.~9 •!th refcrcnc~ to ar~ininc. 
A.~lSO ACID ANALYSIS: 
Chromatogram No. CL-10170 % of Peptide 90.3: 
Theory Found Theory Found 
Lys 1.00 Gly l 1.02 
NH 3 3.47 
Ala l 1.05 
Asp 1.82 Mot l 0.96 
Glu 1.09 Lcu l 0.94 
Pro 1.0~ Tyr l 0.95 
Phi! l 0.99 
Certified by· _ __.;;~_. _4...:;;_;' 6>=.;w=.:I',_,-..:=-="-tt~--
Oua111y Control Manag., 
1265.61 
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Cannulae Placements 
Experiments I - V: Tachykinin Dose-Responses 
Fig. A.: Location of cannula tips (black stars) in the animals used 
in Experiments I (b) V (f). Schematic diagrams of 
coronal sections separated by about 0.5 mm show the 
abbreviations of structures (a) and the cannula place-
ments. 
Abbreviations: 
aq: cerebral aqueduct 
cp: cerebral peduncle 
dr: dorsal raphe nucleus 
dtg: dorsal tegmental nucleus of Gudden 
ic: inferior colliculus 
ipn: interpeduncular nucleus 
ml: medial lemniscus 
mr: median raphe nucleus 
pag: periaqueductal grey 
pn: basal pontine nuclei 
rtp: reticular tegmental nucleus 
scp: superior cerebellar peduncle 
vtg: ventral tegmental nucleus of Gudden 
xscp: decussation of scp 
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Experiment VI: MR/MFB 5.7 DHT Lesions 
Location of cannula tips in the animals used in Exper-
iments VI. Schematic diagrams of coronal sections 
separated by about 0.5 mm show the abbreviations of 
structures in Fig. A. a) black circles - placements for 
control group; b) black squares - placements for MR lesion 
group; c) black triangles - placements for MFB lesion 
group. 
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Experiment IX: Neurokinin Habituated Open Field 
Location of cannula tips (stars) in the animals used in 
Experiments IX. Schematic diagrams of coronal sections 
separated by about 0.5 mm show the abbreviations of 
structures in Fig. A. 
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